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Abstract 
This thesis develops an integrated mathematical model for autonomic nervous system 
control on cardiovascular activity. As a working control system, with diverse feedback and 
feedforward loops interfering with each other, our integrative model is key to understand 
paradoxal phenomenon such as vagally-mediated tachycardia, fluctuation of sinoatrial rhythms 
on denervated heart, Mayer waves and tonic activity of sympathetic premotor pacemaker 
neurons. The model extensively covers cardiovascular neural pathways including a wide range 
of afferent sensory neurons, central processing by autonomic premotor neurons, efferent 
outputs via preganglionic and postganglionic autonomic neurons and dynamics of 
neurotransmitters at cardiovascular effectors organs.  
The results achieved in this work are challenging some established methods for assessing 
autonomic activity on the cardiovascular system, e.g. heart rate variability, blood pressure 
variability, baroreflex sensitivity and conventional mathematical models based on control 
theory. Most of these methods picture a reciprocal control of cardiac vagal and sympathetic 
nervous activity, and neglect simultaneous co-activation of both autonomic efferent branches. 
Furthermore they lack to integrate cardiovascular reflexes across their many levels of 
organization and therefore miss to exhibit emerging properties of the regulatory processes. 
We performed over 500 cardiovascular experiments using clinical autonomic tests on 72 
subjects ranging from 11 to 82 years old and collected typical cardiovascular signals such as 
electrocardiogram, arterial pulse, arterial blood pressure, respiration pattern, galvanic skin 
response and skin temperature. Next to a statistical evaluation in the time and frequency 
domains, the data were especially used to validate the mathematical model by resolving a 
constrained optimization task. Results bring evidences supporting the hypothesis that Mayer 
waves result from a rhythmic sympathetic discharge of pacemaker-like sympathetic premotor 
neurons. Simulation also show that vagally-mediated tachycardia, observed during vagal 
maneuvers on some subjects could be related to the secretion of vasoactive neurotransmitters 
by the vagal nerve. We additionally identified model parameters for estimating the resting 
sympathetic and parasympathetic tone which are believed to be linked to some pathological 
states. Results show higher vagal tone on young subjects with a decreasing trend with aging, 
what agrees with the data from heart rate variability studies. Tonic sympathetic activity was 
found to possibly emerge from pacemaker premotor neurons, but also from activation of 
chemoreceptors to a lesser extent. 
We include a software package as practical work product of this thesis for clinical 
applications. Our web-based telemedicine platform offers features for connecting doctors with 
remote patients, including signal processing, statistical evaluation and messaging. We extended 
the infrastructure with the design of biofeedback solution that upgrades a common mobile 
phone with low-cost sensors for skin temperature and finger pulse measurements, as well as a 
software module for uploading and downloading medical information and cardiovascular signals 
through internet. 
In summary this thesis offers a software and hardware application that could be useful in a 
clinical environment and proposes an integrative model of cardiovascular control that might 
help for educational and research purposes. The thesis also opens perspectives for future work 
including validating the markers of autonomic tone provided by our model against data from 
experiments with pharmacological blockers and invasive neural activity recordings. 
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 Abstract in Czech 
Tato práce pojednává o vývoji integrovaného matematického modelu řízení kardiovaskulární 
aktivity autonomním nervovým systémem. Vytvořený funkční model, využívající navzájem 
interferující řídicí mechanismy jak se zpětnou, tak i přímou vazbou, je klíčovým prostředkem 
k porozumění takových paradoxních jevů, jako jsou vagem zprostředkovaná tachykardie, 
kolísání sinoatriálního rytmu na denervovaném srdci, Mayerovy oscilace, nebo tonická aktivita 
sympatických premotorických pacemakerových neuronů. Model zahrnuje vliv mnohých 
neurokardiovaskulárních vedení, včetně velkého počtu aferentních senzorických nervových cest, 
centrálního zpracování pomocí autonomních premotorických neuronů, eferentních výstupů 
zprostředkovaných pregangliovými a postgangliovými nervovými vlákny i vliv dynamiky 
neurotransmiterů v kardiovaskulárních efektorech. 
Dosažené výsledky mohou být užitečné v diskuzi o některých klasických metodách hodnocení 
autonomní aktivity kardiovaskulární soustavy, jako jsou variabilita srdečního rytmu, variabilita 
krevního tlaku, baroreflexní senzitivita a konvenční matematické modely založené na teorii 
řízení. Nabízejí prostor pro další výzkumné aktivity, zejména při hodnocení markerů tonu 
autonomního nervového systému, stanovených pomocí vytvořeného modelu pro data pořízená 
při experimentech s farmakologickými blokátory, příp. s invazivně zaznamenávanou nervovou 
aktivitou. 
 
Abstract in French 
Cette thèse traite de l'élaboration d'un modèle mathématique intégré du contrôle exercé par 
le système nerveux autonome sur le système cardiovasculaire. Ce modèle représente le 
fonctionnement de divers mécanismes de régulation neurologique, interférant les uns avec les 
autres et est une clé pour comprendre des phénomènes paradoxaux, comme la tachycardie 
parasympathique, les fluctuations à haute-fréquence observées sur le nœud sino-auriculaire du 
cœur dénervé, les oscillations de Mayer, ou encore l'activité tonique des neurones 
sympathiques prémoteurs. Le modèle permet de simuler un grand nombre de voies neurales 
autonomes connues, y compris les voies neurales sensorielles afférentes, les voies neurales 
centrales autonomes, les sorties efférentes incluant les neurones pré-ganglionnaires et post- 
ganglionnaires, ainsi que la concentration des neurotransmetteurs au niveau des organes 
cardiovasculaires tels que ventricules, oreillettes, nœud sino-auriculaire, nœud auriculo-
ventriculaire et vaisseaux sanguins. 
Les résultats obtenus mettent certaines méthodes classiques d'évaluation de l’activité du 
système nerveux autonome sur le système cardiovasculaire à l’épreuve, tels que la variabilité du 
rythme cardiaque, la variabilité de la tension artérielle, la sensibilité baroréflexe, et les modèles 
mathématiques conventionnelles basés sur la théorie du contrôle.  
Ce travail offre des possibilités de poursuivre les recherches, en particulier dans l'évaluation 
des marqueurs du système nerveux autonome à l'aide des données acquises dans des 
expériences utilisant des inhibiteurs pharmacologiques. 
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Matthew 5.1-12 
The Beatitudes 
1
Now when he saw the crowds, he went up on a mountainside and sat down. His disciples came to him,  
2
and he began to teach them saying: 
3
Blessed are the poor in spirit, for theirs is the kingdom of heaven. 
4
Blessed are those who mourn, for they will be comforted. 
5
Blessed are the meek, for they will inherit the earth. 
6
Blessed are those who hunger and thirst for righteousness, for they will be filled. 
7
Blessed are the merciful, for they will be shown mercy. 
8
Blessed are the pure in heart, for they will see God. 
9
Blessed are the peacemakers, for they will be called sons of God. 
10
Blessed are those who are persecuted because of righteousness, for theirs is the kingdom of heaven. 
11
Blessed are you when people insult you, persecute you and falsely say all kinds of evil against you because of 
me. 
12
Rejoice and be glad, because great is your reward in heaven, for in the same way they persecuted the 
prophets who were before you. 
 
 
 
 
Matthieu 5.1-12 
Les Béatitudes 
1
Voyant la foule, Jésus monta sur la montagne; et, après qu'il se fut assis, ses disciples s'approchèrent de lui. 
2
Puis, ayant ouvert la bouche, il les enseigna, et dit: 
3
Heureux les pauvres en esprit, car le royaume des cieux est à eux. 
4
Heureux les affligés, car ils seront consolés. 
5
Heureux les débonnaires, car ils hériteront la terre. 
6
Heureux ceux qui ont faim et soif de la justice, car ils seront rassasiés. 
7
Heureux les miséricordieux, car ils obtiendront miséricorde. 
8
Heureux ceux qui ont le cœur pur, car ils verront Dieu. 
9
Heureux ceux qui procurent la paix, car ils seront appelés fils de Dieu. 
10
Heureux ceux qui sont persécutés pour la justice, car le royaume des cieux est à eux. 
11
Heureux serez-vous, lorsqu'on vous outragera, qu'on vous persécutera et qu'on dira faussement de vous toute 
sorte de mal, à cause de moi. 
12
Réjouissez-vous et soyez dans l'allégresse, parce que votre récompense sera grande dans les cieux; car c'est 
ainsi qu'on a persécuté les prophètes qui ont été avant vous. 
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Preface 
Historical Review 
The first known written description of the human heart and blood vessels appears around 
1600 BC in the Edwin Smith Papyrus. It is also the world's oldest surgical document, credited to 
have been written by the Egyptian Imhotep, the first engineer, architect and physician in history 
known by name [1]. Around 200 BC the Greek physician Galen identified venous (dark red) and 
arterial (brighter and thinner) blood, each with distinct and separate functions. The first known 
description of the pulmonary, capillary and coronary circulations and pulse is attributed to the 
Arabian physician Ibn al-Nafis in 1242 [2]. The English physician William Harvey improved this 
concept experimentally and described in details the systemic circulation in 1628 [3]. Giovanni 
Borelli first postulated the action of the heart to simulate a piston in the middle of 17th century 
and the idea that the arteries have to be elastic [4]. Richard Lower first described the muscular 
fibers of the heart in 1669. Thomas Willis discovered the internal brain carotids, and their 
communications with the branches of the basilar artery in the middle of 17th century. Stephen 
Hales described the effect of the elastic arteries in dampening the arterial pulse and performed 
the first measurements of in vivo blood pressure in horse in 1733 [5]. Jan Evangelista Purkyně 
discovers the Purkinje fibers in 1839 [6]. Claude Bernard established the scientific method in 
experimental medicine, defined the underlying principle of homeostasis, set the stage for 
cardiac catheterization and discovered the existence of vaso-dilator and vaso-constrictor nerves 
in 1851 [7]. DeCyon and Ludwig further demonstrated the ability of afferent nerves to influence 
the behavior of the cardiovascular system in 1867 [8]. Records of heart beat using electrodes 
attached to the chest were first reported by Alexander Muirhead in 1872.  The first 
measurement of monophasic action potential with an extracellular electrode placed on the 
surface of the heart was performed by Burdon-Sanderson and Page in 1883 [9]. Wilhelm His, Jr. 
discovered the bundle of His in 1893 and later recognized that the heartbeat has its origin in the 
individual cells of heart muscle [10]. The atrioventricular node is discovered later by Sunao 
Tawara in 1906 [11]. In 1913, Willem Einthoven designed a device for more precise 
measurements of surface body potentials originating from the heart, what will be the origin of 
modern electrocardiography [12]. Wiggers provided the first descriptions of the simultaneous 
electrical and mechanical events of a cardiac cycle in 1921 [13]. In 1921 Loewi proved 
experimentally that signaling across synapses is chemical and discovered to first 
neurotransmitter to be identified: acetylcholine [14]. He also clarified the blockade and the 
augmentation of nerve action by certain drugs. Hering discovered the carotid baroreceptors in 
1923 [15]. The relationship between baroreceptor firing rate and distension of the vessel wall 
was put in evidence by Bronk and Stella in 1932 [16]. The carotid sinus and aortic arch 
chemoreceptors and their influence on the chemical composition of arterial blood were 
revealed by Heymans in 1933 [17]. The relationship between kidneys and vasoconstriction was 
advanced by Goldblatt in 1934 [18]. In 1946, Alexander demonstrated that cardiac reflex 
functions originating from the medullary cardiovascular center [19]. Artrial mechanoreceptors 
were discovered in 1956 by Henry and Gauer [20]. Randall demonstrated the cardioaugmentor 
and cardioaccelerator pathways projecting to the heart in 1957 [21]. In 1961 Folkow and 
Mellander differentiated the aorta, arterioles, capillaries, small venules, larger venules and veins 
[22]. The fundamental basis of the Frank-Starling mechanism was revealed in 1966 [23]. In 1972 
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Guyton developed the first model of overall long-term circulation regulation including 
interactions of the heart, blood vessels, kidney, baroreceptor and chemoreceptor reflexes [24]. 
In 1979 Korner extended cardiovascular integration from the medulla to hypothalamic, limbic, 
and other forebrain regions, as well as to the spinal cord [25]. In the last quarter of 20th century, 
the emphasis has been on the molecular and cellular bases of cardiovascular function [26]. 
Motivation 
The autonomous nervous system (ANS) together with the hormone and central nervous 
system form the main regulators in human and animal organism. The autonomic division of the 
efferent nervous system influences a great number of life situations at rest, exercise or illness. 
This so-called vegetative nervous system or visceral nervous system controls internal organs, 
which are not under voluntary control (especially smooth muscles). Generally, we can say that 
the sympathetic part of vegetative nervous system controls catabolic processes and its 
parasympathetic part controls anabolic processes. Catabolism is activated by physical exercise 
and illness whereas anabolic processes are activated by rest or recovery from exercise or illness. 
The ANS controls the cardiovascular system. Both its sympathetic and parasympathetic 
branches influence the heart rate via mostly antagonistic control. Also the heart chambers 
contractility and the vessels resistance are modulated by the ANS. Assessing the autonomic 
control over the cardiovascular system is possible directly through its mediators, by specific 
drugs (sympathomimetic, sympatholytic, vagomimetic, vagolytic drugs). Cardiovascular activity 
can also be influenced by non-invasive cardiac autonomic tests. Their clinical importance is 
described in [27]. Those tests are currently used in human medicine with the heart rate 
variability (HRV) being the most often measured parameter, because it is very sensitive to stress 
and other stimuli. For example, in [28] there was spectral analysis applied for measuring the 
HRV, just to evaluate stress conditions in humans. So far, the methods used for assessing level 
of the ANS activity usually utilize heuristically determined characteristics of the HRV frequency 
spectra [29] or time-dependency of the spectrum [30]. Unfortunately, these frequency changes 
are ambiguous [31] what significantly reduces their range of application. Additionally they do 
not provide a detailed insight view on the neural control processes involved, which are not 
directly visible on measured data. These facts evolve an effort to look for more reliable 
alternative algorithms. Rough assessing of the ANS activity based on statistical characteristics of 
interbeat interval sequences [29] can be one of possible alternative methods. Other approaches 
use various tools of nonlinear dynamics theory [32] or so called Weighted Principal Component 
Regression [33]. While such methods provide interesting information, the contribution of neural 
pathways involved is not covered. We believe better insight into the non-linear regulation 
processes during cardiovascular control would be beneficial both to research and health 
services. An approach utilizing mathematical models of cardiovascular control processes (e.g. 
[34], [35]) looks as a promising tool for the analysis of cardiovascular regulation processes. 
Application of this approach enabled us to measure levels of the ANS activity in both its 
branches. Its disadvantages are that it uses parameters of electrical activity of myocardium only 
and its results were not verified using quantified ANS stimulation. 
Following from accessible references and our own experimental work we can claim that 
sufficiently unambiguous and evincible methods for quantization of the ANS activity does not 
exist, yet. Such a method would certainly find important applications in human and veterinary 
medicine. 
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Problem Statement 
The global aim of the PhD thesis is to develop new methods for assessing and quantifying the 
level of Autonomic Nervous System (ANS) activity based on mathematical models of 
cardiovascular control. In order to fulfill this aim we will solve following work packages: 
Experimental Setups 
This work package consists of the definition, arrangement of experiments for appropriate 
quantifiable stimulation of both branches of the ANS in human. The experiments should utilize 
non-invasive physical stimuli and make use of existing cardiac autonomic tests. 
Signal Processing Framework 
This work package consists of developing algorithms for processing cardiovascular signals. 
Adequate measuring equipment should be selected and methodology for noninvasive 
measuring of basic quantities describing performance and control of the cardiovascular system 
(e.g. electrocardiogram, blood pressure, respiration signals) should be defined, so that we might 
be able to assess the reaction to the ANS stimulation. It is necessary to determine and define a 
set of appropriate signal parameters of the noninvasively recorded signals which are suitable to 
assess and quantify response of the cardiovascular system. 
Statistical Evaluation Framework 
This work package consists of choosing appropriate time-frequency transforms to assess 
effectiveness of the stimulation for the given selection of the measured signal parameters. An 
evaluation framework should be defined including statistical parameters having physiological 
meaning and a clinical application. 
Mathematical Model of Cardiovascular Control 
This work package consists of the development of the mathematical models of the 
cardiovascular control by ANS. The models should capture the non-linear processes that 
influence cardiovascular response to external stimulus. It is necessary to cover neural pathways 
and quantify the level of modulation of the efferent part of the ANS on the heart and blood 
vessels. Especially the proposed physiologically-based models should quantify the level of 
sympathetic and parasympathetic discharge as response to an external stimulus applied during 
a cardiac autonomic test. The models should be verified by simulation fitting the experimental 
data. 
Prototypes for Clinical Application 
This work package consists of showing perspectives for a possible application of the results in 
research or in clinical environments. A software or hardware with build-in modules for 
simulation and parameters estimation could be a possible outcome. 
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Outline for the Dissertation 
The dissertation is made of six chapters. While the first chapter presents the state of art, the 
next four chapters mostly contain author contributions and propose novel approaches, which 
are experimentally verified and practically realized as preparation for clinical applications.  
Chapter 1 gives a short overview on the current research on quantitative assessment of 
cardiovascular control. It presents prominent methods for quantifying autonomic nervous 
activity such as heart rate variability. Other time series analysis methods are introduced as well 
as current methods based on mathematical models. Benefits and limitations of each method are 
highlighted. 
Chapter 2 presents our first result achieved. We described an integrated physiologically-
based mathematical model of regulatory processes performed by the autonomic nervous 
system on the heart and vascular beds. The model extensively covers neural pathways between 
sensory neurons, autonomic premotor neurons, preganglionic neurons, neurotransmitter 
dynamics at autonomic ganglionic sites, postganglionic neurons and cardiovascular effectors 
(sinoatrial node, atrioventricular node, atria, ventricles, vascular beds in splanchnic, 
extrasplanchnic, skeletal muscles, brain and heart). The model includes variables for simulating 
baroreflex, respiratory sinus arrhythmias, Mayer waves as well as diverse cardiovascular 
reflexes such as the diving reflex and the oculocardiac reflex. 
Chapter 3 deals with the material and methods we have used in our experimental setups on 
humans. Subjects are presented in details. Each cardiac autonomic test is explained including its 
physiology, its materials, and signals recorded. We present a generic signal processing 
framework developed in the frame of this thesis for batch processing cardiovascular signal and 
for extracting statistical parameters. The chapter also shows results obtained during animal 
experiments. 
Chapter 4 uses the experimental data to fit the model presented in Chapter 2. Optimization 
algorithms are developed for parameters estimation. Estimated values are presented and 
features related to age, gender and race are exhibited. This chapter shows the capability of the 
model to estimate e.g. the parasympathetic tone, sympathetic tone, level of respiratory sinus 
arrhythmias, level of Mayer waves and vagally-mediated tachycardia. 
Chapter 5 demonstrates perspectives for application of our results in a clinical environment. 
We developed a web-based software package offering features for patients and cardiac 
autonomic tests. Signals can be processed and statistical evaluation can be performed online. 
The package is extended as telemedicine platform where doctors can remotely examine 
cardiovascular signals uploaded by patients using built-in features for modeling and simulation. 
Both doctor and patients can communicate using social network features including email and 
forums. The chapter also presents the design of a biofeedback device which can upgrade a 
common mobile phone with sensors for skin temperature and arterial pulse measurements. The 
design includes embedded software capable of processing measured signals by solving a built-in 
light weight mathematical model of cardiovascular control for estimating parameters related to 
autonomic nervous activity and display it to the patient in the context of a biofeedback therapy.  
Chapter 6 concludes the thesis and gives insight into future developments.  
 
 Chapter 1. Existing Methods for Assessing Cardiovascular 
Control Quantitatively 
This chapter gives a very brief overview on the cardiovascular and respiratory physiology. 
It includes an overview on state-of-art in quantitative assessment of cardiovascular control.  
1.1 Background 
1.1.1 Introduction to Cardiovascular Physiology 
The heart is the central organ of the cardiovascular or circulatory system. As illustrated in 
Figure 1.1, this system is a series of tubes (the blood vessels) filled with fluid (blood) and 
connected to a pump (the heart). Pressure generated in the heart propels blood through the 
system continuously. The blood picks up oxygen at the lungs and nutrients in the intestine 
and then delivers these substances to the body’s cells while simultaneously removing 
cellular wastes for excretion. In addition, the cardiovascular system provides cell-to-cell 
communication and immune function. 
 
Figure 1.1 Cardiovascular System (reprinted from [36]) 
The myocardium muscle has a few pacemaker cells (1%) and the rest are contractile cells 
(99%). Heart contraction is normally originated by cardiac pacemaker cells which are located 
in the sinoatrial node (SA node) and are able to generate electrical signals without nervous 
simulation. The electrical and mechanical events of the cardiac cycle can be summarized into 
five phases: atrial and ventricular diastole, atrial systole, ventricular contraction, ventricular 
ejection, and ventricular relaxation. 
Autonomic regulatory mechanisms and circulating hormones modulate cardiovascular 
function in order to ensure cardiovascular homeostasis by regulating e.g. blood pressure, 
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heart rate, force of contraction of the heart chambers and size of blood vessels. A range of 
sensory neurons monitor blood pressure (baroreceptors), blood volume (volume receptors), 
blood chemistry (chemoreceptors) and plasma osmolarity (osmoreceptors). Many afferent 
neurons terminate in the nucleus of the solitary tract, each type of afferent input having its 
specific terminal field within the tract. The nucleus of the solitary tract projects to various 
regions of spinal cord, lower brain stem, midbrain, forebrain, especially to the rostral 
ventrolateral medulla. These control centers integrate sensory input and initiate an 
appropriate response via efferent sympathetic and parasympathetic preganglionic neurons 
which project to an autonomic ganglion outside the central nervous system, where they 
synapse with the postganglionic neurons. These second neurons have their cell bodies in the 
ganglion and project their axons to the target cardiovascular effectors. Parasympathetic 
postganglionic autonomic neurons innervate the sinoatrial and atrioventricular nodes. 
Sympathetic neurons innervate most of the heart and peripheral vessels additionally. 
Several reflexes contribute to the short-term regulation of normal cardiovascular 
function. The baroreflex functions as a negative feedback system controlling arterial blood 
pressure. Respiratory sinus arrhythmia is characterized by increase heart rate during 
inspiration and decrease heart rate during expiration. Thermoreceptors on the face response 
to cold and activate the diving reflex. Increased intracranial pressure elicits the Cushing 
reflex, a strong sympathetic pressor response followed by a baroreflex-mediated 
bradycardia. 
1.1.2 Overview of Respiratory Physiology 
The primary function of the respiratory system is the exchange of oxygen and carbon 
dioxide between the atmosphere and the blood. Additionally lungs can alter body pH, 
protect from inhaled pathogens, help with vocalization, and promote water and heat loss 
from the body. The respiratory system consists of three structures: a conduction system 
(pharynx, larynx, trachea, bronchi, bronchioles), alveoli (exchange surface) and the chest 
cavity (diaphragm, bones and muscles of the thorax). Breathing is an active process which 
involves diaphragm and muscles contraction resulting in an increase of thoracic volume 
during inspiration and decrease of thoracic volume during expiration. According to Boyle’s 
law of gases, change of lung volume during ventilation creates pressure gradient and air 
flows passively from areas of higher pressure to areas of lower pressure. After air has 
reached the alveolar, gas exchange muss occur across the alveolar-capillary interface. Since 
the partial pressure of alveolar oxygen is about 100 mmHg and the partial pressure of 
oxygen in systemic venous blood is only 40 mmHg, oxygen moves down its partial pressure 
gradient from the alveoli into the capillaries until equilibrium is reached. Conversely systemic 
venous blood has a carbon dioxide partial pressure of 46 mmHg, whereas pressure in alveoli 
is 40 mmHg, carbon dioxide moves from the capillaries into the alveoli until equilibrium is 
reached. Muscles involved in the ventilation are not able to contract spontaneously like 
cardiac muscle; instead periodic nervous input is required from a group of neurons located 
mainly within the pons and medulla oblongata. This regulatory system can change its 
behavior according to inputs from peripheral chemoreceptors in the carotid and aortic 
bodies, central chemoreceptors in medulla which respond to low oxygen or high carbon 
dioxide levels in blood. High level of carbon dioxide modulates respiration by increasing the 
rate and depth of ventilation. Higher brain centers in hypothalamus and cerebrum can also 
affect the basic breathing pattern via voluntary control and emotional stress. 
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1.2 Assessing Autonomic Function with Mean Signal Values 
Cardiovascular variables such as blood pressure and heart rate are maintained within a 
narrow range although a multitude of physiological perturbations occur on short and long-
term basis. For example respiration affects venous return and heart rate; vessels diameter in 
vascular bed adapts to local metabolism demand; standing and exercise affect blood 
pressure; low environmental temperature elicits changes in heart rate. Complex regulatory 
reflexes compensate the perturbation in order to maintain cardiovascular homeostasis. A 
quantitative evaluation of autonomic nervous function and level of influence of both 
autonomic nervous branches to cardiovascular system are often desirable in clinical practice 
to monitor disease development and guide therapy; and in research to understand 
mechanisms of physiological regulation such as baroreflex and pathophysiological processes 
such as orthostatic hypotension. A first attempt to assess autonomic function is to apply 
simple statistical methods using mean values of cardiovascular signals. Resting heart rate 
might provide rough measure of autonomic nervous system function only. Subjects with high 
resting parasympathetic activity such as athletes have lower resting heart rate. Conditions 
characterized by increased resting heart rate such as congestive heart failure, anemia or 
hypovolemia are often associated with higher resting sympathetic activity. 
Cardiovascular reaction to input stimulus can provide much more information about 
characteristics of the cardiovascular system and its control. The inputs can be realized either 
by chemical stimuli using drugs or physical provocative maneuvers. The heart rate response 
to cold face test and oculocardiac reflex test for example is often used to assess 
parasympathetic activity while sympathetic activity is typically evaluated by measuring the 
blood pressure change during postural change, cold pressor test, sustained handgrip or 
isometric exercise. In the deep breath test subject is asked to breathe at a paced rate of 6 
breaths per minute and the mean difference or ratio between the maximal RR interval value 
recorded during expiration and the minimal RR interval value recorded during expiration is 
calculated as a marker of vagal activity. In postural change test subject is asked to actively 
stand up from a supine position and the so-called 30:15 ratio between the change in RR 
interval occurring 15 and 30 seconds from assumption of the upright posture is calculated as 
a marker of overall autonomic activity [37]. Exercise heart rate recovery has been proposed 
for assessing parasympathetic tone. With normal parasympathetic reactivation in the post-
phase of exercise, heart rate rapidly decreases in the first 30 seconds followed by a more 
gradual decrease. Such a biexponential pattern of heart rate decrease during early recovery 
is not observed in subjects with heart failure [38]. 
1.3 Heart Rate Variability 
Mean values of physiological variables provide only little insight into regulatory processes. 
Therefore quantitative assessment of autonomic nervous function is preferably performed 
via analysis of fluctuation of measurable physiological variable such as instantaneous heart 
rate, blood pressure or instantaneous lung volume.  
The first link between heart rate and respiration was reported in the 18th century by 
Stephen Hales. Since then different animal and human experiments have put attention on 
the existence of physiological rhythms in the beat-to-beat heart rate signal. Additional 
studies have drawn the relationship between heart rate variability (HRV) and autonomic 
nervous tone on the heart.  
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1.3.1 Time Domain Estimates of HRV 
In a continuous ECG signal the so-called normal-to-normal (NN) interval is the interval 
between adjacent QRS complexes. Following statistics can be calculated and evaluated from 
a series of NN intervals [29]. 
Common time domain parameters include: the root mean squared differences of 
successive NN intervals (RMSSD) as a measure of parasympathetic activity; the standard 
deviation of the NN intervals (SDNN) and the coefficient of variation of the NN intervals (CV), 
both reflecting combined sympathetic and parasympathetic heart rate modulation; the 
standard deviation of the average NN interval calculated over short periods of e.g. 5 minutes 
(SDANN); the mean of the 5-minutes standard deviation of the NN intervals calculated over 
24 hours (SDNN index); the number of interval differences of successive NN intervals greater 
than 50 ms (NN50); the proportion obtained by dividing NN50 by the total number of NN 
intervals (pNN50); the histogram of NN intervals.  
SDNN reflects the overall variability, but strongly depends on the duration of the signal. 
SDNN increases with the length of recording. Although RMSSD and SDNN provide a measure 
of the degree of autonomic modulation, they do not indicate the level of autonomic tone 
regulating heart rate. Moreover RMSSD and SDNN can be subject-specific; values for single 
data sets do not always correspond to the expected increase or decrease of autonomic 
nervous activity. 
The NN interval series can be converted into a geometrical pattern such as sample density 
distribution of NN interval duration and sample density distribution of differences between 
adjacent NN intervals. The following geometrical parameters can be calculated: the integral 
of the density distribution divided by the maximum of the density distribution (HRV 
triangular index) and the base of a triangle that approximates the NN interval distribution in 
space (also called triangular interpolation of NN interval histogram TINN). Both indexes 
reflect overall variability measured over 24 hours but are more influenced by low frequency 
components. Despite of the fact that geometrical methods have the advantage to be 
relatively insensitive to the analytical quality of NN intervals, they need at least 20 minutes 
recording, what makes them inapplicable to assess short-term control of cardiovascular 
system [29]. 
 
1.3.2 Frequency Domain Estimates of HRV 
Time-domain estimates of HRV are single-time statistics which are calculated by sampling 
the variable over the time and by computing quantities that do not depend on the time 
when the samples were taken. The temporal pattern of variation is better captured using 
two-time statistics based on the relative time duration between consecutive pairs of 
samples. Common two-time statistics are the autocorrelation function and power spectral 
analysis.  
Analysis of HRV is usually studied in frequency domain by converting heart rate signal to 
frequency components. Studies have shown that sympathetic and parasympathetic nervous 
activities make frequency-specific contributions to heart rate signal. Power spectral density 
analysis of heart rate fluctuations provides a quantitative noninvasive mean of assessing 
functioning of cardiovascular control and tells how power (i.e. variance) is distributed as 
function of frequency. [39] 
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Spectral Analysis Methods 
The most commonly used methods for calculating power spectral density can be classified 
as non-parametric and parametric. Non-parametric methods use algorithms based on 
discrete Fourier transform (DFT) usually implemented by its effective fast algorithm fast 
Fourier transform (FFT). Fourier (1768–1830) described in his Theorie Analytique de la 
Chaleur (The Analytical Theory of Heat) in 1822 that periodic functions can be expressed as 
the superposition of an infinite series of sinusoidal functions. This observation is true for 
piecewise regular functions with a finite number of discontinuities and extrema; conditions 
that are met by heart rate and blood pressure signals. Therefore the property can be used 
for power spectral analysis of those signals. Parametric methods are based on modeling 
signals by linear system, often represented by autoregressive (AR) frequency response. The 
spectrum resulting from the FFT is derived from all the data present in the recorded signal 
whereas the AR procedure uses the raw data to identify a best-fitting model from which the 
final spectrum is then calculated. AR approach has the ability to identify the central 
frequency of the oscillation in an analytic way and is adequate when attention is focused 
only on rhythmic fluctuations driven by a fixed-rate oscillator. Furthermore AR methods are 
particularly appropriate when the number of samples available for the analysis is low. On the 
other hand, when the analysis is focused on broadband powers, FFT methods are preferable 
[40]. Figure 1.2 shows the same heart rate spectra obtained by means of different analysis 
methods: A, data are plotted with an unsmoothed fast Fourier transform (FFT) algorithm; B, 
data are plotted with an autoregressive (AR) model, the order (=13) of which was 
determined by Akaike criteria; C, data are plotted with a FFT algorithm smoothed with a 
Gaussian window and appear like those obtained with the AR model having an order of 13 
(B); D, data are plotted with an AR model with a high order (=30) and appear like those 
obtained with the unsmoothed FFT algorithm (A). 
Power spectral density can also be calculated using Least-Squares Spectral Analysis (LSSA) 
instead of fast Fourier transform. LSSA is based on least squares fit of sinusoidal functions 
[41], thus is preferable when a straight-forward implementation is needed, for example it 
can be implemented in Matlab in less than a page of code. The magnitudes in the spectrum 
determine the contribution of each frequency band to the power (i.e. variance) of the signal.  
Interpretation of spectral components 
The spectral values for blood pressure and heart rate variability can be calculated for very 
low (VLF: 0-0.04 Hz), low (LF: 0.04–0.15 Hz) and high (HF: 0.15–0.5 Hz) frequency bands. 
Figure 1.3 shows recordings of preganglionic thoracic sympathetic and vagus nerve 
discharges on one artificially ventilated decerebrate cat. A clear correlation between firing 
rate and power spectral density can be seen. Low frequency heart rate oscillations are 
considered to be mediated by combined sympathetic and parasympathetic activity at rest 
while there is a predominance of sympathetic activity during stressful conditions. Some 
studies demonstrate that human cardiovascular rhythms occurring at 0.1 Hz are related to 
activity of the sympathetic nervous system since strong fluctuations of muscle sympathetic 
nerve activity appear about every 10 seconds, a period that is sufficiently long for vascular 
smooth muscle and sinoatrial node effectors to respond to released norepinephrine and to 
modulate arterial pressure and heart rate [42].  
  
Figure 1.2 Heart rate spectrum using FFT and AR techniques (reprinted from [40]) 
A - unsmoothed fast Fourier transform (FFT) algorithm;  
B - autoregressive (AR) model with order 13; 
C - fast Fourier transform (FFT) algorithm smoothed with a Gaussian 
window; 
D - autoregressive (AR) model with high order 30 
High frequency heart rate oscillations are associated with respiratory sinus arrhythmia 
and reflect parasympathetic activity. Vagal cardiac control operates like a low-pass filter with 
a relatively high cutoff frequency, effectively modulating heart rate up to 0.5 Hz, while 
sympathetic cardiac control operates as a low-pass filter with a much lower cutoff frequency, 
capable of significantly modulating heart rate only at frequencies below 0.15 Hz [40]. 
Parasympathetic blockade by atropine eliminates most heart rate fluctuations above 0.15 Hz, 
while leaving those below 0.15 Hz partly unaffected; whereas cardiac sympathetic blockade 
with propranolol reduces heart rate fluctuations below 0.15 Hz, while leaving those above 
0.15 Hz largely unaffected [43]. At frequencies between 0.025 and 0.07 Hz, the factors 
involved in heart rate and blood pressure modulation have been regarded as being the 
renin-angiotensin system, endothelial factors and local influences related to 
thermoregulation [39] [43].  
Measurement of VLF, LF and HF power components is usually made in absolute values of 
power (unit ms2). Sympathovagal balance is the ratio of the absolute value of power at LF 
components over the absolute value of power at HF components [42]. LF and HF can also be 
measured in normalized (also called relative or fractional) units (nu) which represent the 
relative value of each power component centered at the frequency of interest (LF or HF) 
divided by total power without power at VLFs. Thus LF and HF in normalized units, denoted 
by nLF  and nHF respectively, are defined as follows:  
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Figure 1.3 Direct vagal and sympathetic nerves recordings with corresponding HRV (reprinted from [44]) 
Spectral analysis of RR interval, preganglionic sympathetic neural discharge 
(SND) recorded from third left thoracic sympathetic ramus communicans, 
and efferent vagal neural discharge (VND) simultaneously recorded from left 
cervical vagus in an artificially ventilated decerebrate cat. Time series of the 
three signals are illustrated on left panels, whereas their spectra are 
represented on right panels. A predominant low frequency characterizes RR 
and SND spectra, whereas a greater respiratory high-frequency component 
is present in VND variability. PSD, power spectral density.  
Effects of disease, age, race and gender on HRV 
In most autonomic disorders, parasympathetic function is affected before sympathetic 
function. Depressed HRV after myocardial infarction is characterized by prevalence of 
sympathetic activity and decrease in vagal tone. Power spectral density of HRV has been 
used as measure of risk factor after acute myocardial infarction. Reduction of absolute 
values of power (unit ms2) of LF and HF components has been seen to precede the clinical 
expression of neuropathy associated with diabetes mellitus. [29] 
Absolute values of power (unit ms2) of LF and HF components are associated with age and 
sex. With increasing age, the high frequency components, which are related to 
parasympathetic activity, decrease. Women have a lower LF and higher HF/LF ratio than 
men [45]. The effect of race on heart rate variability is not yet established. Whereas studies 
in [46] exhibits lower heart rate variability in Black Americans, the opposite has been 
documented in [45] [47] where black subjects were found to have lower LF, higher HF and 
higher HF/LF ration than white subjects. 
1.3.3 Limitations of Heart Rate Variability 
Findings in [48] suggest that heart rate variability parameters traditionally associated with 
parasympathetic tone do not always reliably measure parasympathetic tone, since they 
decrease with baroreflex parasympathetic stimulation produced by phenylephrine infusion. 
Furthermore simulation of the right vagus nerve with three different stimulation patterns in 
anaesthetized, vagotomized and spinal anaesthetized dogs show that the high frequency 
component of heart rate variability reflects the magnitude of fluctuation in the cardiac 
parasympathetic input rather than parasympathetic firing rate [49]. Constant frequency 
vagal stimulation increased cardiac interval, but did not change HRV markedly. 
Instantaneous stimulation frequency oscillation between 4 and 17 Hz during 5 s period 
produced a marked heart rate variation. With an increased magnitude of modulation, i.e. the 
difference between minimum and maximum instantaneous frequency, the high frequency 
component increased with greater extend. Additional studies put in evidence small 
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respiratory sinus arrhythmia caused by mechanical modulation of sinus rate by stretch after 
combined pharmacological sympathetic and parasympathetic blockade and after cardiac 
transplantation [43]. 
Sympathetic nerve traffic measurement directly by microneurography and intravascular 
resistance measured by forearm venous occlusion plethysmography during intravenous 
infusion of nitroprusside, intravenous infusion of phenylephrine or lower body negative 
pressure have shown that the level of sympathetic cardiovascular modulation cannot always 
be specifically reflected by the power of heart rate and blood pressure spectral components 
around 0.1 Hz (LF) [43]. 
Studies have emphasized the possible occurrence of a high random variability varying 
from behavioral conditions in components of power spectral density of blood pressure and 
heart rate, especially in long-term recordings. Neural modulation is influenced by a large 
number of input signals and a multitude of interactions of central command and reflexes at 
various brain levels, therefore describing these regulatory processes with narrow frequency 
regions around 0.1 Hz and 0.3 Hz might be too simplistic. Furthermore the current 
interpretation of spectral data relies on the assumption that the responses of the system are 
approximately linear, however neural regulation of the cardiovascular system is 
characterized by at least two orders of nonlinearity [40].  
Although several studies display a quantitative relation between power spectral density 
of HF components and vagal-cardiac nerve activity, moderate changes of vagal-cardiac nerve 
activity from baseline do not alter HF power components. Additionally huge changes of 
power spectral density of HF components provoked by changes in breathing may not reflect 
changes of vagal-cardiac nerve traffic at all. Therefore it is unclear how sympathovagal 
balance should be interpreted when changes of breathing frequency occur during recording. 
Moreover LF power components measured in normalized units did not show significant 
correlation to levels of myocardial norepinephrine spillover, muscle sympathetic nerve 
activity or antecubital vein plasma norepinephrine concentrations. [42] 
1.4 Blood Pressure Variability 
High frequency fluctuations of blood pressure are mainly caused by the mechanical 
effects of respiration on the pressure gradients, size, and functions of the heart and large 
thoracic vessels. Vagally mediated changes in heart rate and cardiac output play a role in 
determining the power spectral density of HF components of blood pressure. [43] 
Low frequency blood pressure oscillations are considered to be due to sympathetic 
modulation of vasomotor tone and systemic vascular resistance and also to reflect baroreflex 
influences on rhythmic fluctuations of arterial blood pressure. Therefore, the power spectral 
density of LF oscillations of blood pressures are likely to represent useful estimates of 
sympathetic vascular control [50]. However studies on rats have emphasized that low 
frequency fluctuations of blood pressure depends not only on sympathetic but also to a 
substantial extent on non-sympathetic influences [51]. Moreover, sympathetic influences 
probably do not contribute to low-frequency blood pressure power, having instead a 
restraining effect. The low frequency components of blood pressure variability should 
therefore be regarded as a result of combined sympathetic and vagal influences.  
Because the use of power spectral density of low frequency components of blood 
pressure variability is still under debate, nonlinear indexes were investigated in [52]. Authors 
apply a method of nonlinear time series analysis called recurrence plot. The recurrence plot 
method produces nonlinear indexes of blood pressure variability and can also be applied to 
study heart rate variability. It looks for repeated sequences in the data. Figure 1.4 shows a 
 series of 20 systolic blood pressure values 
the same if their absolute differen
from SBP(1), the algorithm looks
series (i.e., for some j, with j >
19. These recurrences can be plotted as points (1, 4), (1, 7), (1, 10), (1, 13) and (1, 19)
x 20 square the points as shown in 
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called maxL with value 4 in this case.
number of the recurrence points
follows: 
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Sympathetic blockade by hexamethonium and in particular α1
prazosin significantly increased 
Parasympathetic blockade by atropine and β
change the indexes. These results suggest that, 
analysis, nonlinear indexes may be more specific markers of sympathetic tones.
Figure 1.4 Recurrence plot method for 
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1.5 Multivariate Fluctuation Analysis  
All univariate statistical variables presented in the previous sections fail to capture 
dependencies between different physiological phenomenon such as heart rate regulation 
and blood pressure regulation. Multivariable statistics capture such interrelationships and 
can be used to compute cross-correlation functions, cross-spectra or transfer functions [53]. 
Furthermore parametric system identification extends transfer function methods and takes 
into account causality conditions and noises in variables [54]. 
1.5.1 Baroreflex Sensitivity 
A time domain method for computing baroreflex sensitivity is based on the identification 
of sequences of three or more consecutive increasing/decreasing systolic blood pressure and 
lengthening/shortening of RR interval. The slope of the regression line between systolic 
blood pressure and RR interval changes is taken as an index of baroreflex sensitivity (unit 
ms/mmHg).  
A more standard assessment of baroreflex sensitivity is made in frequency domain by 
computation of the squared ratio between the spectral powers of RR interval and systolic 
blood pressure or of the modulus of the cross-spectrum between systolic blood pressure and 
RR interval in the frequency regions (0.04 to 0.35 Hz). Baroreflex sensitivity can also be 
evaluated pharmacologically by relating changes in heart rate to phenylephrine-induced 
increases and nitroglycerin-induced decreases in arterial pressure [55]. 
While above methods provide summary information, continuous baroreflex sensitivity 
can be calculated using Complex Demodulation technique (CDM), which is a nonlinear time 
domain method of time series analysis. It involves shifting the frequency band of interest to 
zero by multiplying the original signal with a complex sinusoid at the center frequency of the 
spectral region of interest (e.g. 0.09 Hz). The resultant complex signal is then low-pass 
filtered and converted to a polar form to produce amplitude and phase, as a function of time. 
CDM can work with less than 15 seconds data and provides a continuous assessment of 
baroreflex sensitivity in the time domain. Other methods presented in the previous 
paragraphs provide only discrete values over a fix time range. CDM shows values similar to 
those obtained by the power spectral analysis. A comparison between both methods in 
supine and standing can be found in [56]. 
1.5.2 Parametric Transfer Function 
Heart rate variability does not provide direct information about how heart rate changes in 
response to varying arterial blood pressure. Pharmacological measurement of baroreflex 
sensitivity provides information about the coupling between blood pressure and heart rate; 
it requires however intravenous administration of a vasoactive agent that disrupts normal 
operating conditions. While the method provides ways for characterizing physiological 
couplings, it cannot impose causality, which is essential for consistent least-squares 
estimation when the data are obtained in a closed loop. 
Parametric system identification using an autoregressive moving average set of equations 
has been applied in [54] to impose causality and quantitatively characterize the transfer 
functions and noise sources associated with closed-loop cardiovascular regulation of heart 
rate ( HR), arterial blood pressure ( ABP) and instantaneous lung volume ( IVL ). The causal 
structure allows to computationally opening the loop of the closed-loop system, therefore 
separating the feedforward from the feedback components. A schematic description of the 
proposed model is shown in Figure 1.5. Circulatory Mechanics represents the feedforward 
coupling between heart rate and arterial blood pressure and is determined by stroke volume 
 and peripheral vascular resistance. HR Baroreflex represents feedback baroreflex mediated 
fluctuations in efferent autonomic activity and SA Node represents the coupling between 
autonomic activity and heart rate. IVL HR→  represents respiratory sinus arrhythmias. 
IVL ABP→  represents mechanical effects of respiration on arterial blood pressure. HRN  
and ABPN  represents perturbing noises on HR which are not caused by fluctuations in ABP
or IVL and perturbing noises on ABP which are not caused by fluctuations in HR or IVL . 
The model includes parameters which were determined by minimizing the residual errors 
using a least squares fit to experimental data obtained during orthostatic stress. According 
to the authors, results indicate an incremental diminution in the magnitude of the impulse 
response functions characterizing the two autonomically mediated couplings (HR Baroreflex 
and IVL HR→ ) and the power spectral density of the autonomically mediated perturbing 
noise source ( HRN ) as one progresses from healthy control subjects to minimal, moderate, 
and severe diabetic autonomic neuropathy groups [54]. 
 A similar approach was adopted in [57] for delineating which major physiological 
mechanisms contributing to RR Interval and systolic blood pressure variability are affected as 
a consequence of chronic exposure to sleep disorder breathing. Fluctuations in RR Intervals 
were assumed to be caused by systolic blood pressure fluctuations via the baroreflex and 
through direct coupling between respiration and heart rate. Fluctuations in systolic blood 
pressure were considered to result from changes in intrathoracic pressure during respiration 
and circulatory dynamics derived from Frank-Starling mechanism and Windkessel runoffs 
effects. Another application of transfer functions was described in [58] and estimated the 
residual heart period variability which is neither related to baroreflex nor to direct effects of 
respiration or low frequency influences independent of baroreflex. This residual fluctuation 
was interpreted as the effect of the dynamic properties of the sinus node.  
 
Figure 1.5 Parametric system identification model (reprinted from [59]) 
heart rate (HR), arterial blood pressure (ABP), instantaneous lung volume (IVL), 
sinoatria node (SA), perturbing noise source (NHR) , pulsatile heart rate (PHR) 
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1.6 Plasma Concentration of Cardiac Neurotransmitters  
When evaluating the cardiovascular regulation using time-frequency methods, time series 
analysis and multivariate fluctuation analysis applied to signals recorded in an experimental 
setup using a provocative maneuver, only baseline values ending approx. 30 seconds before 
the actual autonomic test are usually considered to assure that baseline values are not 
biased by preparatory activities, for example, the subject might be afraid of a cold compress 
approaching the face during the cold face test, what would be reflected by an elevated heart 
rate just before the autonomic test itself and would corrupt the assessment of autonomic 
nervous response to the stimuli [50]. Furthermore fluctuation analysis assumes that the 
regulatory process is stationary, i.e. the statistical properties of the physiological variables do 
not change over time (stationarity can defined as a difference of less than 5% in the spectral 
components calculated in two successive 256-beat series). Such requirements are not always 
fulfilled by the signals and emotional factors make stationary an even unreachable goal. 
Parametric functions and minimal kernel approaches introduced in previous sections 
possibly characterize the dynamics of individual physiological coupling mechanisms involved 
in cardiovascular regulation. This methodology however assumes that the system is linear 
and time invariant. This assumption is generally not valid for cardiovascular autonomic 
control. 
Myocardial norepinephrine spillover has shown good capability for measuring 
sympathetic traffic to the human heart. This measure correlates well with muscle 
sympathetic nerve activity and plasma norepinephrine levels, at rest and during isometric 
exercise and mental arithmetic.  
The cardiac norepinephrine spillover rate is a biochemical index of the global sympathetic 
nerve firing rate in the heart (sinoatrial node, atrioventricular node, atria, ventricles). The 
method requires a continuous intravenous infusion of a radiotracer dose of tritiated 
norepinephrine to reach steady-state concentration in plasma. Norepinephrine 
concentration is measured in the coronary sinus via catheterization. Coronary sinus plasma 
flows is derived from thermodilution-determined blood flows. Endogenous norepinephrine 
plasma concentration is measured by high-performance liquid chromatography. All 
concentration values are then used to calculate norepinephrine spillover rate according to 
the Fick principle. In patients with cardiac failure, the rate was two to three times the value 
found in age-matched healthy controls (59±14 versus 18+3 ng/min). Compared with young 
healthy subjects aged 18 to 35 years, older subjects aged 60 to 75 years had an elevated 
cardiac norepinephrine spillover rate (14.3±2.5 versus 20.1±3.0 ng/min). [60] 
Muscle sympathetic nerve activity (MSNA) can be recorded with a tungsten 
microelectrode, with a tip diameter of a few micrometres, inserted in a muscle fascicle of 
the peroneal nerve at the fibular head. A reference electrode is inserted subcutaneously a 
few centimeters away from the recording electrode. When a muscle nerve fascicle has been 
identified, small electrode adjustments are made until a site is found in which sympathetic 
impulses can be recorded. MSNA was found to have values ranging from 30 to 50 
bursts/min. The mean value of total MSA increased by 81±12% during the last 2 minutes of 
isometric handgrip. A correlated increase of  norepinephrine spillover rate was also 
simultaneously measured. [61] 
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1.7 Model-based Methods for Assessing Cardiovascular Control 
Different methods presented in the previous sections, such as baroreflex sensitivity, 
plasma or urinary catecholamine levels, and heart rate variability analysis have been 
employed to quantitatively evaluate autonomic function. However, these methods are both 
invasive and expensive (e.g. myocardial norepinephrine spillover) or are affected by factors 
other than alterations in autonomic tone like respiration and they cannot accurately 
measure sympathetic and parasympathetic tone separately. For example studies show that 
HRV power in the HF band, above 0.15 Hz, is a satisfactory but incomplete measure of vagal 
cardiac control [43]. 
An attempt for improving the quantitative assessment of autonomic cardiovascular 
control by the spectral analysis approach is to combine the information obtained from the 
recorded physiological signal with the information derived from mathematical models. 
Mathematical models help understanding the nonlinear interactions among the different 
mechanisms and the effect of their individual variability to be accounted for in rigorous 
quantitative terms [62]. Seminal mathematical models to understand how cardiac output is 
determined and regulated in response to metabolic demand of the body have been studied 
for many years by Guyton [24, 63]  and Grodins [64]. Over the last decade there has been a 
large body of research on mathematical models covering features from the molecular to the 
organ system level. A comprehensive summary of architectures of cardiovascular models is 
given in  [65] where a distinction is made between distributed and lumped models. 
Distributed models represent the arterial tree in segments where viscous and inertial effects 
are represented by a resistance and an inductance. Both variables depend on parameters 
such as segment radius, viscosity, density, length, compliance. Lumped models do not go 
into such anatomical details, they rather lump vessels into compartments and describe the 
cardiovascular system as a network of compliances, resistances and inductances. Lumped 
models can be non-pulsatile or pulsatile. Pulsatility is usually included using a time-varying 
compliance function. Lumped models can be coupled with mathematical formulation of 
autonomic nervous control. 
1.7.1 A Lumped Model of Cardiovascular System 
Batzel and coworkers extended the original mathematical model of Grodins with a 
submodel for local metabolic control [66].  The lumped model does not consider blood flow 
in the arterial tree and do not distinguish between individual vessels in the venous and 
arterial part of the systemic or pulmonary circuit. Instead, it lumps them together into four 
single compliant compartments: Venous Systemic Compartment and Arterial Systemic 
Compartment; Venous Pulmonary Compartment and Arterial Pulmonary Compartment. The 
venous systemic and the arterial systemic compartments are connected by the Systemic 
Peripheral Compartment. The venous pulmonary and arterial pulmonary compartments are 
connected by the Pulmonary Peripheral Compartment. Both peripheral compartments 
represent capillaries, arterioles and venules; and are only characterized by the resistance of 
their walls to blood flow. The venous systemic and the arterial pulmonary compartments are 
connected by the Right Ventricle Compartment. The venous pulmonary and the arterial 
systemic compartments are connected by the Left Ventricle Compartment. The right and left 
atrium are assumed to be part of the venous systemic and venous pulmonary compartment 
respectively.  
Since the venous systemic, arterial pulmonary, venous pulmonary and arterial systemic 
compartments are compliance compartments, we have the following relation, where V is 
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the blood volume, P is the blood pressure and c is the compliance constant of the given 
compartment. 
 V c P= ⋅  (1.7.1) 
The left and right ventricle are characterized by the generated blood flow, i.e. the cardiac 
output, which is given by the equation below, where H  is the heart rate and strV  is the 
stroke volume, i.e., the volume of blood ejected by one beat of the ventricle.  
 strQ H V= ⋅  (1.7.2) 
The blood flow F through the pulmonary and systemic peripheral compartments 
depends on the blood pressure in the adjacent compartments and the resistance R  against 
blood in the peripheral regions. This is given by the following relation, where a  stands for 
arterial and v  stands for venous. 
 
1 ( )a vF P PR= ⋅ −  (1.7.3) 
The following equations describe the filling process and the ventricle stroke volume using 
the formula of Frank-Starling; where S  is the contractility of the ventricle; vP is the venous 
filling pressure; aP  is the arterial pressure against which the ventricle has to eject; R  is the 
total resistance to the blood inflow into the ventricle; dt is the ventricle filling time.  
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 (1.7.4) 
If the subscripts , , , , , , ,l r as vs ap vp s p  are used to characterize the left heart and the right 
heart; the arterial systemic, venous systemic, arterial peripheral and venous peripheral 
compartment; the systemic peripheral and pulmonary peripheral compartment respectively; 
then volume change over time can be described using the following system of equations: 
 
1 ( )
1 ( )
as
as l s
vs
vs s r
ap
ap r p
vp
vp p l
s as vs
s
p ap vp
p
dPC Q F
dt
dPC F Q
dt
dP
C Q F
dt
dP
C F Q
dt
F P P
R
F P P
R
⋅ = −
⋅ = −
⋅ = −
⋅ = −
= ⋅ −
= ⋅ −
 (1.7.5) 
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The local metabolic control in tissues is achieved by increasing or decreasing the diameter 
of arterioles, which results in a change of vessel resistance to blood supply with oxygen.  
 
2,
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s
dR P PA C W
dt K R
  
−
= ⋅ ⋅ −   
  
 (1.7.6) 
where sR is the peripheral resistance; peskA  is a positive constant; and 2,a OC  is the 
concentration of oxygen in the arterial blood in the capillary region; K is a positive constant. 
W represents a constant ergonomic workload imposed on muscles in the peripheral region. 
This model has been extended with a receding horizon control for the baroreceptor loop 
in [67]. The controller has to minimize the cost function defined as the error between the 
current and desired state. The output of the controller is the change in heart rate. This 
approach to represent the baroreflex control of heart rate using a stabilizing non-linear 
control derived from optimal control theory however does not quantify the level of activity 
of efferent sympathetic and parasympathetic fibers. 
1.7.2 An Open-Loop Model of Cardiovascular Control 
Key to the short-term control of blood pressure is the baroreflex or baroreceptor loop, 
which stabilizes blood pressure by the mean of neural negative feedback. Ottesen and 
coworkers developed a model of heart rate regulation and divided baroreceptor mechanism 
into three components: an afferent or sensory component, the central nervous system, and 
an efferent component [65]. 
The Sensory Component consists of mechanoreceptor cells located in the carotid sinus 
and aorta arch walls responding to pressure by stretching. Their firing rate n  exhibits a 
number of non-linear phenomena which is modeled using the following system of non-linear 
differential equations. 
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 (1.7.7) 
where 1 2 3, ,k k k are unknown weighting factors; 1 2 3, ,τ τ τ  are unknown time constant 
describing the resetting phenomenon of baroreceptors; M is the high saturation level of the 
firing rates of baroreceptors with constant value 120 Hz and N is the threshold value of the 
firing rates depending on an unknown parameter η . 
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Information processing in the Central Nervous System is complex and the explicit 
interaction between firing rate n , the efferent sympathetic activity 
symT , and the efferent 
parasympathetic activity parT  were modeled by Ottesen as follows [68].  
 [ ]2 0
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u t
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u t b t t u
ub
t
t
t t
τ
β
=
−
− +
=
+ ⋅
= − ⋅ − +
=
= +
 (1.7.8) 
where dτ  is the delay of sympathetic response; β  is the dampening factor of the 
parasympathetic response; ( )u t  is the impulse function accounting for the regulation of the 
sympathetic nerve activity by the vestibulo-sympathetic system; this impulse response is 
modeled as a parabolic function where ,start pert t are the start time and duration of the 
response, 0u  is the amplitude of the response. 
The Efferent Component models the neural response on the chemical concentration of 
norepinephrine norC  and acetylcholine achC . The heart rate potential was modeled by 
Ottesen using an integrate and fire model; when 1φ =  the heart beats and the RR  interval is 
taken as the time from 0φ =  to 1φ =  in milliseconds; the instantenous heart rate H is 
derived from the RR interval duration in beats/min; 0H  is intrinsic heart rate when 
denervated depending on the age; ,s pM M  represent the strength of the response to 
changes in the concentrations. 
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 (1.7.9) 
The model was extended with a nonpulsatile lumped-parameter model of the systemic 
loop, consisting of the left ventricle, which pumps blood to the arteries, the capillaries, the 
veins, and back to the right ventricle [69]. Equations for the conservation of average non-
pulsatile blood volume are given below, where ,as vsP P  are the mean arterial and venous 
pressure respectively; ,as vsC C are the compliance of arterial and venous system respectively;  
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,as vsR R are the resistance to flow through the arterial and venous system respectively; strV is 
the stroke volume. 
 
as as vs
as str
as
vs as vs vs
vs
as vs
dP P PC H V
dt R
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dt R R
−
⋅ = − + ⋅
−
⋅ = −
 (1.7.10) 
The model of Ottesen described above provides a quantification of sympathetic 
symT  and 
parasympathetic level parT  in dimensionless units. It however represents the system as an 
open-loop and lacks various delays which are known to be present at diverse points of 
neural pathways. Cardiovascular control system includes some transport and time delays 
which should be included in mathematical models. The time required for the signals to travel 
from baroreceptors to the medulla including the processing time in the control centers is 
about 100 to 300 ms. Typically there is ca. 2.5 s delay before heart rate changes are seen 
after β-sympathetic nerve stimulation, and a further 7.5 s before the effect is complete. 
There is ca. 5 s delay before peripheral vasoconstriction begins, after stimulation of α-
sympathetic nerves, and a further 15 s delay before vasoconstriction is complete. An 
excellent review of mathematical models of cardiovascular control including delays is given 
in [70].  
1.7.3 A Closed-Loop Model of Cardiovascular Control 
Ursino and coworkers developed a complex distributed closed-loop model of the 
cardiovascular system and applied it to study exercise physiology. Model equations 
describing pressure and volume in systemic arteries, splanchnic peripheral circulation, 
splanchnic venous circulation, extrasplanchnic peripheral circulation, extrasplanchnic venous 
circulation, right atrium, right ventricle, pulmonary arteries, pulmonary peripheral 
circulation, pulmonary veins, left atrium and left ventricle can be found in [71]. 
The afferent baroreflex pathway was modeled by Ursino using a linear derivative first-
order dynamic block and a sigmoidal static block [62] as follows. 
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  (1.7.11) 
where abf is the firing rate of the carotid baroreceptors in response to the pressure sensed 
P% which depends on the arterial pressure asP ; ab,max ab,minf , f are the upper and lower 
saturation levels of firing rate; ,pb zbτ τ are the time constants for the real pole and the real 
zero in the linear dynamic block; nP is the value of baroreceptor pressure at the central point 
of the sigmoidal function; abk is a parameter, with the dimension of pressure, related to the 
slope of the static function at the central point; bG is the maximum baroreceptor gain.  
The afferent chemoreflex pathway was modeled by Ursino using a linear derivative first-
order dynamic block and a sigmoidal static block as follows. 
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where
 ac
f  is the firing rate of chemoreceptors as sigmoidal response to changes in partial 
pressure of oxygen in the arterial systemic compartment 
2Oas
P ; ac,max ac,minf , f are the upper 
and lower saturation levels of firing rate; cτ is a time constant of the chemoreceptors 
dynamics; 
2O nas
P is the oxygen level at the central point of the sigmoidal function; ack is a 
parameter, with the dimension of pressure, related to the slope of the static function at the 
central point. 
The afferent activity of pulmonary stretch receptors was modeled by Ursino using a linear 
derivative first-order dynamic block and a sigmoidal static block as follows. 
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 (1.7.13) 
where
 ap
f is the firing rate of the pulmonary stretch receptors in response to changes in tidal 
volume TV ; cτ is a time constant of the lung inflation; apG is a constant gain. 
Efferent sympathetic responses to vessels and heart were modeled by Ursino as 
exponential trends using weighted sum of afferent inputs from baroreceptors, 
chemoreceptors and pulmonary stretch receptors [62] as follows. 
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 (1.7.14) 
where ,sp shf f are the firing rates of efferent sympathetic fibers to vessels and heart; 
, ,0, , ,es es,max es esk f f f∞ are constants; , , , , , ,, , , , ,b sp c sp p sp b sh c sh p shW W W W W W are synaptic weights; 
,sp shθ θ are offset terms for sympathetic neural activation. 
Efferent parasympathetic response to heart was modeled by Ursino as follows. 
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 (1.7.15) 
where vf is the firing rate of efferent vagal fibers to heart; , ,0, ,ev ev evk f f∞ are constants; 
, ,
,c v p vW W are synaptic weights; vθ is an offset term for parasympathetic neural activation. 
 19 
 
The response of vessel resistances was modeled by Ursino to include a pure latency, a 
monotonic logarithmic static function, and low-pass first order dynamics [62]. 
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 (1.7.16) 
where sR is the resistance of peripheral vessels with (0)sR being its baseline value; SRτ is a 
time constant; 
SR
G is a constant gain factor; 
SR
D is the time delay for sympathetic response 
to take effect; 
,minesf is a threshold for sympathetic stimulation. 
The response of cardiac elastances to the sympathetic drive was modeled by Ursino as 
follows. 
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 (1.7.17) 
where HE is the elastance of heart chambers with (0)HE being its baseline value; HEτ is a 
time constant; 
HE
G is a constant gain factor; 
HE
D is the time delay for sympathetic response 
to take effect. 
The response of heart period to the sympathetic and parasympathetic drive was modeled 
by Ursino as follows. 
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 (1.7.18) 
where T  is the heart period with 0T being its baseline value; ,S VT Tτ τ are a time constants; 
,
S VT T
G G are constant gain factors; ,
S VT T
D D are the time delays for sympathetic and 
parasympathetic responses to take effect. 
The model of Ursino and coworkers described in this section includes analytical 
description of efferent sympathetic and parasympathetic activity as response to exercise. 
However additional stimuli on the cardiovascular system are not covered, such as cold 
stimulation inducing bradycardia and cogbitive stress inducing pressor response. 
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1.7.4 Modeling External Stimuli on Cardiovascular System 
The transition from sitting to standing was modeled by Olufsen by including gravitational 
forces to arterial systemic pressure [72] . 
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 (1.7.19) 
where asP is the pressure in arterial systemic compartment in legs;
31.055 /g cmρ =  is the 
density, 2981 /g cm s=  is the gravitational acceleration, h  is the change in height from 
sitting to standing, stt  is the timestamp when subject stands up, τ  is the duration of the 
transition from sit to stand, Mh  is the maximum height needed for the mean arterial 
pressure to drop (e.g. 25.16 cm). 
Physical exercise can put some challenges to the cardiovascular system. Elstad and 
coworkers developed a non-distributed model which demonstrates that a rapid increase in 
baroreflex setpoint and locally induced vasodilation of vessels in exercising muscles account 
for almost all cardiovascular changes seen during moderated exercise [73]. Local metabolic 
demand in exercising muscles modulates peripheral vessel resistance. Vasodilation induced 
by lower oxygen level in blood was modeled by Magosso using a static gain and first-order 
low pass dynamics [74].  
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 (1.7.20) 
where amR is the peripheral resistance in the active muscles; amτ is a time constant; amG is a 
static gain constant; 
2,v O
C is the oxygen concentration in venous blood leaving the active 
muscles with baseline value 
2,v O n
C ; 
2,a O
C is oxygen concentration in arterial blood entering 
the active muscles; amF is blood flow through the active muscles; amM is the oxygen 
consumption rate with baseline value 
,am nM and depends on exercise intensity I ; Mτ is a 
time constant and MG is a static gain. 
 21 
 
The respiration response to exercise was empirically described by Magosso as a function 
of relative exercise intensity as follows. 
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 (1.7.21) 
where TV is the tidal volume with baseline value ,T nV ; TVG is a static gain; I is exercise 
intensity;V is the minute ventilation with baseline value nV ; VD is the time delay between 
onset of exercise and onset of ventilation response; Vτ is a time constant; ,A B  are constant 
parameters. 
The direct action of central command on sympathetic efferent activity on heart and 
vessels as well as on parasympathetic efferent activity on heart were modeled by Magosso 
and Ursino by modifying equations (1.7.14) and (1.7.15) to include additive terms , ,sp sh vγ γ γ
which are sigmoidal functions, defined as follows. 
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where ,i,min i,maxγ γ are the minimum and maximum saturation level of central command; 0,iI is 
the value of exercise intensity at the central point of the sigmoid; 
,cc ik  is a parameter related 
to the slope of the sigmoid at the central point. 
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1.8 Conclusion 
Autonomic neural regulation of the cardiovascular system is characterized by at least two 
orders of nonlinearity. Examples include the nonadditive nature of the interactions between 
cardiac sympathetic and parasympathetic responses, the cardiac phase–dependent response 
to vagal stimuli and the nonlinear modulation of vagal and sympathetic neural outflow by 
respiration. Additional nonlinearities may originate in specific behavioral and experimental 
conditions. Such system nonlinearities are present regardless the operating point and will 
drive the cardiovascular system control mechanisms to operate out of their linear range. 
Although physiological control systems appear to have steady-state responses that are 
sigmoidal and include a threshold, a linear operating regime and a saturation point, the 
dynamic response can be thought of as continuously moving up and down the sigmoid curve. 
An increase in the mean operating point of the input may be associated with an increase or 
decrease in the dynamic gain of the system. Therefore changes in the activity of 
cardiovascular control mechanisms may not be linearly related to changes in heart rate 
variability (HRV) or blood pressure variability (BPV). Thus, a measure of HRV or BPV may fail 
to quantify alterations of autonomic cardiovascular influences in several instances [40]. 
Interrelating both variables to compute baroreflex sensitivity index overcomes the 
limitations of univariate cardiovascular signal analysis but its frequency variant does not take 
into account the fact that heart rate and blood pressure are physiologically coupled in a 
closed-loop control system while the sequence variant of baroreflex sensitivity does not 
consider the influence of respiration on heart rate.    
Mathematical models, such as those proposed by Ursino and coworkers in the previous 
section 1.7 aim to solve such limitations of signal-based methods for assessing 
cardiovascular control. Whereas these conventional mathematical models of neural 
regulation picture a reciprocal control of cardiac vagal and sympathetic nervous activity, as 
seen during a baroreflex, many other reflexes involve simultaneous co-activation of both 
autonomic efferent branches. Autonomic co-activation occurs during peripheral 
chemoreceptor, diving, oculocardiac, somatic nociceptor reflex responses as well as being 
evoked from structures within higher brain centers.  Vagal activity can by itself produce a 
paradoxical vagally mediated tachycardia. [75] 
Another factor which is missing in most mathematical models is the fact that, even at 
rest, the heart receives tonic drives from both sympathetic and parasympathetic cardiac 
nerves. Presympathetic cardiovascular neurons in the rostral part of the ventrolateral 
medulla have the capacity to generate action potentials in the absence of synaptic inputs. 
These neurons are also chemosensitive and this may contribute to their tonic activation 
under conditions of hypoxia or hypercapnia. [76] 
As emphasized in the work by Eckberg [77], many mathematical models involve 
prediction of cardiovascular changes that occur when a subject is perturbed by diverse 
provocative maneuvers. They however fail to include some index of the intensity of the 
perturbation that elicits the response which is linearly or nonlinearity related to the 
perturbation; and the factor in subjects’ abilities to meet the challenges posed by the 
perturbations. 
All these missing features constitute the challenges which this thesis aims to solve. 
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Chapter 2. Our Integrative Physiologically-based Model of 
Cardiovascular Control 
In the previous chapter we put existing methods for quantitative assessment of 
autonomic nervous activity on the cardiovascular system under loop and identified some 
unfulfilled requirements. In this chapter we adopt a physiological approach and develop an 
integrative model of cardiovascular control that quantifies the activity of both sympathetic 
and parasympathetic branches which determine normal cardiovascular behavior. The model 
should be further used for quantifying the activity of autonomic nervous system on the 
cardiovascular system.  
2.1 Modeling Notation and Requirements 
An excellent introduction to the modeling concept is given in [78]. Modeling is one of the 
basic methods of science used to describe and understand complex systems. A physiological 
model is an abstract representation that enables us to answer questions about the 
underlying physiological system. The model simulates those aspects of the physiological 
system that are relevant to the problem under consideration. The application domain is 
modeled as a set of objects and relationships. 
A modeling notation system is a graphical, mathematical and textual set of rules for 
representing the model. We will borrow the UML notation from the field of Software 
Engineering that provides a standard for modeling complex software systems. UML stands 
for Unified Modeling Language. [78] 
The structure of the physiological systems, i.e. cardiovascular system, respiratory system 
and autonomic nervous system will be described using UML Class Diagrams. Class diagrams 
represent the anatomical features of the system in terms of classes, objects, attributes, 
operations and their associations. An object concept represents a real-world object, e.g. a 
neuron; a class is a set of objects which share common properties, e.g. the class of all 
baroreceptors; an attribute is a property of an object, e.g. threshold of a neuron; an 
operation is a concrete activity that the object can perform, e.g. firing of a neuron; an 
association represents a link between related objects, e.g. the baroreceptor is linked to the 
rostral ventrolateral medulla. The dynamics of the physiological systems will be modeled 
using differential equations.  
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It is necessary to start the modeling activity by defining which parts of the physiological 
system should be topic of the modeling effort. We consider only the cardio-respiratory 
control system.  Following anatomical and physiological structures are in scope of our 
model: 
• The model should focus on autonomic nervous control on the cardiovascular 
system and makes use of well-established models of its mechanical part. 
• The model should include a quantification of various external stimuli influencing 
the cardiovascular system. 
• The model should include a representation of ongoing sympathetic and 
parasympathetic activity in the absence of any inputs. This pacemaker-like activity 
is referred as autonomic tone. 
• The mechanical part of the model should include pulmonary and systemic 
circulation. The model should distinguish between the splanchnic and 
extrasplanchnic circulations since they have different roles in the baroreflex 
control, causing volume redistribution in response to hemodynamic perturbations 
[71]. 
• Arterial pressure pulsatility should be considered since it has a considerable effect 
on the carotid baroreflex. Pulsatile perfusion of the carotid sinuses modifies the 
frequency in the sinus nerve and alters baroreflex gain [71]. 
• Interaction between carotid baroreflex and Frank-Starling relationship should be 
considered since this can strongly modulate cardiac output and venous return. 
• The model should include the effect of chemoreceptors, lung and atria stretch 
receptors and cold receptors on the heart and blood vessels. 
Following anatomical and physiological structures are out of scope of our model: 
• We do not distinguish between individual vessels in the arterial tree since we are 
only interest in global control of peripheral vascular resistance (i.e. mostly in 
arterioles).  
• Long-term regulation is not considered because our experimental setups include 
stimulations which concern a time period of only 1 to 5 min after hemodynamic 
perturbations. During this period hormonal regulation have negligible effects on 
the regulatory response.  
• Gas exchange at lung and tissues level is not included in the model. We focus on 
cardiovascular control with little insight in respiration control. 
• We ignore inertial effect of blood in venous compartments since they generally 
function as blood reservoir and the major inertance is already covered in the 
arterial compartments. 
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2.2 Model of the Cardiovascular System 
2.2.1 Anatomical Model of the Cardiovascular System 
Our anatomical model of the cardiovascular system (without its control by the autonomic 
nervous system) is a modified representation of the model by Ursino [71]. We schematically 
described his model using the UML class diagram depicted in Figure 2.1 where classes 
represent cardiovascular compartments and associations represent blood flow between 
compartments. The minus sign indicates a model parameter and the plus sign indicates a 
model variable. Both notations are derived from the UML convention. 
The heart is composed of cardiac muscle called myocardium, covered by a thin layer of 
epithelium and connective tissues, the whole encased in a though membranous sac, the 
pericardium. The heart is divided by a central wall, or septum, into left and right halves. Each 
half consists of an atrium and a ventricle, represented here respectively by the classes Left 
Atrium ( la ), Left Ventricle ( lv ), Right Atrium ( ra ) and Right Ventricle ( rv ). Atriums receive 
blood into the heart and ventricles pump blood out of the heart. The right atrium receives 
deoxygenated blood coming from body’s organs through the venae cavae and pumps it into 
the right ventricle.  From there it is pumped through the pulmonary arteries to the lungs, 
where it is oxygenated. Arteries, alveolar circulation and veins in the lungs are represented 
by the classes Pulmonary Arteries ( pa ), Pulmonary Peripheral ( pp ) and Pulmonary Venous (
pv ) respectively. Blood travels from the lungs to the left atria through the pulmonary veins. 
It is then passed to the left ventricle. Blood pumped out of the left ventricle enters the large 
artery aorta. The aorta branches into smaller and smaller arteries that finally lead into a 
network of capillaries. The arterial tree is lumped into the class Systemic Arteries ( sa ). The 
network of capillaries and venules is represented by the class Systemic Peripheral ( sp ). After 
leaving capillaries, blood moves to small veins, then into larger and larger veins until it 
reaches the superior and inferior venae cavae, which empty into the right atria again. 
Venous circulation is represented by the class Systemic Venous. Heart valves ensure one-way 
blood flow in the heart: the atrioventricular valves and the semilunar valves. 
  
Figure 2.1 Anatomical Model of Cardiovascular System 
Each class represents an anatomical component. Parameters are preceded 
by the sign “-“ and variables are preceded with by the sign “+” 
The systemic peripheral and venous systemic circulations are subdivided into distinct 
compartments, which exhibit different baroreflex response [71] and different metabolic 
demand [62]. The corresponding peripheral and venous sub-compartments are coronary, 
brain, skeletal muscles, splanchnic (intestine, stomach, liver, pancreas, spleen) and 
extrasplanchnic (kidneys). The corresponding classes are designated using subscripts 
,  ,  ,  ,hp bp mp sp ep  for the systemic peripheral circulation and ,  ,  ,  ,hv bv mv sv ev  for the 
systemic venous circulation, respectively. 
 Venous and arterial compartments are characterized by their compliance, unstressed 
volume and resistance. These properties are modeled as class attributes using corresponding 
symbols , ,
u
C V R . The inertial effect of blood in arteries is modeled as class attribute using 
the inertance symbol L .  
The capability of circulatory components to generate fluid dynamics is modeled by 
defining the operations which are available in the corresponding class. Operations related to 
flow, volume, resistance, elastance and pressure dynamics have the symbols , , , ,F V R E P
respectively. 
Systemic Arteries (sa)
- Csa:  ml/mmHg
- Vu,sa:  ml
- Rsa:  mmHg.s/ml
- Lsa:  mmHg·ml/s^ 2
+ Fsa(t)
+ Psa(t)
Splanchnic Venous 
(sv )
- Csv:  ml/mmHg
- Vu,sv:  ml
- Rsv:  mmHg.s/ml
+ Psv(t)
Systemic Peripheral
Left Atrium (la)
- Cra:  ml/mmHg
- Rla:  mmHg.s/ml
- Vu,la:  ml
+ Pla(t)
Right Atrium (ra)
- Cra:  ml/mmHg
- Rra:  mmHg.s/ml
- Vu,ra:  ml
+ Pra(t)
Right Ventricle (rv )
- Po,rv:  mmHg
- ke,rv:  mmHg
- Vu,rv:  mmHg/ml
- kr,rv:  s/ml
+ Fir(t)
+ For(t)
+ Vrv(t)
+ Rrv(t)
+ Emax,rv(t)
+ Prv(t)
Left Ventricle (lv )
- Po,lv:  mmHg
- ke,lv:  mmHg
- Vu,lv:  mmHg/ml
- kr,lv:  s/ml
+ Fil(t)
+ Fol(t)
+ Vlv(t)
+ Rlv(t)
+ Emax,lv(t)
+ Plv(t)
Pulmonary Arteries (pa)
- Cpa:  ml/mmHg
- Rpa:  mmHg.s/ml
- Vu,pa:  ml
- Lpa:  mmHg·ml/s^ 2
+ Fpa(t)
+ Ppa(t)
Heart Venous (hv )
- Chv:  ml/mmHg
- Vu,hv:  ml
- Rhv:  mmHg.s/ml
+ Phv(t)
Brain Venous (bv )
- Cbv:  ml/mmHg
- Vu,bv:  ml
- Rbv:  mmHg.s/ml
+ Pbv(t)
Muscle Venous (mv )
- Cmv:  ml/mmHg
- Vu,mv:  ml
- Rmv:  mmHg.s/ml
+ Pmv(t)
Extrasplanchnic 
Venous (ev )
- Cev:  ml/mmHg
- Vu,ev:  ml
- Rev:  mmHg.s/ml
+ Pev(t)
Pulmonary Venous (pv )
- Cpv:  ml/mmHg
- Vu,pv:  ml
- Rpv:  mmHg.s/ml
+ Ppv(t)
Heart Peripheral (hp)
- Chp:  ml/mmHg
- Vu,hp:  ml
- Rhp:  mmHg.s/ml
Brain Peripheral (bp)
- Cbp:  ml/mmHg
- Vu,bp:  ml
- Rbp:  mmHg.s/ml
Muscle Peripheral 
(mp)
- Cmp:  ml/mmHg
- Vu,mp:  ml
- Rmp:  mmHg.s/ml
Splanchnic 
Peripheral (sp)
- Csp:  ml/mmHg
- Vu,sp:  ml
- Rsp:  mmHg.s/ml
Extrasplanchnic 
Peripheral (ep)
- Cep:  ml/mmHg
- Vu,ep:  ml
- Rep:  mmHg.s/ml
Pulmonary Peripheral (pp)
- Cpp:  ml/mmHg
- Vu,pp:  ml
- Rpp:  mmHg.s/ml
+ Ppp(t)
Systemic Venous
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2.2.2 Physiological Model of the Cardiovascular System 
The equations for the conservation of mass and balance of flow forces describing the 
mechanical activities resulting in a cardiac cycle have been adapted from [62, 71]. We will 
not describe them in details here since we are only interested in modeling neural control. 
The equations can be found in Appendix A1 and give the relationship between pressure, 
volume, flow, resistance, compliance, inertance and elastance during a cardiac cycle which 
can be resumed in five phases.  
In the first phase, atrial and ventricular diastole, atria and ventricles are relaxing. The 
atria are filling with blood from veins.  The ventricles have just completed a contraction and 
as they relax, the AV valves open and blood flows by gravity from the atria into the 
ventricles. 
In the second phase, atrial systole, although most blood enters the ventricles in the phase 
1, the last 20% of filling is accomplished during atrial contraction. A small amount of blood is 
forced backward into the veins.  
In the third phase, ventricular contraction, blood pushing the underside of AV valves 
forces them to close. Vibrations following closure of the valves create the first heart sound. 
With both AV valves closed and ventricles still contracting, high pressure develops. This 
phase is called isovolumic ventricular contraction. While ventricles are contracting, atria are 
relaxing. When atrial pressure falls below that in the veins, blood flows from the veins into 
the atria again. 
In the fourth phase, ventricular ejection, ventricles have contracted and generated 
enough pressure to open the semilunar valves. High-pressured blood is pushed into arteries.  
During this phase, the AV valves remain closed and the atria continue to fill. The stroke 
volume is approx. 70 mL. Cardiac output is obtained by multiplying the stroke volume with 
the heart rate (e.g. 70 mL X 72 beats/min ≈ 5 L/min, this means that, at rest, one side of the 
heart pumps all the blood in the body through it in only one minute). During exercise cardiac 
output can increase to 35 L/min.  
In the fifth phase, ventricular relaxation, pressure in ventricles falls below the pressure in 
arteries and blood starts to flow backward into the heart. This backflow forces the semilunar 
valves to close. This period is called isovolumic ventricular relaxation because the volume of 
blood in the ventricles is not changing. When ventricular relaxation causes ventricular 
pressure to become less than atrial pressure, the AV valves open and blood rushes from the 
atria into the ventricles. The cardiac cycle has begun again. 
 2.3 Anatomical Model of Cardiovascular Control 
Most of the anatomical and physiological background information in this section can be 
found in any basic physiological textbook [79, 80, 81]. Autonomic control centers in the brain 
monitor and regulate important functions. The hypothalamus is the center for homeostasis, 
it activates sympathetic nervous system, maintains body temperature, controls body 
osmolarity, controls reproductive function, controls food intake, influences behavior,  
emotions and the cardiovascular control center. The pons makes the relay station between 
cerebrum and cerebellum and coordinates breathing. The cardiovascular integration centers 
which receive sensory inputs, the interconnection between nervous control regions, and the 
sources of efferent signals are gradually being identified but the map is far from complete. 
The following five classes of neurons constitute the central neural pathways for 
cardiovascular regulation as depicted in Figure 2.2: 
• Primary afferent neurons that bring sensory information to the brain. 
• Interneurons that forward sensory information and inputs from higher brain 
centers to the premotor neurons. 
• Autonomic premotor neurons that control the activities of preganglionic neurons. 
• Preganglionic autonomic motor neurons that project to the autonomic ganglion. 
• Postganglionic autonomic motor neurons that innervate the effectors organ and 
implement the cardiovascular response. 
 
 
Figure 2.2 Central Cardiovascular Neural Pathways (reprinted from [81]) 
 2.3.1 Primary Afferent Neurons 
A wide range of sensory neurons monitor cardiovascular state. Their organization is 
modeled using the UML Class Diagram depicted in Figure 2.3 where each class represents a 
group of receptors sharing the same functionalities. Main classes are baroreceptors, 
chemoreceptors, stretch receptors, thermoreceptors and nociceptors. They are further 
subdivided in subclasses using the UML notation for specialization (arrow with triangle 
ending).  
Baroreceptors are stretch-sensitive mechanoreceptors located in the walls of the carotid 
arteries and aorta, where they monitor the pressure of blood flowing to the brain (carotid 
baroreceptors) and to the body (aortic baroreceptors). When increased blood pressure in 
the arteries stretches the baroreceptor membrane, firing rate of the receptor increases. If 
the blood pressure falls, the firing rate decreases. 
 
Figure 2.3 UML Class Diagram for Primary Afferent Neurons 
Cardiovascular function can be modulated by input from peripheral receptors other than 
the baroreceptors. For example, low blood flow causes pulmonary ventilation to increase. 
The cardiovascular control center also has reciprocal communication with centers controlling 
respiration. Increase in breathing rate is usually accompanied by increase in cardiac output. 
Additional receptors deliver afferent information: pulmonary artery pressure sensors 
project to the medulla; right and left atria receptors sense intravascular volume; ventricular, 
pericardial and coronary sinus stretch sensors causes a reflex fall in pressure. 
Thermoreceptors in the face sense low temperature and elicit bradycardia. Cerebral or 
muscle chemoreceptors sense oxygen and carbondioxyde level in brain tissues or skeletal 
muscles. Thermoreceptors in the hypothalamus monitor blood temperature. Peripheral 
sensory nerves (pain fibers from viscera and large blood vessels) simulation may elicit a very 
strong depressor response and causes fainting (vasovagal syncope). Muscles and joints 
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stretch receptors sense tension and length of change and can stimulate sympathetic activity 
to help reinforcing cardiovascular response to exercise. 
Many afferent neurons terminate in the nucleus of the solitary tract, each type of afferent 
input having its specific terminal field within the tract. Some studies suggest that the solitary 
tract is capable of modulating or even inhibit afferent input information.  
2.3.2 Autonomic Premotor Neurons 
Sensory neurons projects to autonomic premotor neurons. Their organization is modeled 
using the UML Class Diagram depicted in Figure 2.4 where each class represents a group of 
premotor neurons sharing the same functionalities. Reflex reactions are integrated and 
coordinated through sympathetic and vagal premotor neurons which are further subdivided 
into inhibitory and excitatory subclasses using the UML notation for specialization (arrow 
with triangle ending). Premotor neurons can group to form an autonomic nervous center, 
what is shown using the aggregation notation in UML (arrow with a diamond ending). 
Autonomic nervous centers include specific cell groups in the rostral ventrolateral 
medulla, rostral ventromedial medulla, caudal raphe nuclei, as well as noradrenergic cell 
group in the caudal ventrolateral pons, and the paraventricular nucleus in the hypothalamus. 
They innervate the preganglionic outflow to the adrenal medulla and all major sympathetic 
ganglia.  
The CNS (Central Nervous System) coordinates the reflex control of blood pressure mostly 
from the medulla. Cells in the rostral ventrolateral medulla play a crucial role in the tonic 
and phasic regulation of blood pressure. The primary goal is to maintain adequate blood 
flow to the brain and the heart. Action potentials from the baroreceptors travel to the 
medulla via sensory neurons. The control center integrates sensory input and initiates an 
appropriate response. Excitation of the rostral ventrolateral medulla cells produces an 
increase in blood pressure, increase in heart rate and release of adrenomedullary 
catecholamines. The response is quite rapid and changes cardiac output and peripheral 
resistance within two heartbeats.  Studies indicate that rostral ventrolateral medulla cells do 
not affect the sympathetic output to noncardiovascular effectors.  
Some rostral ventrolateral medulla neurons display an ongoing synaptic pacemaker 
activity, which is propagated in the sympathetic preganglionic neurons. These neurons 
exhibit a spontaneous regular activity even in absence of synaptic inputs. They project to the 
spinal cord and are inhibited by baroreceptors activation. Blocking all sympathetic activity 
leads to a drop of arterial pressure of approximately 50%, indicating a continuous basal level 
of sympathetic firing at normal pressure, called sympathetic tone. The pacemaker neurons 
within the rostral ventrolateral medulla have much higher firing rates and conduction 
velocities than non-pacemaker neurons. [82] 
Stimulation of rostral ventromedial medulla results in modest increase in blood pressure 
whereas stimulation of medullary raphe nuclei can elicit either a decrease or an increase of 
blood pressure depending on the region stimulated. This suggests that medullary raphe 
nuclei includes both sympathoexcitatory and sympathoinhibitory neurons. Stimulation of the 
A5 noradrenergic cell group in the pons produces decrease in heart rate and blood pressure. 
Stimulation of the caudal ventrolateral medulla cells is accompagnied with inhibition of 
sympathetic vasomotor activity and a decrease in cardiac contractility. In contrast inhibition 
of the caudal ventrolateral medulla cells results in the opposite effect. It was suggested that 
these neurons project to the rostral ventromedial medulla. 
  
Figure 2.4 UML Class Diagram for Autonomic Premotor Neurons 
2.3.3 Preganglionic Autonomic Motor Neurons 
Reflex reactions are carried out by the efferent division of the autonomous nervous 
system (ANS) whose organization is modeled using the UML Class Diagram depicted in Figure 
2.5, where each class represents a group of preganglionic motor neurons sharing the same 
functionalities. The autonomic division is subdivided into sympathetic and parasympathetic 
branches which have anatomical differences according to the origin of cell bodies of their 
preganglionic neurons.  
The cell bodies of vagal preganglionic neurons innervating cardiac ganglia are located in 
the nucleus ambiguous within the ventrolateral medulla, but to a lesser extent also within 
the dorsal motor nucleus of the vagus. Cardiac vagal preganglionic neurons fire in synchrony 
with the cardiac cycle, due to an excitatory input arising mainly from baroreceptors. 
However they also react to inputs from peripheral chemoreceptors, cardiac receptors, and 
trigeminal cold receptors activated during the diving reflex. Additionally vagal preganglionic 
nerves are inhibited during the inspiration phase of the respiratory cycle. In general 
parasympathetic ganglia are located close to their target tissues. The major parasympathetic 
pathway is the vagus nerve (cranial nerve X).  [42]  
The cell bodies of sympathetic preganglionic neurons are located in the thoracic (T1) and 
upper lumbar segments of spinal cord (S2 – S4), especially in the intermediolateral cell 
column. Groups of nerves with vasomotor and nonvasomotor functions form entirely 
separate populations and have different locations within the spinal cord. Furthermore 
sympathetic preganglionic neurons controlling blood vessels in different effectors organs 
form separate groups, each with their own physiological characteristics. [42] 
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 Particular physiological situations including emotional stress, pain, exercise, blood loss or 
heart failure activate the adrenal preganglionic sympathetic nerves, which project to both 
suprarenal glands (adrenal medulla). 
 
Figure 2.5 UML Class Diagram for Preganglionic Autonomic Motor Neuron 
2.3.4 Postganglionic Autonomic Motor Neurons 
Postganglionic autonomic neurons have their cell bodies in the autonomic ganglion and 
project their axon to the target tissue. Their organization is modeled using the UML Class 
Diagram depicted in Figure 2.6, where each class represents a group of postganglionic motor 
neurons sharing the same functionalities. Both sympathetic and parasympathetic 
postganglionic motor neurons innervate the heart.   
The main nerve branches controlling the sympathetic behavior of the heart are bunched 
together into the cardiopulmonary splanchnic nerves. They approach the base of the heart 
before splitting into smaller nerves which innervate much of the myocardium, with high 
concentration around the aortic arch and ventricles.  
Parasympathetic postganglionic autonomic neurons originate from ganglia located near 
the sinoatrial and atrioventricular node. They innervate a large portion of artria. The right 
vagus nerve primary innervates the sinoatrial node while the left vagus nerve innervates the 
atrioventricular node. Parasympathetic innervations of ventricles is negligible compared to 
sympathetic innervations (16-50%), whereas parasympathetic division outcomes 
sympathetic division by 30-60% in atria. Endocardial and epicardial distribution of 
sympathetic nerve endings appears to be equal whereas endocardial innervation by 
parasympathetic nerves surpasses epicardial innervations by some 100%. 
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Figure 2.6 UML Class Diagram for Postganglionic Autonomic Motor Neuron 
Sympathetic postganglionic neurons release norepinephrine at cardiac muscle cells. As 
result the muscular contraction commences sooner with greater force, the systole duration 
shortens and the diastole duration increases. With increased relaxation time, the preload 
increases causing a positive inotropic effect after Frank-Starling law. This results in increased 
stroke volume.  
The adrenal medulla release catecholamines into the circulation which modify heart rate 
and peripheral vascular resistance. Heart rate is also dependent on changes in circulating 
thyroxin (thyrotoxicosis causes tachycardia) and by changes in body core temperature 
(hyperthermia increases heart rate).  
Sympathetic postganglionic neurons also innervate blood vessels (arteries, arterioles, 
veins) which respond with vasoconstriction, vasodilation, venoconstriction, venodilation.  
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2.4 Physiological Model of Primary Afferent Neurons 
2.4.1 Model of Baroreceptors 
Baroreceptors are sensitive to the rate of change of blood pressure and to the mean of 
pressure. Reduced mean pressure reinforces the baroreflex when pressure falls. Maximal 
baroreceptors sensitivity occurs when the set point of normal mean arterial pressure is 
reached (ca. 95 mm Hg in adults). Small deviations from the set point induce large change in 
firing rate of baroreceptors, however the set point and response shape is not fixed. The 
resetting of the receptors can occur locally at the level of the baroreceptors themselves or 
centrally in cardiovascular control centers. Long-term blood pressure regulation cannot be 
achieved by baroreceptors inputs because of their adaptative nature. We presented a non-
linear model of baroreceptors dynamics in section 1.7.2 which has been proposed by 
Ottesen and co-workers. The model was used in open-loop condition to successfully 
simulate changes in heart rate induced by orthostatic stress, arterial pressure being provided 
as input. We recall equation (1.7.7) and describe baroreceptors firing rate abf as follows: 
 
b1 sa ab b ab b1
b1 2
b b1
b2 sa ab b ab b2
b2 2
b b2
b3 sa ab b ab b3
b3 2
b b3
2
b b b
b b2
b
ab b1 b2 b3 b
dn dP f (M - f ) n
= k -
dt dt (M / 2) t
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= k -
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M MN = + M -
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η
η
⋅
⋅ ⋅
⋅
⋅ ⋅
⋅
⋅ ⋅
 
⋅ 
 
 (2.4.1) 
where 1 2 3, ,b b bk k k are constant weighting factors; 1 2 3, ,b b bτ τ τ  are time constant describing 
the resetting phenomenon; bM is the high saturation level of the firing rates and bN is the 
threshold value of the firing rates depending on the constant bη . Constant values are given 
in Table 2.4.1 as calculated by Ottesen after fitting the model with heart rate and blood 
pressure data obtained on healthy young subjects [65]. A simulation of the equations above 
is given in Figure 2.7 where a decrease of baroreceptor firing rate can be observed with 
decreased arterial blood pressure from 50th to 60th second. 
 
  
Figure 2.7 Simulation of baroreceptors 
Receptors firing rate (lower graph) with decreasing arterial blood pressure (upper graph) 
 
Table 2.4.1 Constant values for baroreceptors 
Constant Value Description 
1bk  3.50 ± 4.0 mmHg
-1
 gain constant for short time response component of baroreceptor 
2bk  0.73 ± 0.5 mmHg
-1
 gain constant for intermediate time response component of baroreceptor 
3bk  1.41 ± 1.4 mmHg
-1
 gain constant for long time response component of baroreceptor 
1bτ  0.82 ± 0.5 s resetting time for short time response component of baroreceptor 
2bτ  5.58 ± 2.0 s resetting time for intermediate time response component of baroreceptor 
3bτ  262.03 ± 16 s resetting time for long time response component of baroreceptor 
bM  120 Hz maximal firing rate of baroreceptor 
bη  1.28 ± 0.3  model constant 
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 2.4.2 Model of Chemoreceptors 
Peripheral chemoreceptors in the carotid and aortic bodies respond to low oxygen or high 
carbon dioxide levels in blood. Central chemoreceptors lie on the ventral surface of the 
medulla and sense carbon dioxide level in the cerebrospinal fluid and respond to the 
resulting pH change. High level of carbon dioxide modulates respiration by increasing the 
rate and depth of ventilation. A model of chemoreceptors firing rate acf has been described 
in section 1.7.3 as sigmoidal response to changes in partial pressure of oxygen 
2Oas
P  in the 
arterial systemic compartment using equation (1.7.12) . 
We adopt the equation in our model and use the constant values given in Table 2.4.2 as 
calculated by Ursino after fitting the model with experimental data [62]. A simulation of the 
equation is given in Figure 2.8 where an increase of chemoreceptors firing rate can be 
observed with breath holding, i.e. decreased oxygen partial pressure in arterial blood. 
Table 2.4.2 Constant values for chemoreceptors 
Constant Value Description 
cτ  2 s time constant of the chemoreceptor dynamics 
ac
k
 
29.27 mmHg slope of the chemoreceptor sigmoid at the central point 
,minacf  1.16 Hz lower saturation of chemoreceptor discharge 
,maxacf  17.07 Hz upper saturation of chemoreceptor discharge 
2O nas
P
 
45mmHg oxygen partial pressure at  the central point of chemoreceptor sigmoid 
 
 
 
Figure 2.8 Simulation of chemoreceptors  
Receptors firing rate (bottom panel) in response to oxygen partial pressure changes (top panel) 
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 2.4.3 Model of Lung Stretch Receptors 
Inflation of lungs at low pressure activates slowly adapting stretch receptors with vagal 
myelinated A-fibers which project to the medulla. Their activity depends on the tidal volume, 
which depends on chemoreceptors activity. Chemoreceptors inform about low oxygen level; 
response is increased tidal volume; lung stretch receptors measure the response and inform 
medulla, thus creating a closed-loop. We adopt the model of pulmonary stretch receptors 
firing rate 
apf  which has been introduced in section 1.7.3, equation (1.7.13). It describes 
how the firing rate increases with increased tidal volume TV . 
Constant values are given in Table 2.4.3 as calculated by Ursino after fitting the model 
with experimental data [62]. A simulation of the equation is given in Figure 2.9 where a 
decrease of stretch receptors firing rate can be observed with breathe holding after 
expiration, i.e. decreased tidal volume. 
Table 2.4.3 Constant values for lung stretch receptors 
Constant Value Description 
cτ  2 s time constant of the lung stretch receptors dynamics 
apG  23.29 L-1 Hz constant gain factor 
 
 
Figure 2.9 Simulation of lung stretch receptors 
Receptors firing rate (bottom panel) in response to tidal volume change (top panel) 
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 2.4.4 Model of Atria Stretch Receptors 
Stretch receptors in atria are able to respond to changes in preload, afterload, and 
contractility of the heart. The afferent activity is modeled using a linear derivative first-order 
dynamic block and a sigmoidal static block as suggested by Magosso and  Liang [83, 84]: 
 
pv pv,n
aa
pv pv,n
aa
P -P
k
aa,max
aa P -P
k
pv
aa pv pv
f ef =
1+e
dP
t = P - P
dt
⋅
⋅
%
%
%
%
 (2.4.2) 
where aaf is the firing rate of the atria stretch receptor in response to the sensed pressure 
pvP% which depends on the pulmonary venous pressure pvP ; ,maxaaf is the upper saturation 
level of firing rate; aaτ is a time constant; ,pv nP is the value of venous pressure at the central 
point of the sigmoidal function; aak is a parameter, with the dimension of pressure, related 
to the slope of the static function at the central point.  
Constant values are given in Table 2.4.4 as calculated by Magosso after fitting the model 
with experimental data [62]. A simulation of the equations above is given in Figure 2.10 
where a decrease of stretch receptors firing rate can be observed with decreased pulmonary 
venous pressure. 
Table 2.4.4 Constant values for atria stretch receptor 
ConstantValue Description 
,pv nP  6.0 mmHg set-point value of the cardiopulmonary baroreflex 
aa,maxf  18.0 Hz upper saturation of atria stretch receptor 
aa
τ  6.37 s time constant of atria stretch receptor afferent response 
aak  3.429 mmHg slope of the atria stretch receptor sigmoid at the central point 
 
Figure 2.10 Simulation of atria stretch receptors 
Receptors firing rate (dashed line) in response to changes in pulmonary venous pressure (plain line) 
Right and left atria receptors also sense intravascular volume (i.e. atria stretch or preload) 
and project to the hypothalamus and cortex. Stretch causes decreased antidiuretic hormone 
release, which results in increased urine output. Stretch causes also release of atrial 
natiuretic peptide, which acts on the kidneys and promotes body fluid volume reduction. 
Ventricular, pericardial and coronary sinus stretch sensors causes a reflex fall in pressure. 
We do not include these processes in our model for simplicity. 
0 10 20 30 40 50 60 70 80 90 100
4
5
6
7
8
9
10
11
12
13
14
15
seconds
m
m
Hg
 
/ H
z
Response of atria stretch receptors in response to change in pulmonary venous pressure
 
 
Ppv - Pulmonary venous pressure
faa - firing rate of atria strecth receptors
 39 
 
2.4.5 Model of Cold Receptors 
The mechanism of transduction in cold receptors with temperature change is not fully 
understood and we could not find any mathematical model of their function in the known 
literature. In the following paragraphs we will develop mathematical equations that relate 
cold stimuli to the neural activity of cold receptors. 
 Innocuous cold receptors sense nonpainful cold temperature, whereas temperature 
nociceptors respond to noxious cold or heat, which can damage organs. At normal skin 
temperature innocuous cold receptors exhibit a spontaneous, periodic discharge that 
increases with cooling and decreases with warming. In contrast, cold nocireceptors are quiet 
at rest and fire only to extreme low temperatures. It has been recently suggested that 
Transient Receptor Potential Melastatin 8 (TRPM8) is the best molecular candidate to 
explain the mechanism of transduction of cold in both innocuous thermoreceptors and 
nociceptors. TRPM8 are activated by the threshold of 25°C ± 1 [85]. Cold receptors usually 
increase their firing rate when the threshold temperature is reached. Their initial response 
indicates a change in temperature and their sustained response informs about the ambient 
temperature. Some cold receptors also briefly respond to high temperature (> 45°C). This is 
known as a paradoxical response to heat. A repetitive beating activity and burst (grouped) 
discharges were observed in cold receptor populations at constant temperatures and after 
rapid cooling [86]. Such studies were conducted by Hutchison who did a quantitative analysis 
of orofacial thermoreceptive neurons in the superficial medullary dorsal horn of the rat [87]. 
He classified the receptors after their response to decreasing temperatures (see Figure 2.11). 
Type 1 had a bell-shaped static stimulus response function. Type 2 had a high maintained or 
increasing static firing rate as temperature decreased. Type 3 showed highly dynamic 
components in its response function. Similar response functions were obtained in [85] when 
investigating the response of neurons located in trigeminal subnucleus caudalis (Vc) during 
intraoral cooling (via ice water and menthol) of TRPM8 channels on rats.  
We distinguish between facial receptors which are located on the forehead and can elicit 
the diving reflex [88] and receptors which are located on hands and feet. Below a certain 
threshold the firing rate of facial receptors (also called trigeminal thermoreceptors) 
promptly rises until saturation is reached, then rapidly decreases to resting values even 
when stimuli is maintained.  We model this behavior using an exponential decay function 
fat
f  as follows. 
 
( )
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at startf
f f
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at ,min start
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 (2.4.3) 
where ,start stopt t are model inputs representing the start and stop timestamps of cold 
stimulation; 
fat ,min
f is the lower saturation level of firing rate with constant value 5 Hz; 
fat ,max
f is a model parameter representing the upper saturation level of firing rate; 
fat
k is 
model parameter related to the slope of the exponential decay function.  
 When hands or feet are immersed in cold water (temperature around 0 ⁰C), heart rate 
response indicates that cold receptors of type 2 are mostly activated compared to other 
types, since the response is maintained during the whole period of stimulation.  We model 
the firing rate 
sat
f of cold receptors on hands and feet using a sigmoid function as follows. 
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 (2.4.4) 
where ,start stopt t are model inputs representing the start and stop timestamps of cold 
stimulation; 
sat
k  is a parameter related to the slope of the cold response; 
sat ,max
f  is the 
maximal firing rate of cold receptors.  
Typical parameters values are summarized in Table 2.4.5 after we have tried several 
values so that the simulated firing rate will fit the shape of neural spikes measured invasively 
on rats and published in [85]. A simulation of above equations is given in Figure 2.13 and 
Figure 2.14 where cold receptors of face and hands/feet increase their firing rate with 
decreasing temperature, followed by an exponential decay and sigmoidal increase 
respectively. This response shape agrees with experimental data in Figure 2.12.  
 
 
 
 
 
Figure 2.11 Types of cold receptors (reprinted from [87]) 
Left panels – mean firing rates with gradual decreasing temperature 
Right panels – mean firing rates with step decrease and increase temperature 
 Table 2.4.5 Parameters values for cold receptor 
Parameter Value Description 
fat ,max
f  50 Hz upper saturation of facial cold receptor 
fat
k  0.2 s-1 slope of the exponential decay of facial cold receptor 
sat ,max
f  72 Hz upper saturation of cold receptor on hands and feet 
sat
k
 1.03 s
-1
 slope of the sigmoid response of cold receptor on hands and feet 
 
 
Figure 2.12 Cold receptor response to sustained cold stimuli and menthol (reprinted from [85]) 
 
 
 
Figure 2.13 Simulation of trigeminal cold receptors 
Receptors firing rate (bottom graph) as response to low temperature (low graph) 
 
 
 
Figure 2.14 Simulation of cold receptors on hands/feet by low temperature 
Temperature drops from 22⁰C to 0⁰C at 120
th
 second until 160
th
 second  
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2.4.6 Model of Eye Pressure Sensors 
The Oculocardiac reflex is a trigeminovagal reflex that can produce potent bradycardia 
and cardiac arrhythmias such as nodal rhythm, ectopic beats, ventricular fibrillation, or 
asystole. The reflex may be induced by applying pressure on the eyeball or caused by an 
orbital hematoma, ocular trauma, eye pain, and traction of an extraocular muscle during 
treatment of poor alignment of the visual axis (strabismus) [89]. We could not find any 
mathematical model of this reflex in the known literature and will propose such a model in 
the following paragraphs. 
Experimental data recorded in [90] (Figure 2.15) illustrate that receptor activity depends 
on the pressure or stretch applied on the cornea. When pressure occurs, the firing rate 
promptly rises until saturation is reached.  Such a behavior can be modeled using a sigmoid 
function as follows. 
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 (2.4.5) 
where aof is the firing rate of sensors in eyeball in response to the pressure exerted on eye 
ball; ao,maxf is a model parameter representing the upper saturation level of firing rate; aok is a 
model parameter related to the slope of the sigmoid function; ,start stopt t are model inputs 
representing the start and stop timestamps of pressure; 
Parameters values are given in Table 2.4.6 after trying several values so that the 
simulated firing rate fits the shape of electro-oculograms recorded in [90] during 
oculocardiac reflex. A simulation of the equations above is given in Figure 2.16 where oculo-
pressure receptors increase their firing rate with increased pressure on eye balls.  
 
Table 2.4.6 Parameters values for oculo-pressure receptor 
Parameter Value Description 
ao,maxf  17 Hz upper saturation of oculo-pressure receptor 
aok  0.7 s-1 slope of the sigmoid response of oculo-pressure receptor 
 
  
Figure 2.15 Recorded changes induced by the oculocardiac reflex (reprinted from [90]) 
ECG, RR intervals, thoracic respiratory movements by impedancemetry (Imp), right and left 
electroencephalograms (F3O1 and F4O2), left and right electro-oculograms (LEOG and REOG) 
 
 
 
Figure 2.16 Simulation of oculo-pressure receptors 
pressure on eye balls is applied from 90
th
 to 170
th
 second 
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 2.4.7 Model of Central Input during Mental Stress 
Invasive studies with direct microneurographically measurement of muscle sympathetic 
nerve activity (MSNA) have exhibited an increased sympathetic activity during mental stress, 
induced for example by arithmetic tasks and characterized by an overall increase of heart 
rate and blood pressure [91]. Figure 2.17 shows MSNA recordings during mental tasks and 
the corresponding heart rate and blood pressure changes. 
 
 
Figure 2.17 MSNA, heart rate and blood pressure recordings during stress  (reprinted from [91]) 
MSNA (muscle sympathetic nerve activity), CWT (colour word test), MA (mental arithmetic) 
5 min of baseline, 30 min of mental stress, 10 min of recovery 
In order to reproduce the observed heart rate changes, which have a plateau-like shape, 
we assume that there exist some kinds of mental stress sensors, which communicate the 
level of stress to sympathetic premotor neurons using a logistic function asf . We propose 
the following model with outputs normalized in the interval 0 to 1. 
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 (2.4.6) 
where ,start stopt t are model inputs representing the start time and stop time of mental stress; 
ask is a parameter related to the slope of the mental stress sensor response; as,maxf  is the 
maximal value.  
 Typical parameters values are summarized given in Table 2.4.7 after trying several values 
so that the simulated firing rate fits the shape of microneurographically measurement of 
muscle sympathetic nerve activity performed in [91] during cognitive stress. A simulation of 
above equations is given in Figure 2.18 where increased heart rate and blood pressure is 
visible as response to mental stress from 150th to 220th second. 
 
Table 2.4.7 Parameter values for mental stress sensors 
Constant Value Description 
as,maxf  20 Hz upper saturation of mental stress sensors 
as
k  0.2 s-1 slope of the mental stress sensor response 
 
 
 
Figure 2.18 Simulation of mental stress sensors 
Mental arithmetic was performed from 150
th
 to 220
th
 second. 
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 2.5 Physiological Model of Autonomic Premotor Neurons 
2.5.1 Model of Sympathetic Premotor Neurons 
There are evidences that rostral ventrolateral medulla cells do not exert a uniform control 
over the sympathetic vasomotor outflow. Ursino distinguished between premotor neurons 
which control sympathetic preganglionic neurons projecting to heart, brain, skeletal 
muscles, splanchnic and extrasplanchnic vascular beds in his model [62]. We further 
distinguish between SA node, AV node and ventricles. Sympathetic innervation in remaining 
parts of heart is negligible. We denote the firing rate of sympathetic premotor neurons to 
both SA node and AV node, ventricles, brain, skeletal muscles, splanchnic and 
extrasplanchnic vascular beds by , , , , ,
pm pm pm pm pm pmsn sv sb sm ss se
f f f f f f  respectively. The rostral 
ventrolateral medulla receives inputs from interneurons originating in supraspinal nuclei, 
prefrontal cortex, hypothalamic defense area, fastigial pressor area, fastigial nucleus in the 
cerebellum and primary afferent nerves from peripheral baroreceptors, chemoreceptors, 
cardiopulmonary receptors, renal receptors and vestibular receptors as well as inputs from 
the central respiratory rhythm generator. Furthermore studies suggest that rostral 
ventrolateral medulla vasomotor cells have ascending projections to brain stem and 
diencephalic nuclei to inform on the degree of sympathetic motor outflow. 
In our modeling effort we consider inputs from afferent neurons including baroreceptors, 
chemoreceptors, lung stretch receptors, atria stretch receptors, trigeminal cold receptors, 
cold receptors in hands/feet and mental stress sensors characterized by their firing rate 
, , , , , ,
f sab ac ap aa at at as
f f f f f f f .  
We assume that premotor neurons have additive properties of the sensory inputs and 
model their firing rate using an exponential trend with weighted sensory inputs.  The weight 
(W ) is applied negatively when increased sensory input inhibit premotor neuron output and 
positively elsewhere. For example the baroreflex functions as a negative feedback system 
such that baroreceptors firing normally inhibit sympathetic autonomic premotor neurons in 
rostral ventrolateral medulla. Decreased blood pressure causes decreased baroreceptors 
firing, therefore increased sympathetic tone together with decrease vagal tone. Although 
small increases of arterial pressure provoked reciprocal changes of sympathetic and vagal 
neural outflows, larger increases of pressure provoked exclusively increases of vagal-cardiac 
nerve activity (see Figure 2.19). Thus baroreflex stimulation provokes reciprocal changes of 
sympathetic activity (negative weight) and parasympathetic activity (positive weight) 
whereas some physiological interventions such as diving reflex provoke parallel changes. 
 
Figure 2.19 MSNA and RR changes with carotid distending pressure (reprinted from [42]) 
MSNA (sympathetic nerve activity),  RR (RR interval) - Large increase of arterial pressure causes moderate 
decrease of sympathetic activity (left panel) and large increase of RR interval durations (right panel) 
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Some rostral ventrolateral medulla neurons display an ongoing excitatory activity even in 
absence of sensory inputs. The continuous basal level of sympathetic firing at normal 
pressure is called sympathetic tone. The power of this activity lies in the 2 to 10 Hz range in 
anesthetized decebrated animals. The origin of spontaneous activity is still under debate. A 
theory suggests that some premotor neurons are chemosensitive and are tonically excited at 
normal level of oxygen or carbon dioxide partial pressure [76]. Another theory suggests the 
existence of cell groups with electrophysiological pacemaker properties [81]. We developed 
a model of sympathetic tone 
,0,es snf  as follows. 
 ( )es,0,sn es,0,high es,0,c ac es,0,minf = max f +W f , f⋅  (2.5.1) 
where
,0,es highf is a model parameter representing the firing rate of cells group exhibiting a 
pacemaker activity in the frequency range 2 to 10 Hz;  
,0,es cW is a model parameter 
representing synaptic weight applied to sensory inputs from chemoreceptors acf ; es,0,minf is a 
model constant representing the minimal basal firing rate of sympathetic premotor neurons.  
Mayer waves are arterial pressure oscillations lower than respiration rate [92]. They have 
a characteristic frequency of approximately 0.1 Hz and result in fluctuations in sympathetic 
vasomotor tone since they are strongly reduced or abolished with α-adrenoceptors 
blockade. Studies suggest that Mayer waves do not depend on age, gender or posture. The 
origin of the waves remains under investigation with two prominent theories [93]. The 
pacemaker theory suggests a central oscillator implemented by a group of medullary or 
spinal neurons which generate slow sympathetic nervous activity rhythms to vasculature 
independent of afferent inputs. For example sinoaortic denervated, vagotomized and 
decerebrated cats present rhythmic discharge of medullary neurons involved in the 
regulation of the cardiovascular system. This is usually called vascular tone. The baroreflex 
theory suggests that Mayer waves are an epiphenomenon of delayed baroreflex operation. 
They are a resonance effect of the baroreflex mediated sympathetic vasoconstriction control 
loop and have no specific function. We take the pacemaker theory into account at this level 
and introduce an additional model variable 
,0,es pf representing the vascular tone which is 
derived from equation (2.5.1) as follows. 
 ( )es,0,p es,0,high es,0,c ac es,0,low es,0,low es,0,minf = max f +W f +W f , f⋅ ⋅  (2.5.2) 
where 
,0,es lowW is a synaptic weight applied to the variable ,0,es lowf  which represents the rate 
of slower oscillation in premotor neurons activity as modelled in the equation (2.5.3) below. 
We assume that the slow oscillator presents a bursting property characterized by brief 
bursts of oscillatory activity interspersed with quiescent periods. Such phenomenon is 
usually described using FitzHugh-Nagumo models. Hindmarsh and Rose distil this biophysical 
mechanism into a simple model containing only polynomials [82]. We adapt his model and 
describe
,0,es lowf as follows. 
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 where , ,es es esx y z are polynomial variables; ,0, ,0,,es low es lowr k are model parameters that 
determine the bursting frequency; 
,0,es lowf is the instantaneous number of spikes per seconds, 
i.e the firing rate of the slow oscillator generating Mayer waves. 
Parameters of the subsystem generating sympathetic tone and Mayer waves are 
summarized in Table 2.5.1 after trying different parameters sets so that model output fits 
the shape of firing rate of the slow sympathetic oscillator as measured on sham-operated 
and sinoartic baroreceptor denervated rats in [81] [93] [82]. A simulation of the equations 
above is given in Figure 2.20 where the sympathetic basal tone can be seen, as well as the 
vascular tone. 
 
Table 2.5.1 Parameters values for rhythmic sympathetic premotor neurons 
Parameter Value Description 
,0,minesf  16.11 Hz minimal basal firing rate of sympathetic premotor neurons 
,0,es highf  [2-10] Hz firing rate of pacemaker sympathetic premotor neurons exhibiting a pacemaker activity 
, ,0c esW  2.1 synaptic weight applied to sensory inputs from chemoreceptors 
,0,es lowW  2.1 
synaptic weight applied to low frequency oscillators in sympathetic premotor 
neurons 
,0,es lowr  0.05 parameters determining the rate of low frequency oscillators in sympathetic 
premotor neurons 
,0,es lowk  3 
 
 
Figure 2.20 Simulation of rhythmic sympathetic premotor neurons 
Firing rate of neurons generating sympathetic tone (plain line) and Mayer waves (dashed lines) 
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Sympathetic premotor neurons which control sympathetic preganglionic neurons 
projecting to the SA Node and AV node are inhibited by increased activity of baroreceptors, 
lung stretch receptors, atria stretch receptors and trigeminal cold receptors. They are 
excited by increased activity of chemoreceptors, cold receptors in hands/feet and mental 
stress sensors. Therefore we model the firing rate of sympathetic premotor neurons 
controlling SA node and AV node as follows. 
 
es b,sn ab c,sn ac p,sn ap a,sn aa t ,sn at t ,sn at s,sn as snf f s s
pm
pm
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where 
, , , , , , ,
, , , , , ,
f sb sn c sn p sn a sn t sn t sn s sn
W W W W W W W are synaptic weights applied to sensory 
inputs from baroreceptors, chemoreceptors, lung stretch receptors, atria stretch receptors, 
trigeminal cold receptors, cold receptors in hands/feet and mental stress sensors 
respectively; snθ is an offset term for sympathetic neural activation. Experiments reported in 
[81] show that maximal inhibitory input will not abolish the activity of inhibitory premotor 
neurons. Similarly minimal excitatory inputs will not silent excitatory premotor neurons. 
Therefore we model the residual activity of sympathetic premotor neurons using the 
parameter 
,esf ∞ . Additional unknown physiological factors can modulate the weighted sum 
of sensory inputs. We include a corresponding constant gain esk . The maximal firing rate of 
sympathetic premotor neurons is captured by model constant es,maxf . 
The overall shape of equation (2.5.4) is similar to the equation developed by Ursino [62] 
for simulating the activity of efferent sympathetic neurons on heart (see section 1.7.3). Our 
contribution is the inclusion of components 
f f s sa,sn aa t ,sn at t ,sn at s,sn as
-W f -W f +W f +W f⋅ ⋅ ⋅ ⋅  
and es,0,snf .  
 Constant values are given in Table 2.5.2 as calculated by Ursino after fitting their model 
with in-vitro data from invasive neural measurements on dog [94]. A simulation of the above 
equation is given in Figure 2.21 where an increase of premotor neurons firing rate can be 
observed as response to a decrease in arterial blood pressure from 50th to 60th second. 
 
Table 2.5.2 Constant values for sympathetic premotor neurons controlling SA and AV nodes 
Constant Value Description 
es,0,minf  16.11 Hz minimal basal firing rate of sympathetic premotor neurons 
,esf ∞  2.1 Hz residual activity of sympathetic premotor neurons in absence of inputs 
es,maxf  60 Hz maximal firing rate of sympathetic premotor neurons 
esk  0.0675 constant gain of all synaptic inputs to sympathetic premotor neurons 
,b snW  0.3 synaptic weight applied to sensory inputs from baroreceptors  
,c snW  1 synaptic weight applied to sensory inputs from chemoreceptors  
,p snW  0 synaptic weight applied to sensory inputs from lung stretch receptors  
,a snW  0 synaptic weight applied to sensory inputs from atria stretch receptors  
,ft sn
W  1 synaptic weight applied to sensory inputs from trigeminal cold receptors  
,st sn
W  1 synaptic weight applied to sensory inputs from cold receptors in hands/feet  
,s snW  1 synaptic weight applied to sensory inputs from mental stress sensors 
sn
θ  -49 Hz offset term for neural activation of sympathetic premotor neuron 
 
 
Figure 2.21 Simulation of sympathetic premotor neurons controlling SA & AV nodes 
Response to arterial blood pressure decreases between 50
th
 and 60
th
 second 
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Sympathetic premotor neurons which control sympathetic preganglionic neurons 
projecting to ventricles, brain, skeletal muscles, splanchnic and extrasplanchnic vascular 
beds are inhibited by increased activity of baroreceptors, lung stretch receptors, atria and 
stretch receptors. They are excited by increased activity of chemoreceptors, trigeminal cold 
receptors, cold receptors in hands/feet and mental stress centers. Therefore we model the 
firing rate of sympathetic premotor neurons controlling ventricles, brain, skeletal muscles, 
splanchnic and extrasplanchnic effectors as follows. 
, , , , , , ,
( )
, ,0, ,( ) es b si ab c si ac p si ap a si aa t si at t si at s si as sif f s s pm
pm
pm
k W f W f W f W f W f W f W f
si es,max
es es p es
si
si es,maxes,max
f fiff f f ef
if f ff
i = v,b,m,s,e
θ⋅ − ⋅ + ⋅ − ⋅ − ⋅ + ⋅ + ⋅ + ⋅ −
∞ ∞
< + − ⋅
=  ≥
 (2.5.5) 
where 
, , , , , , ,
, , , , , ,
s fb si c si s si p si t si t si s siW W W W W W W are synaptic weights applied to sensory inputs 
from baroreceptors, chemoreceptors, lung stretch receptors, atria stretch receptors, 
trigeminal cold receptors, cold receptors in hands/feet and mental stress sensors 
respectively; siθ is an offset term for sympathetic neural activation. fatf  is positively 
weighted compared to equation (2.5.4) because increased activity of trigeminal cold 
receptors causes increased activity of sympathetic premotor neurons that control vascular 
beds. 
The overall shape of equation (2.5.5) is similar to the equation developed by Ursino [62] 
for simulating the activity of efferent sympathetic neurons on vasculature (see section 
1.7.3). Our contribution is the inclusion of components 
, , , ,f f s sa si aa t si at t si at s si as
W f W f W f W f− ⋅ + ⋅ + ⋅ + ⋅  and 
,0,es pf .  
 Constant values are given in Table 2.5.3 as calculated by Ursino after fitting their model 
with in-vitro data [62]. A simulation of the above equation for ventricles is given in Figure 
2.22 where an increase of premotor neurons firing rate can be observed when there is a 
decrease in arterial blood pressure from 50th to 60th second. 
 
Table 2.5.3 Constant values for sympathetic premotor neurons controlling vascular beds 
Constant Value Description 
,b siW  0.3 synaptic weight applied to sensory inputs from baroreceptors  
,c siW  5 synaptic weight applied to sensory inputs from chemoreceptors  
,p siW  0.34 synaptic weight applied to sensory inputs from lung stretch receptors  
,a siW  1 synaptic weight applied to sensory inputs from atria stretch receptors  
,ft si
W  1 synaptic weight applied to sensory inputs from trigeminal cold receptors  
,st si
W  1 synaptic weight applied to sensory inputs from cold receptors in hands/feet  
,s siW  0.5 synaptic weight applied to sensory inputs from mental stress sensors 
siθ  7.34 Hz offset term for neural activation of sympathetic premotor neuron 
 
 
Figure 2.22 Simulation of sympathetic premotor neurons controlling ventricular vascular beds 
Response to arterial blood pressure decreases between 50
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 and 60
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 second 
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f,sv,pm: firing rate of sympathetic premotor neurons controlling ventricles
10th degree polynomial interpolation of f,sv,pm
 53 
 
2.5.2 Model of Parasympathetic Premotor Neurons 
 The intrinsic depolarization rate of pacemaker cells in the sinoatrial node is 
approximately 1.67 Hz despite the resting rate of a normal adult is maintained at a relatively 
constant value 1.17 Hz. This is achieved via a continuous parasympathetic tonic activity 
called vagal or parasympathetic tone. It becomes diminished in disease states including 
hypertension and heart failure. Measuring and increasing vagal tone may be an effective 
clinical procedure in treating some heart diseases. We propose the following model of 
resting vagal tone 
,0evf . 
 -3
ev,0 ev,0,maxf = f - 1.66 10 age⋅ ⋅  (2.5.6) 
where ev,0,maxf is the intrinsic firing rate of vagal nerves; age is a model input representing the 
age of the subject. -31.66 10⋅  was chosen using a similar method as the one established by 
Jose relating age and intrinsic heart rate [95]. 
Mean value of parasympathetic tone is given in Table 2.5.4 after trying different values to 
obtain a resting heart rate of 70 beats/min on a 30 years old healthy subject. A simulation of 
the equation above provided a corresponding parasympathetic basal tone equals to 3.15 Hz. 
 
Table 2.5.4 Parameter value for parasympathetic premotor neurons generating vagal tone 
Parameter Value Description 
ev,0,maxf  3.2 Hz Maximal intrinsic firing rate of vagal nerves 
 
Parasympathetic premotor neurons which control parasympathetic preganglionic 
neurons projecting to SA node, AV node, atria and ventricles are excited by increased activity 
of baroreceptors, chemoreceptors, trigeminal cold receptors and occulo-pressure receptors. 
They are inhibited by increased activity of lung stretch receptors. Therefore we model the 
firing rate 
pmev
f  of parasympathetic premotor neurons controlling the heart as follows. 
 
,0
,0
,0 ,
,
ab ab
ev
pm f fab ab
ev
f f
k
ev ev
ev c,v ac p,v ap t ,v at o v ao vf f
k
f + f ef +W f -W f +W f +W f -
1+e
θ
−
∞
−
⋅
= ⋅ ⋅ ⋅ ⋅  (2.5.7) 
where 
,
,ev evk f ∞ are model constants; , , , ,, , ,fc v p v t v o vW W W W are synaptic weights; vθ is an offset 
term for parasympathetic neural activation. 
We will now include Respiratory Sinus Arrhythmia (RSA) into our model. RSA is 
characterized by increase heart rate during inspiration and decrease heart rate during 
expiration. It is most pronounced in young subjects and athletes and decreases with age. The 
neural control mechanism involved in respiratory sinus arrhythmia is complex and still under 
debate. Following explanations have been raised [96]. One explanation correlates 
respiratory pump to the baroreflex including cardiopulmonary stretch mechanoreceptors. 
Intrathoracic pressure decreases during inspiration, allowing more venous blood to return to 
heart. Venous return to the right atria increases and the right ventricle pumps more blood to 
the lungs. Therefore blood volume in pulmonary vascular bed increases, but most of it does 
not return to the left atria, because of low pressure in the lungs. This causes the left ventricle 
to fill in a lesser extend and stroke volume is reduced. This decreases blood pressure and 
triggers the baroreflex. Reponse is inhibition of vagal efferent nerves to the heart and 
increase vascular tone. Another explanation suggests a central mechanism via a direct 
coupling of the respiratory centers and the vasomotor center in the brain. This second 
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explanation seems to be more plausible because several studies demonstrate that 
mechanical mechanism in the respiratory pump is unable to account entirely for the 
presence of RSA. They suggest either a pre-inspiratory decrease in sensitivity to 
baroreceptor afferent stimuli or a direct inhibition of vagal efferent nerves just prior to 
inspiration [97]. In order to take RSA into account in our model, we assume a direct coupling 
between respiratory centers and parasympathetic autonomic premotor neurons and we 
modify equation (2.5.7) to include an additional weighted factor so that vagal activity is 
inhibited with increased inspiratory-expiratory somatic motor neurons activity as follows. 
,0
,0
,0 ,
, , , , ,
1
ab ab
ev
pm f fab ab
ev
f f
k
ev ev
ev c v ac p v ap t v at o v ao resp v resp vf f
k
f f ef W f W f W f W f W f
e
θ
−
∞
−
+ ⋅
= + ⋅ − ⋅ + ⋅ + ⋅ − ⋅ −
+
 (2.5.8) 
where 
respf is the firing rate of inspiratory-expiratory somatic motor neurons defined by 
equation (2.8.6) in section 2.8.4; 
,resp vW is a model parameter representing the synaptic 
weight, with initial value 0.105 Hz. 
The overall shape of equation (2.5.8) is similar to the equation developed by Ursino [62] 
for simulating the activity of efferent parasympathetic neurons on heart (see section 1.7.3). 
Our contribution is the inclusion of components 
, , ,f ft v at o v ao resp v resp
W f W f W f⋅ + ⋅ − ⋅  and 
,0evf .  
 Constant values are given in Table 2.5.5 as calculated by Ursino after fitting their model 
with experimental in-vitro data [62]. A simulation of the above equation is given in Figure 
2.23 where a decrease of premotor neurons firing rate can be observed when there is a 
decrease in arterial blood pressure from 50th to 60th second. 
 
Table 2.5.5 Constant values for parasympathetic premotor neurons controlling SA/AV nodes 
Constant Value Description 
,evf ∞  2.1 Hz residual activity of parasympathetic premotor neurons in absence of inputs 
evk  7.06 Hz constant affecting baroreceptor inputs to parasympathetic premotor neurons 
,c vW  0.2 synaptic weight applied to sensory inputs from chemoreceptors  
,p vW  0.105 synaptic weight applied to sensory inputs from lung stretch receptors  
,ft v
W  0.105 synaptic weight applied to sensory inputs from trigeminal cold receptors  
,o vW  0.105 synaptic weight applied to sensory inputs from oculo-pressure receptors  
vθ  -0.68 Hz offset term for neural activation of sympathetic premotor neuron 
 
 
Figure 2.23 Simulation of parasympathetic motor neurons controlling SA & AV nodes 
Response to arterial blood pressure decreases between 50
th
 and 60
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 second 
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f,ev,pm: firing rate of parasympathetic premotor neurons
10th degree polynomial interpolation of f,ev,pm
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2.6 Physiological Model of Preganglionic Autonomic Motor Neurons 
Autonomic premotor neurons synapse with parasympathetic preganglionic neurons in 
medulla oblongata. Premotor neurons synapse with sympathetic preganglionic neurons in 
the thoracic and lumbar region of the spinal cord. 
Autonomic preganglionic neurons project to autonomic ganglia where they release 
acetylcholine (ACh) as neurotransmitter. Neurotransmitters are chemical substance used to 
carry information between two neurons. Additional neurotransmitters can modulate the 
activities of vagal preganglionic nerves, such as excitatory amino acids, gamma-aminobutyric 
acids, serotonin and opioid peptides.[42]  
In order to model the relationship between premotor neuron activity and acetylcholine 
release in autonomic ganglia, Ottesen lumped the long chain of biochemical reactions into a 
single first order reaction equation and took the accumulated release time to be equal to the 
average clearance and consumption time for the respective substances. He kept the 
concentrations in non-dimensional form in order to reduce the number of parameters to 
estimate. [68] An example is equation (1.7.9). We propose a similar equation to model 
acetylcholine concentration in parasympathetic autonomic ganglia using the 
nondimensionalized variable 
,igach v
C  as follows.  
 
, ,
,
ig ig pm
ig
ach v ach v ev
ach v
dC C f
dt τ
− +
=  (2.6.1) 
where 
pmev
f  is the firing rate  of parasympathetic premotor neurons controlling the heart; 
,igach v
τ is a characteristic time scale for vagal acetylcholine. 
Acetylcholine concentration in sympathetic autonomic ganglia where postganglionic 
neurons synapse and project to the SA Node and AV node is modeled using the 
nondimensionalized variable 
,igach sn
C  as follows. 
 
, ,
,
ig ig pm
ig
ach sn ach sn sn
ach sn
dC C f
dt τ
− +
=  (2.6.2) 
where 
pmsn
f  is the firing rate  of sympathetic premotor neurons controlling the SA and AV 
nodes; 
,igach snτ is a characteristic time scale for sympathetic acetylcholine. 
Postganglionic sympathetic neurons which control vascular beds originate in sympathetic 
autonomic ganglia as well. Their activity also depends on acetylcholine concentration. 
Acetylcholine release for vascular control is normally controlled by premotor neurons in 
rostral ventrolateral medulla. However bilateral inhibition of these cells causes a much 
greater decrease in renal than splenic sympathetic activity; the residual activity might be of 
spinal origin. This supports the possibility of other source to maintain blood pressure since 
fall in blood pressure after bilateral lesion of the rostral ventrolateral medulla is not 
sustained.  We model this residual activity by including a new parameter 
ressi
f representing 
the firing rate of spinal neurons capable of releasing acetylcholine in autonomic ganglia 
without central input.  
 Therefore changes in acetylcholine concentration is modeled using the 
nondimensionalized variable 
,igach si
C  (with i equals v  for ventricles, b  for brain, m  for 
skeletal muscles, s  for splanchnic and e  for extrasplanchnic) as follows. 
 
,
,
, , , ,
ig pm resi
ig
ach si ach,si si es
ach si
dC -C + max(f , f )
dt
i v b m s e
τ
=
=
 (2.6.3) 
where 
pmsi
f  is the firing rate  of sympathetic premotor neurons controlling vascular beds; 
,igach si
τ is a characteristic time scale for sympathetic acetylcholine; 
resies
f is a model constant 
representing the firing rate of residual sympathetic  activity originating in spinal cord. 
Constant values for acetylcholine concentration in autonomic ganglia are given in Table 
2.5.6 as calculated by Ottesen after fitting their model with heart rate and blood pressure 
data [65]. A simulation of the equations above is given in Figure 2.24 where an increase of 
acetylcholine concentration in sympathetic autonomic ganglia and a decrease of 
concentration in parasympathetic autonomic ganglia can be observed as response to 
decreased arterial blood pressure between 50th and 60th second.  
 
Table 2.5.6 Constant values for acetylcholine concentration in autonomic ganglia 
Constant Value Description 
,igach v
τ
 1.32 
characteristic time scale for acetylcholine release by parasympathetic preganglionic 
neurons 
,igach sn
τ
 0.72 
characteristic time scale for acetylcholine release by sympathetic preganglionic neurons for 
controlling SA and AV nodes 
,igach si
τ
 0.72 
characteristic time scale for acetylcholine release by sympathetic preganglionic neurons for 
controlling vessels (with i equals v  for ventricles, b  for brain, m  for skeletal muscles, s  
for splanchnic and e  for extrasplanchnic) 
resies
f
 
1 Hz firing rate of residual sympathetic  activity originating in spinal cord 
 
 
Figure 2.24 Simulation of acetylcholine concentration in autonomic ganglia 
Response to arterial blood pressure decreases between 50
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Cach__ig,sn: concentration of ACh released by preganglionic sympathetic neurons for controlling SA & AV nodes
Cach__ig,v: concentration of ACh released by preganglionic parasympathetic neurons for controlling SA & AV nodes
Cach__ig,sv: concentration of ACh released by preganglionic sympathetic neurons for controlling ventricular vascular bed
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2.7 Physiological Model of Postganglionic Autonomic Motor Neurons 
Postganglionic neurons originate from autonomic ganglia and project to cardiovascular 
effectors where they secrete neurotransmitters which modulate the function of target cells. 
Autonomic postganglionic axons end with a series of swollen areas called varicosity, which 
lie across the surface of the target tissue. Neurotransmitters are diffused in the interstitial 
fluid, so that a single postganglionic neuron can affect a large area of the target tissue. 
Sympathetic postganglionic neurons release norepinephrine, whereas parasympathetic 
postganglionic neurons secrete acetylcholine onto the target cell. 
We assume that the concentration of acetylcholine and norepinephrine released on 
target cell by postganglionic neurons linearly depends on the concentration of acetylcholine 
released by preganglionic neurons in the autonomic ganglia. We model acetylcholine 
concentration in SA and AV nodes using the nondimensionalized variable 
,ogach v
C  as follows. 
 
,
, ,og ach v igogach v ach v
C k C= ⋅  (2.7.1) 
where 
,igach vC is the concentration of acetylcholine released by the parasympathetic 
preganglionic neuron in autonomic ganglia and 
,ach vog
k is a model constant representing 
modulation of acetylcholine concentration by local effects at cell membrane receptors in SA 
node. 
Vagally-mediated atropine-sensitive tachycardia has been observed after somatic 
nociceptors stimulation suggesting the presence of vasoactive peptides within vagal nerves 
ending [98]. Therefore norepinephrine concentration in SA and AV nodes might depend on 
concentration of acetylcholine released by both sympathetic and parasympathetic 
preganglionic neurons projecting to heart. We model norepinephrine concentration in SA 
and AV nodes using the nondimensionalized variable 
,ognor sn
C  as follows. 
 
, ,
, , ,og nor sn ig nor v igog ognor sn ach sn ach v
C k C k C= ⋅ + ⋅  (2.7.2) 
where 
, ,
,
ig igach sn ach v
C C are the concentrations of acetylcholine released by the sympathetic and 
parasympathetic preganglionic neuron in autonomic ganglia respectively; 
,nor snog
k  is a model 
constant and 
,nor vog
k is model parameter representing modulation of norepinephrine 
concentration by local effects at cell membrane receptors in SA node. 
We model norepinephrine concentration in vascular beds using the nondimensionalized 
variable 
,ognor si
C  (with i equals v  for ventricles, b  for brain, m  for skeletal muscles, s  for 
splanchnic and e  for extrasplanchnic) as follows. 
 
,
, ,
, , , ,
og nor si igognor si ach si
C k C
i v b m s e
= ⋅
=
 (2.7.3) 
where 
,igach si
C is the concentration of acetylcholine released by the sympathetic preganglionic 
neuron in autonomic ganglia and 
,nor siog
k is a model parameter representing modulation factor 
of norepinephrine by neuropeptides released by vagal nerve endings at SA & AV nodes. 
 Constant values for acetylcholine and norepinephrine concentrations in SA and AV nodes 
are given in Table 2.5.7 as well as constants for norepinephrine concentration in vascular 
beds. For reason of simplicity we assume the values to be equal to 1. Detailed studies of 
neurotransmitter dynamic at ganglionic sites are required for determining more accurate 
constant values. The parameter for vagally-mediated tachycardia is given in Table 2.5.8. 
Simulation of the above equations is given in Figure 2.25 where a decrease of acetylcholine 
concentration in SA & AV nodes and an increase of norepinephrine concentration in SA & AV 
nodes and ventricular vascular beds can be observed as response to decreased arterial blood 
pressure between 50th and 60th second.  
 
Table 2.5.7 Constant values for concentration of postganglionic neurotransmitters 
Constant Value Description 
,ach vog
k
 1 
modulation factor of acetylcholine concentration by local effects at cell membrane 
receptors in SA & AV nodes 
,nor snog
k
 1 
modulation factor of norepinephrine concentration by local effects at cell membrane 
receptors in SA & AV nodes 
,nor siog
k
 1 
modulation factor of norepinephrine concentration by local effects at cell membrane 
receptors in blood vessels wall 
 
Table 2.5.8 Parameter values for vagally-mediated tachycardia 
Parameter Value Description 
,nor vog
k
 0.1 
modulation factor of norepinephrine concentration by neuropeptides released by 
vagal nerve endings at SA & AV nodes 
 
 
 
Figure 2.25 Simulation of acetylcholine and norepinephrine concentrations in heart 
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Cach__og__v: concentration of ACh released by postganglionic parasympathetic neurons for controlling SA & AV nodes
Cnor__og__sn: concentration of Nor released by postganglionic sympathetic neurons for controlling SA & AV nodes
Cnor__og__sv: concentration of Nor released by postganglionic sympathetic neurons for controlling ventricular vascular bed
 Sympathetic autonomic preganglionic neurons also project to the adrenal medulla which 
work as modified sympathetic ganglion. Adrenal medulla include postganglionic neurons 
which however lack axon that would normally project to target cells. Instead they release 
catecholamines (approximately 80% epinephrine and 20% norepinephrine) directly into the 
circulation. We assume that activity in adrenal medulla depends of the weighted sum of 
premotor inputs. We model secreted epinephrine and norepinephrine concentrations using 
the nondimensionalized variables 
, ,
,epi am nor amC C  as follows. 
 
,
,
,
( )
pm pm pm pm pm pmam ach am sn sv sb sm ss seam
am
epi am am
nor am am
C W f f f f f fdC
dt
C 0.8 C
C 0.2 C
τ
− + ⋅ + + + + +
=
= ⋅
= ⋅
 (2.7.4) 
where , , , , ,
pm pm pm pm pm pmsn sv sb sm ss se
f f f f f f  are the firing rate  of sympathetic premotor neurons 
controlling SA/AV nodes, ventricular, brain, muscles, splanchnic and exptrasplanchnic beds 
respectively; 
,ach amW is a synaptic weight. amτ is a characteristic time scale for 
neurotransmitters in medulla. 
Constant values for adrenal epinephrine and norepinephrine concentrations in blood 
stream are given in Table 2.5.9. Simulation of the above equations is given in Figure 2.26 
where a increased concentration can be observed as response to decreased arterial blood 
pressure between 50th and 60th second.  
 
Table 2.5.9 Constant values for concentration of adrenal neurotransmitters 
Constant Value Description 
,ach amW  0.166 
synaptic weight applied to sympathetic premotor inputs to adrenal 
medulla 
amτ  1.32 characteristic time scale for neurotransmitters in adrenal medulla 
 
 
 
Figure 2.26 Simulation of adrenal epinephrine and norepinephrine concentrations 
Response to arterial blood pressure decreases between 50
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Cepi__am: concentration of adrenal epinephrine released in blood stream
Cnor__am: concentration of adrenal norepinephrine released in blood stream
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2.8 Physiological Model of Cardiovascular Effectors 
2.8.1 Modulation of Heart Rate by Postganglionic Neurons 
The interval between action potentials defines heart rate and can be shortened by 
altering the permeability of pacemaker cells to specific ions which in turn can be modified by 
norepinephrine secreted by sympathetic postganglionic neurons and circulating 
catecholamines (norepinephrine) secreted by adrenal medulla and acting via β1-
adrenoceptors located on SA nodal cells. Increased ion flow through If and Ca
2+ channels and 
increased permeability to Na+ and Ca2+ during the pacemaker potential phase speed up 
depolarization and heart rate. Additionally catecholamines norepinephrine and epinephrine 
enhance conduction of action potentials through the AV node.  
Parasympathetic postganglionic neurons release the neurotransmitter acetylcholine (Ach) 
which increases K+ permeability, hyperpolarizing the cell. At the same time ACh causes Ca2+ 
permeability to decrease, slowing the rate at which the pacemaker potential depolarizes. 
Both effects cause the cell to delaying the onset of the action potential, slowing the heart 
rate. ACh also slows the conduction of action potentials through the AV node, thereby 
increasing the AV node delay. 
Existing prominent mathematical models assume that heart period T  is obtained as sum 
of components corresponding to vagal drive 
,ach vog
T∆ , sympathetic drive 
,nor snog
T∆  and intrinsic 
effects 0T . We further include influence from adrenal medulla 
,nor am
T∆  and high frequency 
intracardiac fluctuations rsaT∆   
 
We model the component rsaT∆  in order to simulate the heart rate variability that has 
been observed after combined sympatho-vagal blockade as well as in transplanted 
denervated human heart, suggesting an intracardiac mechanism, which might contribute to 
respiratory sinus arrhythmias (RSA). rsaT∆  has been modelled as positive sinusoidal function 
for simplicity. We model the influence of adrenal medulla (
,nor am
T∆ ) on heart rate using a pure 
latency, a monotonic logarithmic static function, and low-pass first order dynamics. 
Parasympathetic activity dominates in the control of heart rate. Increase in 
parasympathetic tone evokes a pronounced bradycardia even when there is high level of 
sympathetic activity. In the presence of high or moderate parasympathetic tone, change in 
sympathetic activity elicits negligible heart rate modulation. It has been suggested that 
parasympathetic efferent neurons may inhibit release of norepinephrine. This effect is 
considered by including the weighting factor 
,nor snogT
k .  
The remaining parts of equations for vagal drive 
,ach vog
T∆  and sympathetic drive 
,nor snog
T∆  
are adapted from Ursino [62] with the difference that concentration of neurotransmitters is 
used instead of firing rate of premotor neurons. The original model of Ursino is given in 
equation (1.7.18) for comparison. The model of age-related intrinsic effects on heart rate 0T  
is adapted from Jose [95]. 
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The resulting equations that determine heart period in our model are given below.  
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 (2.8.1) 
where HR  is the heart rate (in beats/min); T  is the heart period (i.e. RR interval in seconds) 
with 0T being its intrinsic value in the absence of cardiac innervations, depending on the 
model input age ; 
, , ,
, ,
ach v nor sn nor amog ogT T T
τ τ τ  are time constants; 
, , ,
, ,
ach v nor sn nor amog ogT T T
G G G are constant 
gain factors; 
, , ,
, ,
ach v nor sn nor amog ogT T T
D D D are the time delays for parasympathetic and sympathetic 
responses to take effect; 
ognor ,sn,min nor,am,min
C ,C  are threshold for sympathetic stimulation; rsaf  
is the frequency of high frequency intracardiac fluctuations and 
rsaT
G  is their amplitude; 
,nor snogT
k is a weighting factor describing the inhibiting effect that vagal efferent has on release 
of norepinephrine. 
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Constant values for parasympathetic 
,ach vog
T∆  and sympathetic drive 
,nor snog
T∆
 
are given in 
Table 2.5.10 as calculated by Ursino after fitting the model with data from in-vitro 
experiments [62]. Constant values for the adrenal medulla component 
,nor am
T∆  were assumed 
to be the same as those for the sympathetic component 
,nor snog
T∆ . Table 2.5.11 includes initial 
values for parameters that determine high frequency intracardiac fluctuations rsaT∆ . They 
were calculated after trying several values that fit our own experimental data (heart rate 
signals). A simulation of the above equation is given in Figure 2.27 where increasing heart 
rate can be observed when there is a decrease in arterial blood pressure from 50th to 60th 
second. 
 
Table 2.5.10 Constant values for heart rate modulation 
Constant Value Description 
,ach vogT
τ  1.5 time constant of parasympathetic achetychloline responses 
,nor snogT
τ  2 time constant of sympathetic norepinephrine responses 
,nor amT
τ  2 time constant of adrenal norepinephrine sympathetic responses 
,nor snogT
k  1 weighting factor describing the inhibiting effect that vagal efferent has 
on release of norepinephrine 
,ach vogT
D  0.2 s time delay for parasympathetic achetychloline responses to take effect 
,nor snogT
D  2 s time delay for sympathetic norepinephrine responses to take effect 
,nor amT
D  2 s time delay for adrenal norepinephrine sympathetic responses to take 
effect 
ognor ,sn,min
C  2.66 threshold for sympathetic stimulation by sympathetic norepinephrine 
nor,am,minC  2.66 threshold for sympathetic stimulation by adrenal norepinephrine 
rsaT
G  0.01 gain of intracardiac high frequency fluctuations 
,ach vogT
G  0.09 gain of parasympathetic achetychloline responses on heart rate 
,nor snogT
G  -0.13 gain of sympathetic norepinephrine responses on heart rate 
,nor amT
G  -0.13 gain of adrenal norepinephrine sympathetic responses on heart rate 
 
Table 2.5.11 Parameters values for heart rate modulation 
Parameter Value Description 
rsaf  0.15 Hz frequency of intracardiac high frequency fluctuations 
rsaT
G
 0.01 s amplitude of intracardiac high frequency fluctuations 
 
  
Figure 2.27 Heart rate response to arterial blood pressure drop 
arterial blood pressure decreases between 50
th
 and 60
th
 second 
2.8.2 Modulation of Ventricle Elastance by Postganglionic Neurons 
Sympathetic postganglionic neurons release norepinephrine at ventricle muscle cells. This 
promotes influx of Ca2+ resulting in greater contraction strength and a shorter duration of 
contraction. Cardiac contraction is also modified by circulating epinephrine and 
norepinephrine acting via β1-adrenoceptors located on heart muscle. β2-adrenoceptors are 
more sensitive to epinephrine and are typically not innervated by postganglionic neurons. 
They are located on certain blood vessels and smooth muscles of some organs. They are also 
present in heart and respond to circulating epinephrine. 
Parasympathetic postganglionic neurons release acetylcholine at ventricle muscle cells 
which bind to M2 muscarinic receptors. This results in a reduction in contraction strength 
and lengthening of muscular relaxation. The effect is stronger in atria and relative weak in 
ventricle.  
Our goal is to describe the contractile activity of ventricle by means of a Voigt viscoelastic 
model, i.e., the series arrangement of a time-varying elastance. We model the ventricle 
elastance at the moment of maximal contraction, i.e. end-systolic elastance. Existing 
prominent mathematical models assume that ventricle elastance is only controlled by the 
sum of two components corresponding to sympathetic drive 
,nor svog
E∆  and intrinsic value 0E  . 
We further include a model of parasympathetic drive 
,ach vog
E∆ , effects of adrenal 
norepinephrine 
,nor am
E∆  and effects of adrenal epinephrine 
,epi am
E∆ . 
 Although the sympathetic component 
,nor svog
E∆  is modeled following Ursino [62] as 
compared to equation (1.7.17), the remaining components are own contributions. We 
model the changes in ventricle elastance as response to change in norepinephrine, 
epinephrine and acetylcholine concentrations using a pure latency, a monotonic logarithmic 
static function, and low-pass first order dynamics.  
0 10 20 30 40 50 60 70 80 90 100
0
20
40
60
80
100
120
140
seconds
m
m
Hg
 
/ b
ea
ts
/m
in
Heart rate response to blood pressure drop
 
 
Pas - arterial blood pressure
HR - heart rate
 65 
 
The resulting equations that determine ventricle elastance in our model are given as 
follows. 
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(2.8.2) 
where E  is the ventricle elastance with 0E being its intrinsic value in the absence of cardiac 
innervation; 
, , , ,
, , ,
nor sv nor am epi am ach vog ogE E E E
τ τ τ τ  are time constants; 
, , , ,
, , ,
nor sv nor am epi am ach vog ogE E E E
G G G G are 
constant gain factors; 
, , , ,
, , ,
nor sv nor am epi am ach vog ogE E E E
D D D D are the time delays for sympathetic and 
parasympathetic responses to take effect; 
ognor ,sv,min nor,am,min epi,am,min
C ,C ,C  are threshold for 
sympathetic stimulation. 
We assume that the duration of ventricle contraction depends on norepinephrine, 
epinephrine and acetylcholine concentrations in ventricle muscles with the same extend as 
on the elastance. Therefore we model the length of QT intervals (i.e. duration of ventricle 
contraction) as follows. 
 ( )0 QT 0QT = QT +k × E - E  (2.8.3) 
where 0QT  is baseline QT interval duration and QTk  is a gain factor. 
Constant values for sympathetic drive 
,nor svog
E∆
 
and intrinsic value 0E  are given in Table 
2.5.12 as calculated by Ursino after fitting the model with data from in-vitro experiments 
[62]. Constant values for effects of adrenal norepinephrine 
,nor am
E∆  and effects of adrenal 
epinephrine 
,epi am
E∆   were assumed to be the same as those for the sympathetic component
 
,nor svog
E∆ . Constant values for parasympathetic drive 
,ach vog
E∆  were assumed to be the same as 
those for parasympathetic drive on heart period (see Table 2.5.10). Table 2.5.13 includes 
initial values for parameters that determine the duration of QT intervals. They were 
calculated after trying several values that fit our own experimental data (QT time series). A 
 simulation of the above equation is given in Figure 2.28 where increasing ventricle elastance 
can be observed when there is a decrease in arterial blood pressure from 50th to 60th second. 
 
Table 2.5.12 Constant values for ventricle elastance modulation 
Constant Value Description 
0E  2.392 mmHg mL-1 Baseline elastance of ventricles 
,ach vogE
τ  1.5 s time constant of parasympathetic achetychloline responses 
,nor svogE
τ  8 s time constant of sympathetic norepinephrine responses 
,nor amE
τ  8 s time constant of adrenal norepinephrine sympathetic responses 
,epi amE
τ  8 s time constant of adrenal epinephrine sympathetic responses 
,ach vogE
D  0.2 s time delays for parasympathetic achetychloline responses to take effect 
,nor svogE
D  2 s time delays for sympathetic norepinephrine responses to take effect 
,nor amE
D  2 s time delays for adrenal norepinephrine sympathetic responses to take 
effect 
,epi amE
D  2 s time delays for adrenal epinephrine sympathetic responses to take 
effect 
,epi amC  2.66 threshold for sympathetic stimulation by adrenal epinephrine 
,ach vogE
G  -0.09 mmHg  mL-1 Hz-1 gain of parasympathetic achetychloline responses on ventricle elastance 
,nor svogE
G  0.475 mmHg  mL-1 gain of sympathetic norepinephrine responses on ventricle elastance 
,nor amE
G  0.475 mmHg  mL-1 gain of adrenal norepinephrine sympathetic responses on ventricle 
elastance 
,nor amE
G  0.475 mmHg  mL-1 gain of adrenal epinephrine sympathetic responses on ventricle 
elastance 
 
Table 2.5.13 Parameters values for ventricle elastance modulation 
Parameter Value Description 
0QT
 
300 ms baseline QT interval duration 
QTk
 
10 mmHg
-1
 mL gain of elastance on QT interval duration 
 
 
Figure 2.28 Changes in ventricle elastance as response to arterial blood pressure drop 
arterial blood pressure decreases between 50
th
 and 60
th
 second 
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2.8.3 Modulation of Peripheral Vascular Resistance 
The smooth muscle cells within arteriole walls remain constantly slightly contracted via a 
combination of neuronal, hormonal influences and local effects. The relative degree of 
contraction within the arterioles is referred to as their basal tone. Veins and venules have a 
lower basal tone. The arterioles have large amount of smooth muscles in their walls and are 
the main site of variable resistance. They contribute to more than 60% of the total 
peripheral resistance. [79] 
Sympathetic postganglionic neurons innervate vascular beds. Tonic secretion of 
norepinephrine on α-receptors causes vasoconstriction. The adrenal medulla also secrete 
large amount of epinephrine during the flight-or-fight response or strong emotional 
conditions at arteriolar cell α-receptors enhancing vasoconstriction. However it is noted that 
α-receptors have a low affinity for epinephrine.  
At the opposite of other vascular beds, vessels of heart, skeletal muscle and liver 
additionally have β2 receptors which elicit vasodilatation in the presence of adrenal 
epinephrine. During the flight-or-fight response while increased sympathetic activity will 
cause vasoconstriction on other peripheral vessels, vasodilatation will predominate in 
coronary arteries, skeletal muscles and liver. This diverts blood from nonessential organs, 
such as gastrointestinal tract, to the skeletal muscles, liver, and heart. However if 
sympathetic activity is high then more norepinephrine will be released and the more 
numerous α1 receptors will be activated, causing vasoconstriction. 
Blood flow in arterioles is also regulated by local metabolic demand coupled with oxygen 
consumption. Low oxygen and high carbon dioxide dilate the arterioles. A similar 
vasodilatation can be observed on vessels of exercising muscles whereas vessels in non-
exercising muscles remain constricted.  
Existing mathematical models assume that peripheral resistance is determined by the 
activity of sympathetic neurons and local metabolic demand; an example is equation (1.7.16) 
from Ursino [62]. We further include the effects of adrenal epinephrine and model 
peripheral vascular resistance ipR  as sum of three components representing effects of 
sympathetic norepinephrine 
,nor siog
R∆ , adrenal epinephrine 
, ,epi am i
R∆ and baseline values 
,0ipR . 
At the opposite of existing mathematical models, we distinguish between regions which 
respond to circulating epinephrine with vasoconstriction, these are brain, splanchnic and 
extrasplanchnic vascular beds; and regions which respond with vasodilation, i.e. heart and 
muscles. Each component is modeled using a pure latency, a monotonic logarithmic static 
function, and low-pass first order dynamics.  
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The resulting equations that determine peripheral vascular resistance in our model are 
given as follows. 
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where ipR is the peripheral resistance with basal value ,0ipR ; 
,
,
nor epi amogR R
τ τ  are time constants; 
, , ,
,
nor si epi am iogR R
G G are constant gain factors; 
, , ,
,
nor si epi am iogR R
D D are the time delays for sympathetic 
responses to take effect; 
ognor ,min epi,am,min
C ,C  are threshold for sympathetic stimulation; ipM
represents the metabolic demand in the vascular bed as described in equation (2.8.8) in 
section 2.8.4. 
There is ca. 5 s delay before peripheral vasoconstriction begins, after stimulation of α-
sympathetic nerves, and a further 15 s delay before vasoconstriction is complete [70]. These 
delays in baroreflex response implementation on peripheral vessels is a possible explanation 
to Mayer waves (slow oscillation in vasomotor tone around 0.1 Hz) [92]. They are taken into 
account in our model using constants 
, , ,
,
nor si epi am iogR R
D D .  
The relationship between peripheral vascular resistance and skin conductance has been 
investigated in [99], where authors maintained  a finger under isothermal conditions while 
inducing vasoconstriction by cooling the rest of the hand. They found out an artificial relation 
between peripheral vascular resistance and skin conductance, usually measured as galvanic 
skin response. We assume this relationship to be linear when pronounced vasoconstriction 
occurs and model the level of galvanic skin response mpG  at finger site as follows. 
 
mpmp G mp
G k R= ⋅  (2.8.5) 
where 
mpG
k  is a gain parameter applied to peripheral vascular resistance in skeletal muscles 
mpR . 
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Constant values for sympathetic drive 
,nor siog
R∆
 
and baseline values 
,0ipR  are given in Table 
2.5.14 as calculated by Ursino after fitting the model with data from in-vitro experiments 
[62]. In their studies the baseline vascular resistance in brain was not measured, but 
deduced with the assumption that normal blood flow entering the brain is 14 to 15% of total 
cardiac output. Constant values for effects of adrenal epinephrine 
, ,epi am i
R∆
 
were assumed to 
be the same as those for the sympathetic component
,nor siog
R∆ . Table 2.5.15 includes initial 
values for parameters that determine the galvanic skin response mpG . They were calculated 
after trying several values that fit our own experimental data (galvanic skin response 
signals). A simulation of the above equation is given in Figure 2.29 where increasing 
peripheral vascular resistance and galvanic skin response can be observed when mental 
stress is induced from 150th to 220th second. 
 
Table 2.5.14 Constant values for peripheral resistance modulation 
Constant Value Description 
,0vpR  2.392 mmHg s ml-1 baseline resistance of vascular beds in ventricle 
,0bpR  6.57 mmHg s ml-1 baseline resistance of vascular beds in brain 
,0mpR  2.106 mmHg s ml-1 baseline resistance of vascular beds in skeletal muscles 
,0spR  2.49 mmHg s ml-1 baseline resistance of vascular beds in splanchnic 
,0epR  1.655 mmHg s ml-1 baseline resistance of vascular beds in extrasplanchnic 
,nor siogR
τ  6 time constant of sympathetic norepinephrine responses 
,epi amR
τ  6 time constant of adrenal epinephrine sympathetic responses 
,nor siogR
D  5 s time delays for sympathetic norepinephrine responses to take effect 
, ,epi am iR
D  5 s time delays for adrenal epinephrine sympathetic responses to take effect 
,nor siogR
G  1.94 mmHg s ml-1 
gain of sympathetic norepinephrine responses on vascular beds (with i
equals v  for ventricles, b  for brain, m  for skeletal muscles, s  for 
splanchnic and e  for extrasplanchnic) 
, ,epi am iR
G  1.94 mmHg s ml-1 
gain of adrenal epinephrine sympathetic responses on vascular beds (with 
i equals v  for ventricles, b  for brain, m  for skeletal muscles, s  for 
splanchnic and e  for extrasplanchnic) 
 
Table 2.5.15 Parameter value for peripheral resistance modulation 
Parameter Value Description 
mpG
k
 
12 µS mmHg
-1
 s
-1
 ml 
gain parameter applied to peripheral vascular resistance in skeletal 
muscles 
  
Figure 2.29 Changes in vascular resistance and galvanic skin response as response to mental stress 
Mental stress between 150
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 and 220
th
 second 
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2.8.4 Effects of Respiration and Exercise 
Some studies suggest that the intrinsic rhythmic efferent activity to pulmonary muscles is 
maintained by pacemaker neurons in respiratory control centers. Respiratory neurons are 
mostly found in two centers in the medulla: the dorsal respiratory group contains inspiratory 
somatic motor neurons that control the diaphragm, external intercostals, scalene and 
sternocleidomastoid muscles; the ventral respiratory group contains expiratory somatic 
motor neurons that control abdominal muscles used for active respiration, internal 
intercostals, larynx, pharynx and tongue. During quiet respiration at a rate of 12 
breaths/min, inspiration is characterized by a gradually increase stimulation of the 
diaphragm by inspiratory somatic motor neurons for approximately 2 seconds. Over the next 
3 seconds passive expiration occurs because of the elastic relaxation of inspiratory muscles 
and lungs. Expiratory somatic motor neurons are mostly inactive during quiet respiration. 
We assume that the inspiratory and expiratory somatic motor neurons present a periodic 
sine pattern. Respiration can be modulated by exercise intensity and by voluntary control 
from higher brain centers. We include an arbitrary function representing voluntary 
respiration pattern 
,resp volf  and model the resulting respiration pattern respf , respiration rate 
rateresp
f and respiration amplitude 
ampresp
f as follows. 
 
( )
1
rate
amp
amp rate
resp,vol
resp respresp
resp,vol resp,vol
resp resp resp,vol
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resp,vol resp,vol
resp resp resp,vol
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resp,vol re
if f = 0
T - k If =
rate(f ) if f 0
A + k I if f = 0f =
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f sin 2 f t if f = 0f =
f if f
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⋅
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⋅
 ≠
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sp,vol 0


≠
 (2.8.6) 
where 
respA  is a model input representing the strength and depth of quiet respiration; respT is 
a model input representing the period of a quiet respiration cycle; 
,resp volf is a model input 
representing the pattern of voluntary respiration; I  is a model input representing exercise 
intensity; 
respk  is a gain factor applied to exercise intensity. 
 The volume of air that moves during a single inspiration or expiration is called tidal 
volume. The average tidal volume for a 70kg-man during quiet breathing is about 500 mL. 
The additional air volume which can be inspired to reach maximal inspiration is called 
inspiratory reserve volume and can reach 3000 mL. The additional air volume which can be 
exhaled to reach maximal exhalation is called expiratory reserve volume and averages about 
1100 mL. The volume of air still remaining in the lungs after maximal exhalation is called 
residual volume, ca. 1200 mL. We assume that tidal volume depends on respiration signal 
and exercise intensity and slightly modify the equation (1.7.21) from Magosso [74] (see 
section 1.7.4) as follows. 
 1 T
T T
V resp
T T,n resp
V V
G f
V = V (f + )+
A + B I
⋅
⋅
⋅
 (2.8.7) 
where TV is the tidal volume with baseline value ,T nV ; TVG is a static gain; I  is a model input 
representing exercise intensity;
 resp
f is the respiratory signal; ,
T TV V
A B are model constants. 
Constant and input values for respiration and tidal volume are given in Table 2.5.16 and 
Table 2.5.17. Simulation of the above equations is given in Figure 2.30.  
Table 2.5.16 Constant values for tidal volume 
Constant Value Description 
TV
A  33 
constant for exercise intensity 
TV
B  61 
respk  2 static gain for exercise intensity 
,T nV  0.583 L  basal tidal volume 
TV
G  1.62 L  static gain for tidal volume 
Table 2.5.17 Input values for respiration and tidal volume 
Input Value Description 
 
[0 .. 1] exercise intensity 
respA  1  amplitude of respiration signal 
respT  5 s period of the respiration cycle 
,resp volf  [-1 .. 1] voluntary respiration pattern 
 
 
Figure 2.30 Simulation of respiration signal and corresponding tidal volume 
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Local metabolic demand in brain, heart, muscles, splanchnic and extrasplanchnic tissues is 
adapted from Magosso [74] using a static gain and first-order low pass dynamics as follows. 
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 (2.8.8) 
where ipM is the metabolic demand with baseline value ,ip nM ; I  is a model input 
representing exercise intensity; 
ipM
τ are time constants and 
ipM
G are static gains; M is the 
total metabolic demand. 
Oxygen is diffused into pulmonary blood by ventilation and removed by metabolism in 
peripheral tissues. We model the dynamics of partial pressure of oxygen in arterial systemic 
compartment as follows. 
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 (2.8.9) 
where 
2Oas
P is oxygen partial pressure with basal value
2 ,Oas n
P ; TV is the tidal volume; 
2asO
Pτ is a 
time constant and 
2asO
PG is a static gain; 
2asO
Pk is a static gain representing oxygen consumption 
to answer metabolic demand M . 
Constant values for metabolic demand and oxygen consumption are given in Table 2.5.18. 
Simulation of the above equations is given in Figure 2.31.  
 
Table 2.5.18 Constant values for metabolic demand and oxygen consumption 
Constant Value Description 
,ip nM  0.516 mL s-1 baseline metabolic demand in vascular beds (with i  equals v  for ventricles, b  
for brain, m  for skeletal muscles, s for splanchnic and e for extrasplanchnic) 
ipM
τ  40 s time constants of metabolic demand responses to exercise intensity 
ipM
G
 
40 s 
static gains applied to exercise intensity (with i  equals v  for ventricles, b  for 
brain, m  for skeletal muscles, s for splanchnic and e for extrasplanchnic) 
2 ,Oas n
P  100 mmHg baseline value of oxygen partial pressure in arteries 
2asO
Pτ  10 s time constant of oxygen partial pressure 
2asO
PG  0.2 s mL-1 gain of tidal volume on oxygen partial pressure 
2asO
Pk
 
0.01 s
2
 mL
-1
 static gain of metabolic demand 
  
Figure 2.31 Effects of exercise on the cardiovascular system 
Simulation of respiration signal (2
nd
 graph), metabolic demand (3
rd
 graph) and oxygen 
partial pressure (4
th
 graph) as response to increased exercise intensity (1
st
 graph) 
2.8.5 Effects of Gravitational Forces 
Change of posture from a sitting or lying position to standing has a reducing effect on 
venous return and is characterized by reduced arterial blood pressure, activation of 
baroreflex and increasing heart rate. Studies in [68] with mathematical models exhibit 
differences in cardiovascular response between head-up tilt and sit-to-stand. During head-up 
tilt, the head is slowly moved to a location above the heart, while during sit-to-stand no 
hydrostatic pressure changes are enforced between the head and the heart. The model used 
is however an open-model of cardiovascular control using the blood pressure as input. In our 
closed-loop model we were required to model gravitational forces of both types by 
introducing new variables. Examples of variables have been presented in section 1.7.4 where 
arterial blood pressure in legs was a function of height. Trial of including these variables in 
our model was unsuccessful since they exclusively model cerebral blood flow control during 
postural change from sitting to standing only [72]. Therefore we adopt a different approach 
based on the observation that heart rate response has a peak increase followed by an 
exponential decay during sit-to-stand, and a sustained sigmoid-like shape during head-up 
tilt.  
In order to reproduce observed heart rate changes, which have a sigmoid-like shape, we 
model gravitational forces during head-up tilt as follows. 
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 (2.8.10) 
where ,start stopt t are model inputs representing the start time and stop time of tilting; ttk is a 
parameter related to the slope of the orthostatic response; tt,maxg  is the maximal value.  
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 Upon standing from sitting, heart rate promptly rises until saturation is reached, then 
rapidly decreases to resting values even when standing is maintained.  Such a behavior can 
be modeled using an exponential decay function 
ssg  as follows. 
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 (2.8.11) 
where ,start stopt t are model inputs representing the time when subject starts standing and 
time when he stands; ssk is a model parameter related to the slope of the exponential decay 
function; ss,maxg  is the maximal value.  
We rewrite equation (A1.20) from Appendix A1 in order to include the effect of 
gravitational forces on venous return to right atrium as follows. 
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1ra hv ra bv ra mv ra sv ra ev ra
i r tt ss
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dt C R R R R R
 
− − − − −
= ⋅ + + + + − − − 
 
(2.8.12) 
Parameter values for gravitational effects are given in Table 2.5.19. Simulation of the 
above equations is given in Figure 2.32 (head-up tilt) and Figure 2.33 (sit-to-stand).  
 
Table 2.5.19 Parameter values for gravitational effects 
Parameter Value Description 
ss,maxg  2000 mL 
Maximal value of effects due to gravitational forces during active standing from 
sitting 
ssk  0.051 s
-1
 Slope of the heart rate response during active standing from sitting 
tt,maxg  1000 mL Maximal value of effects due to gravitational forces during head-up tilt 
ttk  0.2 s
-1
 Slope of the heart rate response during head-up tilt 
 
 
Figure 2.32 Simulation of heart rate response during head-up tilt 
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Figure 2.33 Simulation of heart rate response during sit-to-stand 
2.8.6 Effects of Intra-thoracic Pressure Elevation 
An abrupt transient increase of intra-thoracic and intra-abdominal pressure provoked by 
blowing into a resistance of approx. 40 mmHg for about 15 seconds induces complex 
hemodynamic changes in the cardiovascular system which can be summarized into four 
phases [100] as modeled in the next paragraphs. 
During the Phase 1, the gradual increase in intra-thoracic and intra-abdominal pressure 
will cause aortic and peripheral vessels compression. This results in increased peripheral 
resistance. We model this slight increase using a Gaussian function 1P : 
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1 1ampP = P e
⋅
⋅  (2.8.13) 
where 1ampP  is the amplitude of pressure increase in mmHg; startt is the timestamp in seconds 
when the expiration starts; 1durP  is the duration of the Phase 1 in seconds. 
Therefore equation  (2.8.4) can be rewritten as: 
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 (2.8.14) 
where ipR  are the resistances in vascular beds. 
The sustained high intra-thoracic and intra-abdominal pressure is modeled using a logistic 
function sP : 
 ( )
( )
( )
rate start
rate start
dP t t-1
max
start stopdP t t-1
maxs
stop
Ps 10 e if t t t
Ps +10 e +1P =
0 if t > t
⋅ −
⋅ −
 ⋅ ⋅ ≤ ≤
⋅


 (2.8.15) 
where maxPs  is the maximum intra-thoracic pressure with constant value 40 mmHg, ratedP is 
the growing rate of pressure development at the beginning of the expiration and stopt  is the 
timestamp in seconds when the forced expiration is released, usually 15 seconds after startt . 
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We assume that this intra-thoracic pressure has a linear effect on the pressure in the 
venous compartments, thus we can rewrite the equations of venous pressures (from 
Appendix A1) as follows: 
 
, , , ,
iv iv,0 ev sP P k P
i v b m s e
= + ⋅
=
 (2.8.16) 
where evk  is a weighting factor and iv,0P  is the baseline venous pressure.  
During the Phase 2, the sustained intra-thoracic and intra-abdominal pressure hinders 
venous return. We include the resulting decrease of transmural pressure in the venous 
extrasplanchnic compartment and model stroke volume changes as follows: 
 ev ev s
str str
as
P - 2 k PV = k
P
⋅ ⋅
⋅  (2.8.17) 
where strk  is a weighting factor.  
During the Phase 3, the forced expiration is released, resulting in a decrease in venous 
pressure. We model this marked decrease using a negative Gaussian function 3P : 
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2
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-
2 P / 8
3 3ampP = -P e
⋅
⋅  (2.8.18) 
where 3ampP  is the amplitude of pressure drop in mmHg, 3durP is the duration of the phase 3 in 
seconds.  
Therefore, equation (2.8.17) can be rewritten as follows. 
 ev ev s 3
str str
as
P - 2 k P + PV = k
P
⋅ ⋅
⋅  (2.8.19) 
During Phase 4, the accumulated venous blood returns to heart and is pumped into the 
constricted arteries causing an overshoot of stroke volume above the normal level. We can 
rewrite the above equation and include the overshoot effect, as follows: 
 
ev ev s 3
str start stop
as
ev ev s 3 4amp
str str stop stop 3dur 4dur
as
4amp
ev ev s 3
str stop 3dur 4dur
as
P - 2 k P + Pk if t t t
P
P - 2 k P + P + P
V k if t t t + P + P
P
P
P - 2 k P + P +
5k if t > t + P + P
P


⋅ ⋅
⋅ ≤ ≤


⋅ ⋅
= ⋅ < ≤


 ⋅ ⋅

⋅

 (2.8.20) 
where 4ampP  is a model parameter representing the overshoot effect on the stroke volume, 
4durP  is the duration of phase 4 in seconds. 
 Parameters values are given in Table 2.5.20. Simulation of the above equations is given in 
Figure 2.34. During phase 1 a brief increase in arterial blood pressure and decrease in heart 
rate is observed. In phase 2 sustained high intra-thoracic and intra-abdominal pressure 
hinders venous return, leading to a rapid decrease in arterial blood pressure and increased 
heart rate. During phase 3, the forced expiration is released resulting in a sudden decrease in 
arterial blood pressure. During phase 4, the accumulated venous blood returns to heart and 
is pumped into the constricted arteries causing an “overshoot” of arterial pressure followed 
by bradycardia. 
 
Table 2.5.20 Parameters values for intra-thoracic pressure elevation 
Parameter Value Description 
ev
k  0.29 weighting factor of intra-thoracic pressure elevation on venous pressure 
strk  0.57 liter weighting factor of intra-thoracic pressure elevation on stroke volume 
1durP  2.49 s duration of phase 1 of intra-thoracic pressure elevation 
1ampP  1.18 mmHg s ml-1 amplitude of phase 1 of intra-thoracic pressure elevation 
3durP  3.94 s duration of phase 3 of intra-thoracic pressure elevation 
3ampP  2.46 mmHg s ml-1 amplitude of phase 3 of intra-thoracic pressure elevation 
4durP
 
3.66 sec duration of phase 4 of intra-thoracic pressure elevation 
4ampP
 
3.06 mmHg s ml
-1
 amplitude of phase 4 of intra-thoracic pressure elevation 
ratedP
 
2.24 rate of intra-thoracic pressure elevation 
 
 
Figure 2.34 Mean arterial pressure (plain line) and heart rate (dashed line) changes during the VM 
The maneuver covers the timeline from the 15th  to the 30th second. Phase 1 goes from 
15th to 16th second, phase 2 ends at 30th second, followed by phase 3. The last phase 4 
runs from 31st to 38th second. 
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2.9 Summary and Conclusion 
In Chapter 1 we presented major limitations of established methods for assessing 
autonomic nervous activity on the cardiovascular system such as univariate analysis (heart 
rate variability, blood pressure variability), multivariate analysis (baroreflex sensitivity, 
transfer functions), biochemical analysis (norepinephrine spillover, muscle sympathetic 
activity) and model-based analysis (lumped or distributed mathematical models based on 
control theory). In this Chapter 2 we have proposed a novel integrative approach to 
mathematical modeling of cardiovascular control and covered single levels of cardiovascular 
neural pathways from receptors to effectors.  
Our major contribution includes novel mathematical models of sympathetic tone, 
parasympathetic tone, Mayer waves, respiratory sinus arrhythmias, spinal residual activity, 
vagally-mediated tachycardia and high-frequency intra-cardiac fluctuations. Furthermore we 
propose unique models of diving reflex, cognitive stress reflex, oculocardiac reflex, reflex 
reaction to low temperature, reflex reaction to gravitational forces, reflex reaction to intra-
thoracic pressure elevation, firing rate of respiratory somatic neurons and concentration of 
adrenal catecholamine.  
An overall overview of the model described in the previous sections is depicted as 
package diagram in Figure 2.35. The model consists of several negative feedback processes 
for controlling internal cardiovascular variables such as heart rate, ventricle elastance, 
arterial blood pressure, and peripheral vascular resistance. The current state of these 
variables is measured by primary afferent neurons which are lumped into the Measuring 
Subsystem. Their anatomical structure and physiological function were modeled in sections 
2.3.1 and 2.4. The Controller Subsystem is composed of autonomic premotor neurons as 
described in sections 2.3.2 and 2.5. The controller subsystem integrates the sensory 
information and initiates regulatory commands to actuators. The Actuator Subsystem 
consists of preganglionic and postganglionic autonomic neurons as described in sections 
2.3.3, 2.3.4, 2.6 and 2.7. They translate the command signals into chemical substances that 
affect the response of effectors. Cardiovascular effectors build the Plant Subsystem including 
heart and blood vessels. Outputs from effectors are physiological variables which are 
measured by the measuring subsystem and feedback to the controller, thus starting the loop 
again. The model also includes feedforward loops especially when the cardiovascular system 
should face major external disturbances such as cold. Such external disturbances are sensed 
and feedforward to the controller before they affect the system.  
Our physiologically-based model is characterized by input variables (Table 2.9.1), internal 
state variables (Table 2.9.2), observed output variables (Table 2.9.3) and unknown 
parameters (Table 2.9.4). The observed output variables can be fit to the measured data in 
order to provide unique values for the model parameters. Chapter 3 will deal with 
experimental setups which we have designed in order to gather enough physiological data. 
Chapter 4 will cover the estimation of values for model parameters and will check the 
validity of model outputs. The quantitative feature of our model will also be demonstrated 
and methods for assessing autonomic neural activity of both sympathetic and 
parasympathetic branches will be developed. 
  
Figure 2.35 Diagram for Overall Cardiovascular Control 
 
 
Table 2.9.1 Model inputs 
Variable Value Range Description 
age [10 .. 100] years age of the subject 
,resp volf  [-1 .. 1] voluntary respiration pattern 
respA  [0 .. 1] 
amplitude of the signal representing the strength and depth of quiet 
respiration 
respT  [1 .. 60] s period of the signal representing the duration of a quiet respiration cycle 
,start stopt t
 
[1 .. 300] s 
start and end timestamps for external stimulation (e.g. cold stimuli 
applied to the skin, mental stress, sit to stand, head-up tilt) 
I
 
[0 .. 1] exercise intensity 
nQT
 
[100 .. 500] ms baseline QT interval duration 
Plant Subsystem
Measuring Subsystem Controller Subsystem
Actuator Subsystem
External Pertubation
Cardiovascular State
«flow»
Regulatory Command
«flow»
Sympathetic and Parasympathetic Outflow
«flow»
Outputs
«flow»
 Table 2.9.2 Selected state variables 
Variable Value Range Description 
abf  [0 .. 120] Hz firing rate of baroreceptor 
acf  [1.16 .. 17.07] Hz firing rate of chemoreceptor  
apf  [0 .. 15] Hz firing rate of pulmonary stretch receptor 
aaf  [1 .. 18] Hz firing rate of atria stretch receptor 
fat
f  [5 .. 50] Hz firing rate of trigeminal cold receptor 
sat
f  [5 .. 50] Hz firing rate of  cold receptor in hands/feet 
aof  [5 .. 50] Hz firing rate of oculo-pressure receptor 
as
f
 
[5 .. 20] Hz firing rate of mental stress sensors 
,0,es snf  [16.11 .. 20] Hz sympathetic tone to heart 
,0,es pf  [16.11 .. 25] Hz sympathetic tone to vessels 
,0evf  [1 .. 3.2] Hz vagal tone to heart 
respf  [0 .. 2] Hz firing rate of inspiratory and expiratory somatic motor neurons 
pmsn
f
 
[2 .. 60] Hz 
firing rate of sympathetic premotor neurons controlling SA node and AV 
node 
pmsi
f
 
[2 .. 60] Hz 
firing rate of sympathetic premotor neurons controlling vascular beds (with 
equals  for ventricles,  for brain,  for splanchnic and  for 
extrasplanchnic) 
pmev
f
 
[2 .. 20] Hz firing rate of parasympathetic autonomic premotor neurons 
ipR  
[1 .. 50] mmHg s 
mL
-1
 
peripheral resistance in vascular beds (with i equals v  for ventricles, b  for 
brain, s  for splanchnic and e  for extrasplanchnic) 
E  [2 .. 10] mmHg mL-1 ventricle elastance 
2Oas
P  [70 .. 110] mmHg oxygen partial pressure in arteries 
respf  [-1 .. 1] respiration signal 
rateresp
f
 [0 .. 60] cycles/min respiration rate 
TV  [0.583 .. 0.75] L tidal volume 
 
Table 2.9.3 Observed variables 
Variable Value Range Description 
HR  [20 .. 200] 
beats/min 
heart rate 
asP  [40 .. 200] mmHg arterial blood pressure 
QT  [200 .. 500] s duration of QT intervals 
mpG  [1 .. 50] µSiemens level of galvanic skin response in skeletal muscles 
 
i v b s e
  
 
Table 2.9.4 Model parameters 
Parameter Value Range Description 
Characteristics of sympathetic tone and parasympathetic tone 
,0,es highf  10 Hz [2 .. 12] firing rate of pacemaker sympathetic premotor neurons 
, ,0c esW  3 
[1 .. 5] synaptic weight applied to sensory inputs from chemoreceptors 
,0,es lowW  2.1 
[1 .. 5] synaptic weight applied to low frequency oscillators in sympathetic 
premotor neurons 
,0,es lowr  0.05 
[0.01 .. 0.1] 
parameters determining the rate of low frequency oscillators in 
sympathetic premotor neurons 
,0,es lowk  3 [1 .. 5] 
ev,0,maxf  3.2 Hz [1 .. 20] maximal intrinsic firing rate of vagal nerves 
Characteristics of respiratory sinus arrhythmias & Inspiratory and expiratory somatic motor neurons 
,resp vW  0.105 Hz 
[0.1 .. 5] synaptic weight applied to inputs from inspiratory-expiratory 
somatic motor neurons 
rsaf  0.15 Hz [0.1 .. 1] frequency of intracardiac high frequency fluctuations 
rsaT
G  0.01 [0.01 .. 0.1] gain of intracardiac high frequency fluctuations 
Characteristics of heart period and QT interval duration 
,nor vog
k
 60 
[0 .. 100] 
modulation factor of vagally-mediated tachycardia  
QTk
 
10 
mmHg
-1
 
mL 
[10 .. 20] 
gain of elastance on QT interval duration 
Characteristics of peripheral vascular resistance 
mpG
k
 
12 µS 
mmHg
-1
 
s
-1
 ml 
[1 .. 20] 
gain parameter applied to peripheral vascular resistance in skeletal 
muscles 
Characteristics of cold receptors 
fat ,max
f  50 Hz [0 .. 100] upper saturation of facial cold receptor 
fat
k  0.2 s-1 [0.01 .. 1] slope of the exponential decay of cold receptor on face 
sat ,max
f  72 Hz [0 .. 100] upper saturation of cold receptor on hands and feet 
sat
k
 1.03 s
-1
 [0.01 .. 5] slope of the sigmoid response of cold receptor on hands and feet 
Characteristics of mental stress sensors 
as,maxf  20 Hz [1 .. 50] upper saturation of mental stress sensors 
as
k  0.2 s-1 [0.1 .. 1] slope of the mental stress sensor response 
Characteristics of gravitational forces during orthostatic stress 
ss,maxg  2000 mL 
[500 .. 5000] maximal value of effects due to gravitational forces during active 
standing from sitting 
ssk  0.051 s
-1
 [0.01 .. 1] slope of the heart rate response during active standing from sitting 
tt,maxg  500 mL 
[100 .. 2000] maximal value of effects due to gravitational forces during head-up 
tilt 
ttk  0.2 s
-1
 [0.01 .. 2] slope of the heart rate response during head-up tilt 
Characteristics of oculo-pressure receptors 
ao,maxf  17 Hz [0 .. 50] upper saturation of oculo-pressure receptor 
 0.7 s
-1
 [0.1 .. 2] slope of the sigmoid response of oculo-pressure receptor aok
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Characteristics of intra-thoracic pressure elevation 
evk  0.29 [0.1 .. 1] 
weighting factor of intra-thoracic pressure elevation on venous 
pressure 
strk  0.57 L [0.1 .. 1] 
weighting factor of intra-thoracic pressure elevation on stroke 
volume 
1durP  2.49 s [2 .. 5] duration of phase 1 of intra-thoracic pressure elevation 
1ampP  
1.18 
mmHg s 
ml
-1
 [1 .. 5] 
amplitude of phase 1 of intra-thoracic pressure elevation 
3durP  3.94 s [2 .. 5] duration of phase 3 of intra-thoracic pressure elevation 
3ampP  
2.46 
mmHg s 
ml
-1
 [2 .. 5] 
amplitude of phase 3 of intra-thoracic pressure elevation 
4durP
 
3.66 sec [2 .. 5] duration of phase 4 of intra-thoracic pressure elevation 
4ampP
 
3.06 
mmHg s 
ml
-1
 [3 .. 5] 
amplitude of phase 4 of intra-thoracic pressure elevation 
ratedP
 
2.24 [0.5 .. 5] rate of intra-thoracic pressure elevation 
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Chapter 3. Material and Methods for Experiments 
In the previous chapter we used prior knowledge of physiological processes running in the 
body and built an integrative model of cardiovascular control. The model includes a set of 
unknown parameters with physiological meaning. The goal of this chapter is to define 
experimental setups for qualitative data collection which will be further used to estimate 
values of those unknown parameters. 
There are an important number of patients exhibiting cardiac autonomic disorders. 
Several studies could link sudden cardiac death and the autonomic nervous system. In the 
clinical practice a method to investigate cardiac autonomic tone is to perform provocative 
tests known as cardiac autonomic tests, which are simple, low-cost, non-invasive and can be 
performed in clinical routine. They trigger cardiovascular reflex arcs with responses, which 
can be measured using non-invasive techniques (electrocardiography, impedance 
cardiography, blood pressure, galvanic skin response ...) that can give diagnostic information 
about cardiac autonomic disorders.  
We selected  the mental arithmetic test, the Valsalva Maneuver, slow deep breathing, 
cold face test, cold pressor test, tilt table test, active change of posture and oculocardiac 
reflex test. We also tried various other experiments such as breathe holding, yawning, 
aerobic exercise, sustained handgrip, which were finally not included into our framework 
because of technical and time constraints.  
We first experimented on horses in order to verify hypothesis on a denser 
parasympathetic innervations of equine ventricle causing sudden cardiac death during 
surgery [101]. Equine experiments accounted only for a small portion of our trials. The 
majority of experiments were performed on human subjects. Additional species were not 
included in our research because of technical and administrative boundaries. 
This chapter describes all cardiac autonomic tests we have performed; including their 
physiological background, indications, contraindications, the entry conditions which should 
be fulfilled before the subject is allowed to take the test, the instrumentation, the activities 
flow performed during the test, the exceptions which might cause test interruption and 
examples of normal cardiac signals plots. 
 3.1 Generalities 
3.1.1 Human Subjects 
Experiments were carried out on 72 subjects (ages from 11 to 82 years, mean 36±17 
years) in accordance with the Declaration of Helsinki and informal consent was obtained 
from each participant. Our studies included 25 black women, 17 white women and 13 black 
men and 16 white men in total (see Figure 3.1). Among those subjects 35 were living in 
Bafoussam, 1 in Yaoundé, 1 in Douala, Cameroon; 16 live in Kladno, 7 in Prague, 5 in Liberec, 
Czech Republic; 1 was living in Brussels, Belgium and 1 in Grenoble, France. Details about 
subjects are given in the Appendix A2. 
     
Figure 3.1 Subjects by age and gender 
Young (less than 29 years); Older (30 to 59 years); Elderly (over 60 years) 
3 subjects (n = 8, 10, 26) were presenting palpitation at the moment of the experiment, 2 
subjects (n = 8, 20) were suffering of cardiac insufficiency, 4 subjects (n = 16, 20, 45, 55) had 
hypertension and 1 had aortic stenosis. Some subjects additionally presented non-
cardiovascular diseases such as hepatitis B (n = 5), gastric ulcer (n = 8, 10), sleep apnea (n = 
38) and diabetes mellitus (n = 41). 
Three different experimental sessions were realized in collaboration with the Department 
of Biomedical Informatics at the Czech Technical University in Prague on February 25, 2009, 
April 28, 2009 and May 20, 2009. 7 women (ages from 25 to 77 years, mean 42±21 years) 
and 7 men (ages from 25 to 82 years, mean 48±23 years) underwent the cold face test (CFT) 
and cold pressor test (CPT) in the first session. The tilt table test (TTT), valsalva maneuver 
(VM), cold pressor test and oculocardiac reflex test (OCT) were performed on 7 women (ages 
from 20 to 24 years, mean 21±1 years) and 7 men (ages from 22 to 29 years, mean 24±3 
years). The third session consisted of performing the tilt table test, valsalva maneuver and 
oculocardiac reflex test on 4 women (ages from 15 to 46 years, mean 26±14 years) and 2 
men (age 23 years). 
Two additional experimental sessions were carried in collaboration with the Department 
of Computer Science at the University of Yaounde I in Cameroon and District Hospital of 
Dschang in Cameroon on January 27 and January 28, 2010 where subjects underwent the 
cold face test, deep breath test (DBT), mental stress test (MST), valsalva maneuver, cold 
pressor test, active standing and oculocardiac reflex test. The first session included 26 
women (ages from 11 to 70 years, mean 37±16 years) and 12 men (ages from 23 to 56 years, 
mean 47±11 years). The second session included 2 women (ages 17 and 48 years) and 1 man 
(age 56 years). 
 3.1.2 Instrumentation 
Diverse types of instrumentation have been reported in the literature for cardiovascular 
signal acquisition. Subjects in [102] were instrumented with a Finapres Ohmeda 300 
instrument for beat to beat heart rate and blood pressure measurements. Systolic and 
diastolic blood pressure was continuously measured in [103] from the left radial artery with 
noninvasive arterial tonometry (Colin Pilot; Colin Medical Instruments). The tonometer 
consisted of an array of 31 equally spaced piezoresistive pressure transducers, an automated 
positioning system, signal conditioning and initial calibration by oscillometric cuff 
measurement of brachial artery blood pressure. Skin blood flow was monitored at the first 
toe pulp with a Periflux laser Doppler (Perimed). Respiratory frequency was monitored with 
a two-belt chest-abdomen inductance plethysmograph after calibration (Respitrace 
calibrator). A Biopac MP35 measurement system was used in [104]. Authors of [105] 
additionally measured the cardiac output using a Doppler electrocardiographic device 
(Hewlett-Packard model 77020AC). 
We have chosen Biopac MP150 and MP35 measurement systems in our studies (BIOPAC 
Systems, Inc., Goleta, Figure 3.2). A 3 leads ECG was recorded using Biopac SS2L electrodes 
placed on the left and right wrists, and on the left part of the abdomen just above the belt 
(see Figure 3.3). Pulse was measured using a SS4LA Pulse Plethysmograph Transducer placed 
on the index finger of the right hand. Two Biopac electrodes SS57L were fixed around the 
index (ground) and middle finger (+) of the left hand for measurement of galvanic skin 
response. The body skin temperature was measured using a SS6L Temperature Transducer 
placed closed to the skin. Respiration rate was measured using a Biopac SS5LB transducer to 
record chest expansion and contraction. The sensors are depicted in Figure 3.4 and Figure 
3.5. 
 
Figure 3.2 Biopac MP35 Measurement System (reprinted from [106]) 
   
Figure 3.3 Biopac SS2L Electrodes for ECG measurement (reprinted from [106]) 
 
       
Pulse measurement (left);  skin temperature measurement (center); galvanic skin response measurement (right)
Figure 3.
 
The Biopac MP150 or MP35 system 
PRO software was installed for continuous signal acquisition at a frequency of 500 Hz. A 
Biopac acquisition file was created with the following settings:
Recording and Append into Memory
was set to 2 hours; analog channel CH1 
had the preset PPG (Pulse) with 
EDA (GSR) (0 - 35 Hz)  with a 2 Hz
Respiration (SS5LB); calculation c
C2 had the preset Heart Rate
channel C4 had the preset Respiration Rate
Additionally to the Biopac System, a blood pressure device, model OMRON M10
used for collecting arterial blood pressure samples which were further used to calibrate the 
pulse waveform. The device was later connected to a PC and the Omron HealthCare 
Management Software was used to download 
were synchronized based on the same time.  
Figure 3.6 OMRON M10
Image reprinted from user manual, 
        
Figure 3.4 Biopac Sensors (reprinted from [106]) 
 
 
5 Respiration signal measurement (reprinted from [106]) 
was connected to a PC where the Biopac Student Lab 
 the acquisition 
 at a sampling rate of 500 Hz; the total acquisition length 
had the preset ECG (.5 - 35 Hz); analog c
a 50 Hz low pass filter; analog channel CH3 
 low pass filter; analog channel CH4 
hannel C1 had the preset R-R Interval; calculation c
; calculation channel C3 had the preset Pulse Rate
.  
measured data. Biopac and OMRON system
 
 
-IT device for cuff blood pressure measurement 
http://www.omron.com/, visited June 2010
 
  
was set up for 
hannel CH2 
had the preset 
had the preset 
hannel 
; calculation 
-IT, was 
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3.1.3 Experimental Protocol 
Drugs (blockers) that interfere with parasympathetic or sympathetic transmission were 
contraindicated before and during the test. Alcohol and smoking was not allowed 24 hours 
prior to the test. Physical exercise was avoided 24 hours prior to the test in order to avoid 
long term changes in heart rate variability. Most tests were performed according to 
following protocol: 
1. Instruction 
The subject was shortly informed about the physiology of the test. He was instructed in 
details about the activities flow which will be performed. He was asked to report about the 
degree of discomfort or pain during the test by moving the small finger of his right hand. The 
faster he moves the finger, the more pain or discomfort he has and the test should be 
interrupted. The subject was instructed not to talk during the whole measurement. 
2. Demonstration 
The test was first performed on an unwired control person at the presence of the subject, 
so that he could learn how to behave during the test and be confident on what will be done 
on him. 
3. Instrumentation 
Subject was wired with a Biopac MP35 measurement system for recording 3 leads ECG, 
arterial pulse, galvanic skin response, skin temperature and breathing rate signals at 500 Hz. 
The subject was then stabilized in a supine position on a comfortable table or bed; or in a 
sitting position on a comfortable chair according to the type of test. 
4. Baseline Measurement 
Baseline measurements were performed using the Biopac Student Lab PRO software until 
all signals were stable, i.e. until the heart rate did not vary greatly, no tachycardia was 
present, successive pulse values had a similar amplitude, the galvanic skin response was 
constant and the breathing frequency was regular. During baseline measurements blood 
pressure samples were taken using the OMRON device with automatic cuff inflation. Systolic 
and diastolic values were added to the protocol. 
5. Preparatory Measurement 
A preparatory period of typically 30 seconds was included in the protocol. Recording 
performed during this period were not part of baseline recordings because during this 
period the subject was usually influenced by emotional factor induced for example by a cold 
compress approaching the face during a cold face test. 
6. Measurement during Autonomic Test 
After cardiac signals have stabilized, the external stimulus was applied according to the 
procedures described in next sections (e.g. cold compress on the face, pressure on eye lids, 
deep breathing, mental exercise or forced expiration). The current timestamp displayed on 
the Biopac Student Lab PRO timeline was added to the protocol as starting time of the 
external stimulus. The subject was observed for pain or discomfort sensation and the test 
was interrupted if he displayed great discomfort. Otherwise the external stimulus was 
maintained for the predefined maximal duration depending on the test type (e.g. 15 s for the 
valsalva maneuver, 180 s for the cold pressor test).  
 7. Post Measurement 
After the external stimulus 
and to relax. The current timestamp displayed on the Biopac Student Lab
added to the protocol as end time of the external stimulus. Recordings 
all cardiac signals were stabilized.
8. Diagnostic Measurement
After the first autonomic test the subject 
real diagnostic assessment was
Post Measurement activities were
9. Release and Post Evaluation
After the diagnostic measurement elect
asked to rate the pain and discomfort factor on a scale of 
being strong pain or intense discomfort. He 
for example if headache, fainting or nausea were present. His feeling after the test at the 
moment of post evaluation was
3.1.4 Extracting ECG Parameters
Electrocardiogram (ECG) is used to record the electrical activity in the
electrocardiogram consists of
T) and intervals consisting of a combination of waves and segments (PR, QRS, QT and TP).
The first wave is the P wave, which corresponds to the depolarization of the atria. The a
repolarization is too small to be seen but appears as distortion of the PR segment or
incorporated into the QRS complex. The bundle of His and bundle branches are activated 
during the P-R segment. The PR interval measures the time between atria and
activation. It can reflect vagal control on atrioventricular node. PR interval duration longer 
than 200 milliseconds suggests conduction impairment. The next trio, the QRS complex, 
represents the progressive wave of ventricular depolarization. T
typically 100 milliseconds. The S
sound (peak of ventricle contraction and opening of aortic valve) and ventricle ejection. The 
QT interval corresponds to the duration between
relaxation. It has a value ranging from 250 to 500 milliseconds. The final T wave represents 
the repolarization of the ventricles. The amplitude of the T wave has been proposed as 
measured of sympathetic activity. 
3.7. 
Figure 3
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environment: non-syntactic QRS Detection [108] and nonlinear high-pass filter R-wave 
detection [109]. Both algorithms use standards methods of detection by thresholding on the 
original ECG, or after application of a highpass linear filter, or the methods of detection by 
derivation and thresholding.  They are enough precise in the simplest cases.   
The ECG signals were sampled at 500 Hz using the Biopac Student Lab PRO acquisition 
software. They were exported in time series ASCII files for further processing in Matlab. R-
peaks were detected from the ECG signal using an implementation of the non-syntactic QRS 
detection algorithm offered by the open ANSLAB (Autonomic Nervous System Laboratory) 
library [110]. For this purpose the ECG signal was sampled down to 400 Hz and filtered to get 
rid of shifting baseline (baseline wandering noise), muscle artifacts and power line 
interference using a Butterworth band pass filter. NN intervals durations were calculated as 
differences of timestamps of consecutive R-peaks in milliseconds. 
We developed the following algorithm for automatically removing artifacts from NN 
intervals series using a smoothing technique. The algorithm plots the series on a graph 
where the x-axis is the time and the y-axis is the NN interval duration; then calculates a 
straight line (first order polynomial) that best fits the series and determines the baseline 
heart rate, i.e. the y-point where the line cuts the y-axis. Next step is to loop through the NN 
interval durations, to calculate the mean of previous 10 NN interval durations (previous_hr) 
and smooth up or down the current value if it exceeds or is less than a certain percentage 
(smoothup_hr or smoothdown_hr) of the previously calculated baseline value. The algorithm is 
given in Matlab code below, where hr is the original vector of NN interval durations and hrr is 
the corresponding smoothed vector. An illustrative example is given in Figure 3.8. 
 
    smoothup_hr = 1.8; 
    smoothdown_hr = 0.6; 
    hrr = hr; 
    t=t(1:length(hr)); 
    baseline_hr = polyval(polyfit(t', hr, 1),0);  
    i=2; 
    while i<length(hrr) 
        previous_hr = mean(hrr(max(1,i-10):i-1)); 
        while hrr(i) < smoothdown_hr*baseline_hr && i<length(hrr) 
           hrr(max(1,i-2):min(length(hrr),i+2))=previous_hr; 
           i = i+1; 
        end           
        i=i+1; 
    end; 
    i=2; 
    while i<length(hrr) 
        previous_hr = mean(hrr(max(1,i-10):i-1)); 
        while hrr(i) > smoothup_hr*baseline_hr && i<length(hrr) 
           hrr(max(1,i-2):min(length(hrr),i+2))=previous_hr; 
           i = i+1; 
        end           
        i=i+1; 
    end 
 
 
  
Figure 3.8 Ouput of the smoothing algorithm for a noisy heart rate signal 
original signal (hr), smoothed signal (hrr) 
The smoothed NN time series was manually edited for removing NN values outside 
physiological range, due to measurement failures such as electrodes displacement. It was 
then sampled down to 10 Hz and stored in a vector RR  (in milliseconds) for further analysis. 
The series of beat-to-beat heart rate HR  (in beats/min) was calculated from the RR intervals 
as follows: 
 
60000HR =
RR
 (3.1.1) 
The algorithm for QT interval duration calculation is relatively simple. It first detects the 
timestamp of a Q point by differentiating the ECG portion shortly before the R peak . After 
differentiation the maximal slope is computed in this area. The algorithm then goes back to 
the first flat slope which is the Q point. We used a window of 0.12 second for searching back 
Q point from R. The next step is to detect the starting time of the T wave using a wave 
detection algorithm described in [111]. We used the open ANSLAB (Autonomic Nervous 
System Laboratory) library [110] for processing in Matlab and stored the QT interval 
durations in a vector QT  (unit milliseconds). 
3.1.5 Estimating Blood Pressure Signal from Pulse Waveform 
The arterial blood pressure is the pressure applied on arterial walls as blood traverses the 
arteries measured in millimeters of mercury (mmHg). The systolic blood pressure sysBP  is the 
highest value reached during systole and diastolic blood pressure diasBP  is the lowest value 
reached during diastole. The pulse pressure PP  is the difference between the systolic and 
diastolic blood pressures and an estimation of mean blood pressure MAP  is the time-
weighted mean pressure value over one cardiac cycle.  
 
/ 3
sys dias
dias
PP BP BP
MAP BP PP
= −
= +
 (3.1.2) 
Blood pressure can be measured noninvasively using palpation, Doppler method, 
auscultation method, oscillometry, plethysmography or arterial tonometry [80].  
The auscultation method consists of placing a cuff on the upper arm and a stethoscope 
over the brachial artery. The cuff is inflated to a pressure that cuts off blood flow in all 
arteries until no sound is heard. The cuff is then slowly released until the first so-called 
Korotkoff sound is heard; the pressure at which this happens is the systolic blood pressure. 
The cuff is further released and when all sounds disappear, the diastolic blood pressure is 
obtained. The palpation method is similar to the auscultation method where the 
stethoscope is replaced by palpation of the artery. The Doppler method is a further 
modification of the auscultation method where the stethoscope is replaced by a Doppler 
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probe, which detects ultrasounds caused by blood flow. Only systolic blood pressure can be 
determined by the palpation and Doppler methods. The oscillometry method detects the 
oscillation caused by blood flow under a cuff.  
A tonometry device flattens the artery by applying pressure non-invasively to squeeze the 
artery against bone using an adjustable air chamber. The applied pressure necessary to 
maintain the flattened shape is measured by an array of pressure sensors. An algorithm is 
applied to derive the intraluminal arterial pressure. 
Plethysmography method uses a finger plethysmograph to determine the minimum cuff 
pressure needed to maintain constant finger blood volume. A light-emitting diode and a 
photoelectric cell detect changes in blood volume and adjust the cuff pressure. The pressure 
within the transparent inflatable cuff is controlled by an electro-pneumatic system and a PID 
(Proportional, Integral and Derivator) controller. Any deviation of vascular volume due to 
changes of intravascular pressures is instantaneously compensated by automatic adjustment 
of the cuff pressure. This is the principle of FINAPRES and provides a continuous 
measurement of aortic intravascular blood pressure.  
In our studies we had some limitations in measuring blood pressure continuously due to 
the implied high cost of FINAPRES devices. We rather measured the volume wave form using 
a Biopac photoplethysmograph as described in section 3.1.2, what gives the relative pulse 
waveform. The transducer measures the density of blood in the fingertip by shining a light 
into the finger and measuring how much light gets reflected back. The transducer consists of 
a matched infrared emitter and photo diode, which transmits changes in blood density, 
caused by varying blood pressure in finger. A built-in two-stage IR filter and ergonomic 
housing reduces artifacts from ambient light and subject movement [106]. The signal was 
sampled at 500 Hz using the Biopac Student Lab PRO acquisition software and was exported 
in time series ASCII files for further processing in Matlab. The signal was sampled down to 
400 Hz, a 20 Hz low-pass filter and 0.30 Hz high-pass filter were applied. The resulting signal 
was stored in a time series variable PPG (unit millivolts)  
Diverse parameters can be extracted from the pulse time series including the beat-to-
beat pulse rise time, pulse travel time PTT , pulse amplitude PA, pulse shape and the 
variability of each of them [112]. Pulse transit time is the time it takes a pulse wave to travel 
between two arterial sites. A relatively short PTT  is observed with high blood pressure, 
aging, arteriosclerosis and diabetes mellitus. An estimate of PTT  is the interval between the 
R peak on the ECG and the onset of the corresponding pulse in the finger [113]. The 
algorithm for calculating PTT  simply determines the time of pulse peak as the time when 
the maximal amplitude is observed between two consecutive R peaks. The difference 
between that time and the time of R peak is stored for each cardiac cycle in the time series 
PTT (in milliseconds). The maximal pulse amplitude is stored in the time series PA  (Biopac 
measuring system delivers proportional values of pulse amplitude in millivolts, a 
transformation to mmHg is performed after calibration as explained in the following 
paragraph). 
Pulse amplitude PA has been suggested as marker of autonomic nervous activity [114]. It 
is well known that pulse amplitude is related to the underlying mean arterial blood pressure
MAP . A model of relation between both quantities is proposed in [115] as follows: 
 b PA d PAMAP a e c e× ×= × + ×  (3.1.3) 
Using such a model blood pressure can be approximated continuously. Such an 
approximation does not provide clinically relevant absolute values but is sufficient for our 
research since we are only interest in the magnitude of change of blood pressure in 
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response to commands from autonomic nervous system. The equation above contains 
unknown parameters , , ,a b c d which can be determined by fitting correct blood pressure 
values to pulse amplitudes during a calibration phase.  
In order to obtain enough data for estimating the four parameters, we performed a 
separated measurement session for each subject where we measured pulse wave amplitude 
calPA  and took blood pressure samples at the same time using a digital tonometer device 
(model OMRON M10-IT) which inflates the cuff automatically and provides ca. 6 samples per 
minute. The systolic and diastolic values were downloaded from the device using the Omron 
HealthCare Management Software tool as ASCII file for further processing in Matlab where 
mean arterial pressure calMAP was calculated by applying equation (3.1.2). Both calMAP  and 
calPA  were fit to equation (3.1.3) using Matlab’s implementation of the non linear least 
squares algorithm. The process converged rapidly to unique parameter values for , , ,a b c d  
for each subject. Example values are 104.9 mmHg, -3.8 mV-1, 0.2 mmHg and 17.8 mV-1 
respectively. It was therefore possible to estimate mean arterial pressure MAP  from the 
recorded pulse signal continuously. 
3.1.6 Processing Respiration Signal 
Thoracic contraction and expansion were recorded using a respiration effort transducer. 
This is useful for determining depth of breath and respiration rate as well as the dispersion 
index which provides an estimation of the regularity of the breathing activity. The respiration 
signals were sampled at 500 Hz using the Biopac Student Lab PRO acquisition software. They 
were exported in time series ASCII files and further processed in Matlab. We used an 
algorithm based on well-known volume and thorax circumference relationships. The 
algorithm ideally requires a calibration phase where subjects repeatedly inhale and exhale 
750 mL of air in controlled conditions. We did not have materials for controlling respiratory 
volume or for pacing respiration. Therefore we selected measurements corresponding to 
quiet regularly breathing and used them for calibration. The algorithm determined 
calibration weights which were specific to the subject’s respiration pattern. Weights were 
further used to translate measured thoracic circumference into calibrated respiration 
variables using algorithms offered by the open ANSLAB library [110]. 
The instantaneous minute respiration rate (in cycles/min) was calculated as the number 
of respiration cycles per minute. The instantaneous tidal volume (in milliliters) was obtained 
as volume of lung at the end of inspiration. The instantaneous minute volume (in liter/min) 
was extracted as the total volume of air flowing into lungs per minute. The instantaneous 
duty cycle (dimensionless unit) was obtained as ratio of inspiratory duration over total cycle 
duration. The values were respectively stored in time series , , ,RSR RST RSF RSD . 
In some experimental setups, respiration signal was not recorded because of technical 
limitations. In such cases we had to estimate the respiration signal from the ECG signal. 
Pioneer work of Moody and co-workers introduced a signal-processing method which 
derives respiratory waveforms from ordinary surface electrocardiogram [116]. The so-called 
ECG-derived respiratory signal (EDR) is calculated from changes in the lead axes of the 
electrodes on the chest surface using the amplitudes of R-peaks ( RV ). We implemented an 
algorithm that normalizes the vector of R-peak amplitudes in an interval between -1 and 1 
by removing the mean amplitude and dividing the result by the maximal value. Since the R-
peak amplitude decreases with inspiration, we switch the signal over the x-axis in order to 
obtain the ECG-derived respiratory signal. Figure 3.9 shows a Measured Respiration Signal 
recorded using a respiration effort transducer during deep breathing, the Normalized R-peak 
 Amplitude signal derived from the ECG and finally the obtained ECG-derived respiration 
signal, which shows an acceptable match with the measured respiration signal despite of 
some differences in the amplitude. 
 
Figure 3.9 Example of ECG-derived respiration signal 
3.1.7 Processing Galvanic Skin Response 
A galvanic skin amplifier applies a constant low voltage to the skin through electrodes and 
measures the current flow. Using Ohm’s low the resistance of the underlying conductor can 
be obtained. The inverse of the resistance is the skin conductance expressed in units called 
microSiemens (µS). Change in conductance occurs when sweat glands fill or empty sweat.    
The glands respond to sympathetic nervous stimulation via efferent postganglionic 
sympathetic nerves releasing acetylcholine [117, 118]. The Galvanic Skin Response (GSR) 
signals were sampled at 500 Hz using the Biopac Student Lab PRO acquisition software and 
were exported in time series ASCII files for further processing in Matlab using algorithms 
offered by the open ANSLAB library [110]. Room temperature was maintained at 20 – 22 ⁰C 
for reproducible GSR response. 
Skin conductance level SCL  was obtained as baseline tonic level ranging from 10 to 50 µS 
in absence of discrete environmental event. The non-specific fluctuation rate NSF was 
extracted as the number of phasic fluctuations per minute, which are not related to 
experimental events. Skin conductance response amplitude SCR  was calculated (in µS) as 
difference between the peak response and the baseline tonic level. Skin conductance 
response rise time SCT  was obtained (in seconds) as duration between of the onset of the 
response and peak conductance. Half-response time SCH was calculated (in seconds) as the 
duration between the peak response and time when conductance returns to a value that is 
one-half of the amplitude of the peak.  
3.1.8 Processing Temperature Signal 
Temperature signals were used to continuously control skin temperature during 
experiments with cold stimuli. They were not processed further. 
3.1.9 Overview of Our Signal Processing Framework in Matlab 
We performed over 500 experiments during which up to 6 different signals were 
recorded simultaneously. Processing all the data in structured way required the 
development of a signal processing framework. An overview of the workflow is given in 
Figure 3.10, including loading measured signals into the processing environment, extracting 
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 cardiovascular variables, calculating statistics and displaying time course of variables. We 
implemented the workflow in the Matlab environment and could batch-process all 500 data 
sets automatically. 
 
Figure 3.10 Signal Processing Workflow 
The program first loads descriptive information about experiments and subjects. Figure 
3.11 shows how these metadata have been structured. Each experiment is represented by a 
Cardiac Autonomic Test Metadata object which is characterized by the Abbreviation of the 
test (e.g. CFT) and it’s Name (e.g. Cold Face Test). Each subject who underwent the test is 
represented as Participating Subject together with some characteristics including his unique 
identifier n (e.g. n=1), his Name (e.g. Jan Novak), his Sex (e.g. male), his Age (e.g. 21 years) 
and his Race (e.g. white). A subject can participate to one or many Experiment Sessions 
which took place on a specific Date (e.g. 20090520) in a given City (e.g. Kladno). Raw signals 
which were recorded during an experiment session are stored in a Biopac Acquisition File 
characterized by a Filename (e.g. Jan_Novak.acq) and a Sampling Frequency (e.g. 500 Hz). A 
Measured Data Set is the portion of a signal that was recorded on a particular Channel (e.g. 
ECG channel) for a given time interval delimited by a Start Timestamp (e.g. 100th second) and 
an End Timestamp (e.g. 160th second).  
Our signal processing software extracts diverse cardiovascular variables from 
cardiovascular signals, e.g. RR intervals are extracted from the ECG signal. For each variable 
X  we split the time series into four vectors: , , ,baseline preparatory test postX X X X  corresponding to 
values recorded during baseline measurements, values recorded during a preparatory period 
shortly before applying the stimuli on the subject, values recorded during the cardiac 
autonomic test and values recorded after the test. The preparatory period of 30 seconds 
means that baseline measurements end 30 seconds before the cardiac autonomic starts. 
During this period the subject can be influenced by emotional factor, e.g. fear of a cold 
compress approaching the eyes during a cold face test. The resulting notch in the heart rate 
signal is neither part of baseline measurements nor part of the autonomic test itself. That’s 
the reason why we take a preparatory period into account and exclude it from statistical 
analysis or model fitting. 
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Figure 3.11 Experimental Metadata Structure 
 
Subjects displayed various responses to cardiac autonomic tests. A statistical survey was 
realized in order to organize them into groups according to their level of response. This gave 
us insights into differences related to age, gender, or race and helped us testing hypothesis 
using the mathematical model developed in Chapter 2. The following statistical parameters 
were calculated on the recorded variables. 
• ( ), )baseline baselinemean X max(X  as the mean and maximum of values recorded during 
baseline measurements. 
• test testmean(X ),min(X )  as the mean and minimum of values recorded during the 
cardiac autonomic test. 
• ( )diffmean X  as the difference between ( )testmean X  and ( )baselinemean X . 
• ( )incrmean X  as the percentage of increase in mean value between baseline and test 
phases, i.e. test
baseline
mean(X )100• -1
mean(X )
 
 
 
. 
• )baselinestd(X  as the standard deviation of values recorded during baseline 
measurements. 
• )teststd(X  as the standard deviation of values recorded during cardiac autonomic test. 
• ( )diffstd X  as the difference between ( )teststd X and ( )baselinestd X . 
• ( )incrstd X  as the percentage of increase in standard deviation between baseline and 
test phases, i.e. test
baseline
std(X )100• -1
std(X )
 
 
 
. 
• )baselinermssd(X  as the root mean square of successive differences of values recorded 
during baseline measurements. 
• )testrmssd(X  as the root mean square of successive differences of values recorded 
during during cardiac autonomic test. 
• ( )diffrmssd X  as the difference between )baselinermssd(X  and )testrmssd(X . 
Cardiac Autonomic Test 
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• ( )incrrmssd X  as the percentage of increase in root mean square of successive 
differences between baseline and test phases, i.e. test
baseline
rmssd(X )100• -1
rmssd(X )
 
 
 
. 
For the deep breath test we additionally calculated ( )totalEI X  as the difference between 
the maximal heart rate during inspiration and minimal heart rate during expiration. We also 
computed ( )ratioEI X  as the ratio of minimal heart rate during expiration over maximal heart 
rate during inspiration.  
We also performed a recurrence plot analysis of the heart rate and blood pressure 
variables and calculated the following statistics using the software KubiosHRV [119] and the 
Cross Recurrence Plot Toolbox for Matlab [120]. Details of the algorithm have been given in 
section 1.4. 
• ( )%rec X  as percentage of reccurence 
•  %det  as percentage of determinism 
•  maxL  as maximal line length 
Heart rate and blood pressure variables were additionally analyzed in the frequency 
domain using an implementation of the Least-Squares Spectral Analysis (LSSA) in Matlab 
[121]. The magnitudes in the spectrum determine the contribution of each frequency band 
to the power (i.e. variance) of the variable. We evaluated the low frequency ( )LF X  and 
high frequency ( )HF X components in the bands [0.015 .. 0.15] Hz and [0.15 .. 0.4] Hz . 
 3.2 Cold Face Test 
3.2.1 Physiology of the Cold Face Test
Figure 3.12 Principal components of the diving reflex 
The Cold Face Test, abbreviated 
reflex. A cold stimulus applied to 
afferent temperature sensitive neurons (
leads to the activation of cardiac efferent vagal neuron fibers, resulting in a marked decrease 
of heart rate. The observed bradycardia resu
the sinoatrial node and was not influenced by 
activation during CFT has not yet been put in evidence
sympathetic efferent fibers to peripheral arteries in the arms and legs is additionally 
observed. This results in increases in vascular resistance and eventual rise in blood pressure
[124]. Figure 3.12 shows the physiological components involved durin
as the messages flow between them.
to provide sensory information to the brain. Its ophthalmic division is purely sensory. It 
includes cold temperature receptors, free nerve
layers of the skin on the forehead. They are sensitive to temperatures lower than the normal 
body temperature. The receptive field of one thermoreceptor is about 1 mm in diameter. 
The sensory path consists of a p
trigeminal ganglion. From there a single secondary sensory root enters the pons in the 
brainstem. The pons relay the cold stimulus down to the medulla, where it is integrated. The 
vagal response is carried out by the vagus nerve and gives rise to increases in efferent 
parasympathetic tones on the sinoatrial node of the heart.  CFT 
an increased sympathetic response on the 
Because the cold face test
activity to the sinoatrial node and enhance parasympathetic activity 
suitable experimental setup for gathering experimental data which will fit to our integrated 
mathematical model of cardiovascular control developed in the previous chapter
help quantifying vagal activity
 
(reprinted from [122])
CFT, is a simple clinical test, which activates the diving 
the forehead, usually using a cold compress, activates the 
ophthalmic division of the trigeminal nerve
lts from increased parasympathetic activity on 
β-adrenoreceptor blockade 
 [123]. Increased activity in 
g cold face test as well 
 The trigeminal nerve or the fifth cranial nerve is mainly 
 endings that terminate in the subcutaneous 
rimary sensory neuron, which has its cell body in the 
might simultaneously lead
ventricles and vasculature.  
 is a vagal maneuver known to inhibit sympathetic efferent 
[125, 126]
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 3.2.2 Subjects and Materials 
We have performed the cold face test on 50 subjects: 32 women (ages 11 to 77 years, 
mean 38±17 years) and 18 men (ages 23 to 82 years, mean 48±16 years).  
A first experimental session was performed in winter in the Czech Republic on February 
25, 2009. A second and third session was performed one year later on January, 27 and 28 in 
Cameroon during the dry season. In the first experimental session, all 14 subjects were 
instrumented with a Biopac MP35 system and 3 leads ECG was recorded. Skin temperature 
was additionally measured on 6 subjects. Galvanic skin response was recorded on 5 subjects 
following the recommendations in [127].  
38 subjects participated in the second experimental sessions (including 2 subjects n = 13, 
37 from the first session), 3 of them repeated the test in a third experimental session. In 
both sessions subjects were instrumented with a Biopac MP35 system and ECG, galvanic skin 
response and skin temperature were measured.  
We had 3 subjects with palpitations (n = 8, 10, 26); 2 with cardiac insufficiency (n = 8, 20); 
3 with hypertension (n = 16, 20, 45); 1 with diabetes mellitus type 1 (n = 41); 1 with sleep 
apnea (n = 38); 1 with gastric ulcer (n = 8, 10) and 1 with hepatitis (n = 5). Literature does not 
highlight contraindications to the cold face test regarding sex, age or health status. For 
example the cold face test was performed on swimmers ages 12 to 19 years [88]. Studies in 
[102] described tests on healthy men and women, age 21 to 54 years. Subjects in [128] were 
healthy men aged from 24 to 60 years. Subjects in [103] were men and women having 
familial dysautonomia (Jewish Ashkenazi ancestry, absent deep tendon reflexes, absence of 
overflow tears, absence of fungiform papillae of the tongue, absent axon flare response 
after intradermal histamine injection), aged 10 to 44 years. Authors of [123] performed the 
test on two patients with baroreflex impairment. Studies in [105] support the hypothesis 
that black males would show greater cardiovascular reactivity to forehead cold stimulation 
than whites, suggesting taking racial differences into consideration while evaluating the cold 
face test.  
 
Figure 3.13 Iced-water filled plastic bag used for the cold face test 
In our studies, after one period of at least 5 min adjustment, baseline measurement was 
performed for 60 seconds. After baseline measurements a preparatory recording of 30 
seconds was included in order to reduce the non-stationary effects induced by experimental 
conditions. An iced-water filled plastic bag with wet contact surface 15 cm x 5 cm and mass 
ca. 400 g (Figure 3.13) was then applied bilaterally to the forehead during a period of 
maximum 60 seconds while measurement was resumed. In general the cold compress had a 
temperature of 0 degree Celsius and was large enough to cover the forehead, but increasing 
the mass did not seem to amplify the response. However care was taken to avoid triggering 
an oculocardiac reflex response. The plastic bag was filled with melting ice-water and was 
flexible to allow direct contact with the skin. In between tests the plastic bag was be kept in 
a bucket containing iced-water so that the exterior of the bag remained wet. The test was 
interrupted when the subject could not sustain the cold pain any more. Subject was 
encouraged to take a short deep inspiration prior to the test and to hold breathing as long as 
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he could. Most of subjects however disagreed and performed the test while breathing 
normally.  
Studies in [102] recommend performing the cold face test in a setting where the subjects 
did not continue breathing during the test. Fall in heart rate was larger if the subject was not 
able to continue breathing. However results in [50] show that bradycardia, blood pressure 
increase, sympathetic and parasympathetic modulation of the heart rate and blood pressure 
are independent from the respiratory pattern. The environmental temperature is another 
factor to be taken into account. In [102] the tests were performed in a quiet room having a 
constant temperature of 22 degree Celsius. The room was mildly lighted. A swimming pool 
with water temperature 25 degree Celcius was used in [128]. In our three studies, the 
subject was sitting on a comfortable chair in a quiet room with constant temperature (21 oC ) 
and lighted with daylight. 
3.2.3 Results 
We performed the cold face test 71 times and responses were evaluated using statistics 
introduced in section 3.1.9. The ( )incrrmssd X  was selected as criteria for the overall 
response since it is a parameter of heart rate variability that should reflect the increase in 
parasympathetic activity on heart. An increase of 20% or more was rated as Over Average 
response, a lesser increase was rated as Average response whereas no increase was 
evaluated as Abnormal response. Subjects were divided into Young, Older and Elderly groups 
according to their age (less than 30 years for young, between 30 and 60 years for older and 
more than 60 years for elderly). The distribution of subjects according to their gender and 
their response to cold is depicted in Figure 3.14 (left panel). Many subjects presented an 
average or over-average response to the cold stimuli with women being more sensible. We 
also analyzed the effect of geographical environment on the cardiovascular responses to 
cold stimuli and noticed e.g. decreasing response intensity with decreasing environmental 
temperature (see Figure 3.14, right panel), suggesting a certain degree of acclimatization of 
cold receptors. Figure 3.15 shows how heart rate and RR interval durations were changing 
during the cold face test on subject ID 4. Mean heart rate dropped from 68 to 62 beats/min 
while reaching the floor value 54 beats/min at the 40th second during cold stimuli 
application. RMSSD increased by 54%. A similar but less strong increase of QT intervals 
duration is observed and maintained even after the release of cold stimulation (see Figure 
3.16). CFT induces an increase of systolic blood pressure in the first moment during the 
application of cold stimuli. This is followed by a drop of systolic pressure which appears to 
trigger the baroreflex as characterized by some fluctuation in pressure at the end of the test 
(see Figure 3.17). A test duration of more than 40 seconds seemed to be most appropriate to 
subjects under 60 years old. The heart rate change diminishes in older subjects and the 
duration of sustainable cold application, which enhances the fall of heart rate, was also 
reduced with aging.  
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Figure 3.14 Overall CFT Response 
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Figure 3.16 QT response to cold face test 
 
th
-degree polynomial interpolation of the signal 
 
60 80 100 120 140 160
HR response to CFT, n=4
seconds
TestPreparatory
60 80 100 120 140 160
seconds
QT reponse to CFT, n=4
 
 
 
180 200
Post
180 200
 
  
Figure 3.17 Blood pressure response to cold face test 
measurements were performed on a representative subject with ID n=4 
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3.3 Oculocardiac Reflex Test 
3.3.1 Physiology of the Oculocardiac Reflex Test 
The Oculocardiac Reflex (OCR) is a trigeminovagal reflex that can produce potent 
bradycardia and cardiac arrhythmias such as nodal rhythm, ectopic beats, ventricular 
fibrillation, or asystole. The OCR is most often induced during strabismus surgery in children 
but also occasionally during retinal surgery [89]. The reflex can also be induced by traction 
on the extrinsic muscles of the eye, intraorbital injections or haematomas, acute glaucoma, 
and stretching the eyelid’s muscles [129].  Positive OCR was considered to have occurred 
when the heart rate slowed at least 7.2 beats/min in [129]. OCR was defined as decreasing 
of heart rate by more than 20% from the baseline value in [130].  
The oculocardiac reflex is mediated by the ophthalmic part of the trigeminal nerve. It is 
suggested in [131] that the sensory nerve endings of the trigeminal nerve send neuronal 
signals via the gasserian ganglion to the sensory nucleus of the trigeminal nerve, forming the 
afferent pathway of the reflex arc. The afferent pathway continues along the short 
internuncial fibers in the reticular formation to connect with the efferent pathway in the 
motor nucleus of the vagus nerve. Cardioinhibitory efferent fibers arising from the motor 
nucleus of the vagus nerve terminate on the myocardium. These vagal stimuli provoke 
negative chronotropic and inotropic responses. Consequently, the clinical features of the 
OCR range from sudden-onset of sinus bradycardia, bradycardia terminating asystole, 
asystole with no preceding bradycardia, arterial hypotension, apnea, and gastric 
hypermotility. The pathways are illustrated in Figure 3.18. 
3.3.2 Subjects and Materials 
We have performed the oculocardiac reflex test on 36 subjects: 23 women (age 11 to 51 
years, mean 30±14 years) and 13 men (ages 22 to 56 years, mean 36±16 years); among them 
1 with aortic stenosis (n = 56), 2 with palpitations (n = 8, 26); 1 with cardiac insufficiency (n = 
8). 15 subjects were white and 21 black. The first experimental session was performed in the 
Czech Republic on April 28, 2009. All 14 subjects were instrumented with a Biopac MP35 
student system and following signals were recorded: 3 leads ECG, skin temperature and 
galvanic skin response. 5 subjects were included in the second experimental sessions with 3 
leads ECG and galvanic skin response measurement. The third session included 38 subjects 
and the fourth included 3 subjects. Both last sessions were realized on January 27-28, 2010 
in Cameroon. ECG, galvanic skin response and skin temperature were measured.  
The literature provides little information about the oculocardiac reflex test on adults. The 
study population in [90] comprised 50 asymptomatic, premature neonates (22 females, 28 
males) whose mean (±SD) gestational age at birth was 33.5 ± 1.6 weeks. Studies in [129] 
were conducted on 49 infants and children (53% male, 47% female), aged 6 months to 9 
years requiring correction of strabismus. Age limitation or contraindication to the OCR could 
not be found in the literature. Neither sex nor age differences seemed to cause any 
statistical difference in the incidence of the OCR.  
The OCR was performed in [90] by linking a mercury column to a three-way tap 
connected to two bags inflated to a pressure between 100 and 140 mmHg. A bag was placed 
on each closed eye, and a constant pressure of +100 mmHg was then applied for 10 s, or 
until heart rate decreased by one-third of its baseline value for >2 s. In [132] the subject 
receives a massage from an instructor, who used his index finger to apply pressure on the 
eyeballs. Studies in [129] evoked the OCR by traction on the extrinsic muscles of the eye 
using a mechanical dispositive. The first type of stimulus was the most reflexogenic and 
 consisted of an acute traction of 150 g to 300 g sustained for a minimum of 30 s followed by 
an acute release. The second stimulus was a slow gradual traction reaching a peak between 
150 g and 300 g followed by an acute release. The third stimulus applied a fast progressing 
traction until a peak between 150 g and 300g followed by an acute release. 
 
Figure 3.18 Oculocardiac reflex neural pathways (reprinted from [129]) 
LCN (long ciliary nerves), SCN (short ciliary nerve), CG (ciliary ganglion), O (ophthalmic branch of the Vth cranial 
nerve), GG (gasserian ganglion), 1 (main sensory nucleus of the trigeminal nerve), 2 (short internuncial fibres in the 
reticular formation), 3 (motor nucleus of the vagus nerve), X (cardiac depressor nerve form the Xth cranial nerve) 
We employed a simpler procedure in our studies. The oculocardiac reflex test was 
performed with the subject in sitting relaxed position with closed eyes. Pressure was applied 
on the eyes by rotating subjects’ eyeballs with closed lids over the outer corner of eyes using 
the index finger. Subject was asked to concentrate on the light between the eyebrows. This 
procedure was very delicate because pressure on eyes can be uncomfortable. Subjects were 
very closely informed about upcoming events and were encouraged to notify any issue. 
Despite the fact that some subjects reported having blur visibility after the test, no subject 
requested test interruption.  In a different study we lay a small water filled plastic bottle 
with weight 670 g and contact surface ca. 5 cm2 on each eye. This had applied a pressure of 
ca. 100 mmHg (1 mm Hg = 0.0013595 g/cm2) for 60 seconds.  
3.3.3 Results 
Figure 3.19 shows the heart rate response to oculocardiac reflex test for one 
representative subject from our experiments. Heart rate dropped from 71 beats/min to 65 
beats/min in average while reaching the floor value 59 beats/min just at the beginning of the 
eyes massage. RMSSD increased by 8%. 
 
Figure 3.19 Heart rate response to oculocardiac reflex test 
measurements were performed on a representative subject with ID n=65 
dashed line is a 10
th
-degree polynomial interpolation of the signal 
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3.4 Deep Breath Test 
3.4.1 Physiology of the Deep Breath Test 
Deep breathing has proven to be a useful clinical test for assessing cardiovagal 
dysfunction in autonomic disorders, including diabetic autonomic neuropathy, uremic 
neuropathy, familial autonomic neuropathies, small fiber neuropathies, pure autonomic 
failure and multisystem atrophy [133]. It enhanced respiratory sinus arrhythmia (RSA) which 
is related to the variation in heart rate that occurs during a breathing cycle. Heart rate 
increases during inspiration and decreases during expiration [97]. During deep breathing at 6 
breaths/min (=0.1 Hz), the magnitude of sinus arrhythmia increases profoundly in normal 
subjects because respiration-mediated and baroreflex-mediated low frequency RR interval 
oscillations (which normally occur at about 0.1 Hz) synchronize [97] . The depth of breathing 
for a maximum result requires a tidal volume of approximately 1.2 L for an average adult. 
Protocols that involve breathing for more than 90 seconds may induce hypocapnea, which 
can reduce heart rate variability. [133] 
3.4.2 Subjects and Materials 
We have performed the deep breath test on 38 subjects: 26 women (ages from 11 to 70 
years, mean 37±16 years) and 12 men (ages from 23 to 56 years, mean 47±11 years); among 
them 3 with palpitations (n = 8, 10, 26); 2 with cardiac insufficiency (n = 8, 20); 3 with 
hypertension (n = 16, 20, 45); 1 with sleep apnea (n = 38); 1 with gastric ulcer (n = 8, 10) and 
1 with hepatitis (n = 5). The experiments were performed on January 27, 2010 and January 
28, 2010 in Cameroon.  
The known literature does not exhibit particular distinctions in subjects undergoing the 
deep breath test. The study population in [134] was composed of 185 patients admitted 
after a first myocardial infarction 5 days before, 79% male, 21% female, 53% age less than 60 
years, 47% age above 60 years. Deep breath tests were conducted in [135] on 10 patients (2 
females, 8 males), aged 58±2 years, average height was 173±3 cm, average weight 87±6 kg 
and BMI 28.8±1.7 kg/m2 who had a confirmed diagnosis of type 2 diabetes mellitus. The 
study also included 11 healthy controls (four women and seven men). Their average age was 
54±3 years, average height 168±2 cm, average weight 76±5 kg and average BMI 26.6±1.3 
kg/m2.  Studies in [136] included 6 males and 4 females with familial dysautonomia, mean 
age 25±12 years. Heart rate variability during deep breathing is in general reduced in 
individuals on cardiac medication, with left ventricular hypertrophy or ECG signs of 
myocardial infarction. Even in healthy persons the parasympathetic function is inversely 
associated with age and left ventricular mass [137]. Contra-indications to the deep breath 
test include avoiding nicotine, caffeine or alcohol for 24 h before the experiments and 
studies should be performed at least 4 h after consuming a light meal [135]. A history of 
chronic alcohol abuse, carcinoma, myopathy, hyper- or hypothyroidism, arterial 
hypertension, cardiac arrhythmia, diagnosed atherosclerosis, previous organ 
transplantation, renal disease could be a possible contraindication for the deep breath test 
[135]. In a large population study, patients who had fever, diarrhea, atrial fibrillation, 
frequent arrhythmias, liver cirrhosis, glaucoma or chronic renal failure, and those who took 
minor or major tranquilizers were excluded [138]. 
Regarding experimental setups for deep breath test, it is common to execute the test at a 
rate of 6 respiration cycles per minute, which corresponds to 0.1 Hz: 5 seconds for each 
inhalation and 5 seconds for each exhalation [134]. The examiner has a chronometer and 
raises his hand to signal the start of each inhalation and lowered it to signal the start of each 
exhalation.  Participants can also be asked to breathe according to a continuous graph 
 106 
 
presented on a computer monitor in front of them [139]. The test usually begins with 
calibration during spontaneous breathing followed by paced breathing. Next to the pacing 
frequency, another parameter is the subject position. Tests were conducted with patients in 
a semi-reclining position of 45° in [139]. The tests in [135] were performed in a quiet, 
temperature controlled (24°C) room with the participant lying in a supine position; however 
subjects underwent the test in a sitting position in [137] without measurable impacts in the 
results. The time of day when the test is performed, seems to be of minor importance. 
Studies in [134] were performed in the morning; however in [136] the test was conducted 
between 4 and 6 p.m. in order to avoid the circadian influence on heart rate and autonomic 
nervous system function. 
In our studies, participants were in a relaxed sitting position and were taught to perform 
three deep breathes in a first experimental setup. Participants of the second experimental 
setup were instructed to breathe at a rate of 6 respiration cycles per minute. The examiner 
paced the breathing with a chronometer and gave a vocal signal for the start of each 
inhalation and exhalation. 
3.4.3 Results 
Simple indexes can be used for the response evaluation to deep breath test [134]. The 
respiratory stress response (RSR) can be calculated as the ratio of pick area, which is the net 
peak energy around the breathing frequency (0.1 Hz), by the sum of all the other areas of 
the power spectrum curve in order to indicate significant coronary disease [139] . In [133] 
the mean heart rate range (MHRR or E-Imean) was calculated as difference between the 
maximal heart rate during inspiration and minimal HR during expiration for a single 
breathing cycle. The expiratory-to-inspiratory ratio (E/I) is calculated as the longest RR 
interval during expiration divided by the shortest RR interval during inspiration for a single 
breathing cycle. MHRR and E/I can also be averaged over successive breaths. Response to 
deep breathing is elevated in children and trained adults; and decreases with age or 
inactivity, so it is essential to use evaluating methods with well-defined age-stratified normal 
values [140]. Values of MHRR above (4.39 - 0.033 · age)2 and of E/I above 1 + exp(-1.12 - 
0.0198 · age) can be regarded as normal [137].  
Additional measures are E-Itotal, which is the difference between the maximal heart rate 
during all 6 inspirations and minimal heart rate during all expirations; E-Imax, which is the 
difference between maximum and minimum heart rate for every breathing cycle, with the 
largest difference being selected; E-Imedian, which is the calculation of differences between 
maximum and minimum heart rate for all breathing cycles, thereafter sorted by their 
magnitude. Averaged difference of the third and fourth value is computed. Similarly E/Imedian 
is the median ratio of the longest RR interval during expiration over the shortest RR interval 
during inspiration within every breathing cycle. E-Imedian, E/Imedian, and MCR are most 
resistant to anomalies (in-test variance, premature ventricular contraction, deviation of the 
respiration rate). E-Imedian should be used preferentially, providing the highest precision and 
independence from heart rate [141]. The peak power at the highest frequencies (> 0.15 Hz) 
in the spectral analysis of RR intervals can also be calculated if the signal does not contain 
premature beats.  
Figure 3.20 shows heart rate and pulse amplitude responses to deep breath test at 0.1 Hz, 
which we performed on one representative subject. The response corresponds to a value of 
E-Itotal and E/I equal to 21.2 beats/min and 0.69 respectively. 
  
 
 
 
 
Figure 3.20 Heart rate and pulse response to deep breath test 
measurements were performed on one representative subject with ID n=37 
respiration pattern (top graph), heart rate (middle graph), pulse amplitude (bottom graph) 
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3.5 Mental Stress Test 
3.5.1 Physiology of the Mental Stress Test 
Diverse tests can induce mental stress such as mental arithmetic, computer quiz, delayed 
auditory feedback task, reaction-time task; what lead to an increase in mean heart rate, 
systolic and diastolic pressure, and cardiac output. Invasive measurements of muscle 
sympathetic nerve activity have demonstrated increased sympathetic activity during mental 
stress. Results with pharmacological blockades demonstrate an increased sympathetic 
control of heart rate; atropine did not appear to affect the magnitude of the response [142]. 
Functional magnetic resonance imaging (fMRI) shows that sympathetic activation through 
mental stress is associated with distinct cerebral regions being immediately involved in task 
performance (visual, motor, and premotor areas). Other activated regions (right insula, 
dorsolateral superior frontal gyrus, cerebellar regions) are unrelated to task performance. 
These latter regions have previously been considered to be involved in mediating different 
stress responses [143]. 
Spectral analysis of heart rate variability has shown increased LF power and LF/HF ratio, 
which are both indices of sympathetic activity [142] and decrease of HF power. Baroreceptor 
sensitivity decreases as well, suggesting an increased autonomic reactivity. Baroreflex 
function can be modulated by behavior or mental challenges at relay sites in the medulla, 
pons and hypothalamus [144]. MST is considered effective if the mean heart rate increased 
by at least 15 beats/min [142]. Changes in systolic and diastolic blood pressure, cardiac 
output and ventricular pre-ejection period can also be assessed. 
3.5.2 Subjects and Materials 
In our studies 26 women (ages from 11 to 70 years, mean 37±16 years) and 12 men (ages 
from 23 to 56 years, mean 47±11 years) were asked to resolve a series of arithmetic 
operations including additions, subtractions and multiplications. Each operation was given 
spontaneously and randomly by an instructor. Subject could speak and calculate aloud. The 
test was conducted for 60 seconds. We had additional experimental setups where a limited 
number of subjects were asked to subtract the number 17 from 1000, then from the results, 
and so on. 
Alternatively subjects can be asked to subtract continuously the numbers 6 or 7 from a 2 
or 3 digit number as fast as possible with each calculation lasting max 5 seconds. A new 
number is randomly provided every 5 seconds on a computer screen fixed at eye level. 
Halfway through the mental stress, subjects are asked to answer more correctly, irrespective 
of the number of correct answers. These procedures are designed to help reduce adaptation 
to the stress condition [144]. In order to avoid increased HF of the spectrum of HRV, 
speaking is avoided in some studies and the computer displayed each time four possible 
solutions and the participants are asked to choose the correct one by pressing a keyboard 
key placed closed to the finger. They are given feedback on the display that their answer was 
incorrect, regardless of the accuracy of their response, for a predetermined 60% of the 
questions in order to ensure that all participants are stressed, independently of individual 
mental arithmetic abilities. Some studies however recommend to perform the tests aloud in 
order to improve sympathetic response, however this adds more respiratory sinus 
arrhythmia influence on the spectral analysis heart rate variability, by increasing its high 
frequency component, what could be mistaking as increased vagal tone [142].  
The Stroop test (Colour Word Interference Test [145]) is another kind of cognitive stress 
using a card that contains 5 lines and 4 rows. Each line has the names of 4 colors: green, 
 pink, blue, and brown. The sequence of the 4 colors is different in each line but the color 
names are printed in an ink color different from the color itself. The subject is requested to 
respond with the colors he is seeing as fast as he could. This task can be initiated using a 
software tool that displays a four-digit number on a computer screen [146]. 
Mental stress can be performed by combining diverse kind of tests. For example in [147], 
all patients underwent serial subtractions, Stroop color word task, public reading, 
emotionally charged public speaking, and a competitive video computer game. 
There are references in the literature where the MST was conducted on special groups of 
patients. The MST was performed on 15 migraine patients (13 females, 2 males) and 15 
healthy control subjects (13 females, 2 males), age 27±9 years [145]. 38 healthy students (19 
men, 19 women), ages 26±5 years were recruited for studies in [146]. 35 patients with 
evidence of ambulatory ischemia during Holter monitoring sessions participated in MST 
studies in [147]. 36 mild hypertensive men (57%) and women (23%), mean age 50±8 years 
with 12 or more years of education, underwent a mental arithmetic test in [148]. 12 healthy 
control subjects were also included, mean age 46±9 years. 16 healthy right-handed male 
subjects (mean age 23±2 years) with no report of neurological or psychiatric disorders were 
examined with the MST in [143]. 
3.5.3 Results 
Figure 3.21 illustrates heart rate response; we have recorded during mental stress on a 
representative subject, who was asked to subtract 17 from 1000. Heart rate increased by 
14% from a baseline value 52 beats/min. Heart rate variability decreased by 10% indicating 
vagal withdrawal. Respiration rate increased while tidal volume, minute volume and duty 
cycle decreased (see Figure 3.22). The stress state is also reflected in the galvanic skin 
response (Figure 3.23). Tonic skin conductance level (SCL) increased by 13%. Non-specific 
fluctuations increased as well as their rise time and half-recovery time. All these factors 
indicate increased sympathetic activity to sweat glands. 
 
 
Figure 3.21 Heart rate response to mental stress test 
measurements were performed on one representative subject with ID n=37 
dashed line is a 10
th
-degree polynomial interpolation of the signal 
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Figure 3.22 Changes in respiration during mental stress test 
measurements were performed on one representative subject with ID n=37 
 
 
 
Figure 3.23 Galvanic skin response during mental stress test 
measurements were performed on one representative subject with ID n=37 
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3.6 Valsalva Maneuver 
3.6.1 Physiology of the Valsalva Maneuver 
The Valsalva Maneuver (VM) is a cardiac autonomic test, named after the physician and 
anatomist Antonio Maria Valsalva (1677-1723), which consists of taking a deep breath and 
expiring against a 40 mmHg resistance for approx. 15 seconds. This cardiac autonomic test 
induces physiological changes and initiates a complex reflex. The reflex pathways involved 
are both of sympathetic and parasympathetic nature [142]. The reflex arcs involved in the 
Valsalva maneuver can be summarized in four phases [142]. During phase 1 a brief increase 
in arterial blood pressure and decrease in heart rate is observed. In phase 2 sustained high 
intra-thoracic and intra-abdominal pressure hinders venous return, leading to a rapid 
decrease in arterial blood pressure and increased heart rate. During phase 3, the forced 
expiration is released resulting in a sudden decrease in arterial blood pressure. During Phase 
4, the accumulated venous blood returns to heart and is pumped into the constricted 
arteries causing an “overshoot” of arterial pressure. Parasympathetic blockade with atropine 
abolishes the heart rate change, whereas sympathetic blockade does not. 
3.6.2 Subjects and Methods 
We have performed the Valsalva maneuver on 54 subjects: 32 women (age 11 to 70 
years, mean 33±16 years) and 22 men (ages 22 to 56 years, mean 33±15 years); among them 
1 with multiple sclerosis (n = 60), 3 with palpitations (n = 8, 10, 26); 2 with cardiac 
insufficiency (n = 8, 20); 3 with hypertension (n = 16, 20, 45); 1 with sleep apnea (n = 38); 1 
with gastric ulcer (n = 8, 10) and 1 with hepatitis (n = 5). 17 subjects were white and 37 
black.  
The first two experimental sessions were performed in the Czech Republic on April 28, 
2009 and May 20, 2009. Two additional sessions were performed on January, 27 and 28 in 
Cameroon. In the first experimental session, all 14 subjects were instrumented with a Biopac 
MP35 system and following signals were recorded: 3 leads ECG, skin temperature and 
galvanic skin response. 5 subjects were included in the second experimental sessions with 3 
leads ECG and galvanic skin response measurement. The third and fourth sessions included 
38 subjects and 3 subjects respectively. ECG, galvanic skin response and skin temperature 
were measured.  
The maneuver was performed in a non-standardized way without galvanometer. A 
galvanometer and other accessories were not available in our experimental environment. 
After taking a deep breath, the subject was asked to blow inside an empty plastic bottle 
(volume 1,5 liters) hold by the instructor at the level of mouth. The subject was encouraged 
to exhale as strong and as long as he could. The common test duration was 15 seconds. The 
maneuver was repeated until the heart rate response had a typical VM shape. Subject was 
sitting during the maneuver as recommended in [149].  
The duration of the expiratory straining varies from 10 seconds to 30 seconds in studies 
but the 15 seconds duration is the most common protocol employed. A 20 seconds protocol 
is recommended for autonomic assessment. Healthy controls, chronic Chagas’ disease 
patients have been able to sustain the expiratory strain for 20 seconds very well. In general it 
depends on the capacity of the subject to sustain a continuous strain, the presence of 
undesirable effects, and sufficient amplitude to detect autonomic disorders. The maneuver 
should be considered effective when facial flushing and plethora, neck vein engorgement, 
and increased muscle tension in the abdominal wall are observed in addition to the full 
expansion of the thoracic cage. The maximum depth of inspiration before straining, the 
 duration of straining and its magnitude dictated by the magnitude of the intraoral pressure 
should all be well controlled to generating uniform and persistent elevation of intrathoracic 
pressure during the straining. The supine position appears to be consensual, but when 
necessary a sitting or standing position can be used, but these later positions have significant 
influence on arterial pressure changes and baroreflex sensitivity. It is recommended to 
repeat the maneuver up to four times for a more precise functional evaluation and the mean 
of indexes should be obtained. [149] 
Subjects who performed the VM were from diverse population groups in the literature. 
Studies in [150] included 27 diabetic patients: 12 women (2 with diabetes type I and 10 with 
diabetes type II) and 15 men (4 with diabetes type I and 11 with type II). The age of the 
patients ranged from 28 to 76 years with a mean of 48 years and the duration of the 
diabetes range from 1 to 45 years with a mean of 13 years. In [149] the maneuver was 
performed on 52 healthy subjects (39 men and 13 women) aged 17 to 49 years. Potential 
complications include retinal hemorrhage, urinary incontinence, syncope, chest pain, 
arrhythmias, severe hypertensive, hypotensive reactions and cerebral stroke. Subjects with 
hypertension, hypotension, coronary disease, valve disease, cardiac congenital disease, 
heart failure, cardiovascular asthenia and previous syncopal attacks should perform the 
maneuver very cautiously, preferentially using the 15 seconds straining duration. [149] 
3.6.3 Results 
The Valsalva Ratio is determined as the maximum heart rate obtained during the 
maneuver divided by the lowest heart rate occurring within 30 seconds after the peak. Time 
change-dependent indexes, such as the time for phase III to IV bradycardia and the velocity 
for attaining this bradycardia, are more sensitive for the detection of cardiac autonomic 
dysfunction than amplitude related indexes. An index of the baroreceptor reflex sensitivity 
can be calculated from the correlation between each systolic pressure peak and the 
corresponding subsequent R-R interval during the hypertensive overshoot in phase IV. [149] 
Figure 3.24 illustrates the dynamics of heart rate changes during the four phases of the 
maneuver, performed on one representative subject from our experiments. 
 
Figure 3.24 Heart rate response to Valsalva maneuver 
measurements were performed on one representative subject with ID n=19 
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 3.7 Other Cardiac Autonomic Tests 
3.7.1 Active Change of Posture 
Change of body posture involves complex interactions between the autonomous nervous 
system and the cardiovascular system. Postural change from sitting or lying to standing pulls 
blood to lower parts of the body due to gravitational forces, triggering reflex response to the 
resulting drop in arterial blood pressure and cerebral perfusion. Subject with orthostatic 
intolerance disorders manifest signs of syncope, orthostatic hypotension or falls [151]. 
Orthostatic intolerance is diagnosed on the basis of a drop in arterial blood pressure or an 
excessive increase in heart rate measured a certain time after the assumption of the upright 
posture [152]. In [151] subjects were sitting in a straight-backed chair with their legs 
elevated at 90° in front of them and were then asked to stand. Standing was defined as the 
moment both feet touched the floor.  
In our studies subjects were taught to actively stand up from a sitting position on a chair. 
They were given a vocal signal for starting standing and care was taken not to displace 
electrodes while standing. Subject was asked to remain standing with relaxed muscles for 30 
seconds. In another experimental setup, electrodes on both hands were hold using an elastic 
band or gloves, the left arm was stabilized using a sling and subject was asked to stand up 
from a lying position. 
In our studies 16 women (ages between 17 and 54 years, mean 42±10 years) and 7 men 
(ages between 23 and 56 years, mean 37±12 years) underwent active change of posture. 
Figure 3.25 shows a typical heart rate response recorded on a subject who moved from a 
sitting to standing position. Venous blood pooling triggers the baroreflex which responds by 
increasing heart rate from 52 beats/min to 72 beats/min. Sit from standing causes an initial 
heart rate increase followed by a stronger decrease (see Figure 3.26). 
 
 
Figure 3.25 heart rate response to active standing from sitting 
measurements were performed on one representative subject with ID n=37 
dashed line is a 10
th
-degree polynomial interpolation of the signal 
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Figure 3.26 Heart rate response to active sitting from standing 
measurements were performed on one representative subject with ID n=37 
dashed line is a 10
th
-degree polynomial interpolation of the signal 
 
3.7.2 Tilt Table Test 
Tilt table test is another way to induce orthostatic stress. Whereas active standing can be 
achieved within a couple of seconds, tilt is a slower process where the subject is lying on a 
tilt table which is then slowly tilted towards the upright position so that regulatory processes 
are activated even before the subject is fully tilted. Another difference is that limited muscle 
activity is involved in tilt table test. Furthermore intracranial pressure decrease and venous 
return from cerebral circulation increases as result of higher gravitational forces between 
the neck and the torso; meanwhile venous return from lower parts of the body decreases 
[68]. 
Our studies included 9 women (ages between 15 and 46 years, mean 26±11 years) and 8 
men (ages between 22 and 29 years, mean 23±2 years). After being stabilized on a lying 
position, the table was manually and slowly tilted up to 70⁰ during approx. 10 seconds. The 
upright position was kept for approx. 180 seconds. The table was then slowly tilted back to 
the horizontal position and post-recordings were resumed for another 60 seconds. An 
example of the corresponding heart rate, recorded in our experiments, is visible on Figure 
3.27. 
 
Figure 3.27 Heart rate response to tilt table test 
measurements were performed on one representative subject with ID n=57 
dashed line is a 10
th
-degree polynomial interpolation of the signal 
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 3.7.3 Cold Pressor Test 
The cold pressor test is performed by immersing hands or feet of the subject into cold 
water with temperature between 0 and 5 °C. The low temperature excites skin nociceptors 
which project to brain centers. The response is a strong global sympathetic activation 
resulting in increased blood pressure, heart rate and in some cases galvanic skin response 
[153] [154] [155]. 
 In our studies 33 women (ages between 11 and 77 years, mean 36±16 years) and 20 men 
(ages between 22 and 82 years, mean 42±16 years) underwent the cold pressor test. Both 
left and right feet were immersed in a bucket filled with iced-water with temperature 
around 0 °C. Most subjects reported painful sensation but were able to sustain the cold 
stimuli for 40 to 180 seconds. An example of the corresponding heart rate response, 
recorded in our experiments, is visible in Figure 3.28. 
 
Figure 3.28 Heart rate response to cold pressor test 
measurements were performed on one representative subject with ID n=37 
dashed line is a 10
th
-degree polynomial interpolation of the signal 
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3.8 Experiments on Horses 
3.8.1 Materials and Methods 
In humans, activation of the diving reflex by a cold stimulus to the face (Cold Face Test) 
results in bradycardia, peripheral vasoconstriction and increased blood pressure (see section 
3.2). Immersing hands or feet into cold water during the so-called Cold Pressor Test results in 
a strong sympathetic response (see section 3.7.3). Responses of horses to Cold Face Test or 
Cold Pressor Test have not yet been evaluated in the known literature. We undertook this 
study to assess the effect of both tests on the cardiovascular system of horses and identify 
potential future development in the application of our model of cardiovascular control in 
equine organism.  
All procedures described were approved at the Equine Clinic of the University of 
Veterinary and Pharmaceutical Sciences in Brno, Czech Republic. Five healthy clinic owned 
horses with no evidence of cardiac disautonomia, pulmonary or metabolic diseases were 
chosen based on physical characteristics such as: age, sex, weight, height, body mass index, 
degree of acclimatization to cold and level of exercise. We had three stallion and two gelding 
thoroughbreds, age 5 to 7 years, weight 500 to 600 kg, body score 6 (moderately fleshy). 
Horses were normotensive and were not taking any medication. They were not feed 3 hours 
before the test and were not submitted to exercise 24 hours prior to the test. 
The tests were performed with the subjects in relaxed, standing position in a quiet room 
with an ambient temperature of ca. 22°C or in the stage with an ambient temperature of ca. 
15°C. The cold stimulus was applied using cold blue gel packs with dimension 20 x 30 cm. 
Some packs were stored at 4°C in a fridge and the rest at -18°C in a freezer. A Biopac MP150 
research system was used together with 3-leads ECG equipment. Biopac Acknowledge 
software was used to record a 500 Hz signal, which was exported in ASCII files for further 
processing in Matlab, where RR, QT interval durations, as well as T-wave amplitudes were 
extracted. 
Table 3.8.1. illustrates the experimental setups we performed, using the following factors: 
• Stimulus Temperature: 4°C, -18°C or 20°C 
Either cold gel packs from the fridge (with a temperature around 4°C) or from the 
freezer (with a temperature around -18°C) were used. A special setup was realized with 
warmed packs at 20°C. 
• Direct Application: yes or no  
In the case of -18°C gel packs, a cotton bandage was used between skin and pack to 
protect the skin. A direct application means, the cotton bandage was not used and gel 
packs were directly applied to the skin. 
• Body Place: forehead, eyes, nose, neck, face side, metacarpus or forelimb  
During the Cold Face Test, the gel packs were applied on the forehead (and maxillary 
region), between the eyes, on the nose, on the right side of the face or around the neck. 
During the Cold Pressor Test, the gel packs were applied around the distal part of both 
forelimbs (around the metacarpus, area between the carpus or hock and the fetlock 
joint), or around the proximal part of the both forelimbs (around the antebrachium, 
area of the front leg between the carpus and elbow). 
• Test Duration: 60 to 300 seconds 
The cold gel packs were applied for a duration of 60 to 300 seconds. 
  
Table 3.8.1 Experimental Setups 
Test Name Temp. Direct Body Place Test Duration 
Cold Face Test Forehead with 4°C +4°C yes forehead 60 seconds 
Cold Face Test Forehead with -18°C -18°C no forehead 60 seconds 
Cold Face Test Forehead with -18°C Direct -18°C yes forehead 60 or 300 seconds 
Cold Face Test Eyes with -18°C Direct -18°C yes between eyes 300 seconds 
Cold Face Test Nose with -18°C Direct -18°C yes nose 300 seconds 
Cold Face Test Side with -18°C Direct -18°C yes face side 300 seconds 
Cold Face Test Neck with 4°C +4°C yes neck 60 seconds 
Cold Face Test Neck with -18°C -18°C no neck 60 seconds 
Cold Face Test Neck with -18°C Direct -18°C yes neck 60 seconds 
Cold Face Test Head with 20 °C Direct +20 °C yes head 60 seconds 
Cold Pressor Test Distal with 4°C +4°C yes metacarpus 180 seconds 
Cold Pressor Test Distal with -18 °C -18°C no metacarpus 180 seconds 
Cold Pressor Test Distal with -18 °C Direct -18°C yes metacarpus 180 seconds 
Cold Pressor Test Proximal with -18 °C Direct -18°C yes forelimbs 180 seconds 
3.8.2 Equine Response to Cold Face Test 
In our study horses did not show significant bradycardia as expected when using a cold 
stimulation of 4°C (see heart rate response in Figure 3.29, cold packs were applied from the 
60th to 120th second). Horses were rather afraid of the packs approaching their face and the 
heart rate did not decrease like it would have been the case in humans. When cold packs at 
much lower temperature (-18°C) were applied to the forehead with an isolating bandage to 
protect their skin, the horses also appeared afraid and showed signs of discomfort with 
increased heart rate (see Figure 3.30, cold packs were applied from the 60th to 120th second). 
 
Figure 3.29 Equine HR Response - Cold Face Test - forehead with 4°C 
cold packs were applied from the 60
th
 to 120
th
 second 
dashed line is a 10
th
-degree polynomial interpolation of the signal 
 
 
Figure 3.30 Equine HR Response - Cold Face Test - forehead with -18°C 
cold packs were applied from the 60
th
 to 120
th
 second 
dashed line is a 10
th
-degree polynomial interpolation of the signal 
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 When the same cold packs (-18°C) were directly applied to the face of the horse without 
isolating bandage, a similar tachycardia response was observed (Figure 3.31, cold packs were 
applied from the 60th to 120th second). Probably the diving reflex was triggered but was too 
weak compare to the pain response via skin nociceptors. Noxious cold induces pain and may 
elicit cardiovascular changes [156]. The QT intervals, which reflect the ventricular 
depolarization time, also shorten during the test (Figure 3.32). T-wave amplitude of ECG is 
thought to reflect the sympathetic tone on the heart; it decreases during elevated 
sympathetic discharge [157]. The T-wave amplitude increase just at the beginning of the 
response could indicate a surplus of vagal activity. A short time after application of cold 
stimulus, the T-wave amplitude became lower as shown in Figure 3.33. 
 
Figure 3.31 Equine HR Response - Cold Face Test - forehead with -18°C Direct 
cold packs were applied from the 60
th
 to 120
th
 second 
dashed line is a 10
th
-degree polynomial interpolation of the signal 
 
Figure 3.32 Equine QT Response - Cold Face Test - forehead with -18°C Direct 
first 45 values were recorded before the cold application 
last 45 values were recorded during cold application 
dashed line is a 10
th
-degree polynomial interpolation of the signal 
 
Figure 3.33 Equine T-wave Amplitude - Cold Face Test - forehead with -18°C Direct 
cold packs were applied from the 60
th
 to 120
th
 second 
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 Since cooling the forehead of horses did not appear to activate the diving reflex as 
expected, additional experimental setups were arranged to investigate the place of the face 
and neck where cold receptors are likely to trigger the diving reflex. Applying the cold packs 
around the neck of the horses did not show significant heart rate change (Figure 3.34, cold 
packs were applied from the 60th to 120th second). At 4°C the RR interval durations did not 
change and cold packs at -18°C without skin isolation did not trigger a response either. 
However weak increase of heart rate was noticed when cold packs at -18°C were directly to 
the neck with an isolating bandage. 
 
Figure 3.34 Equine HR Response - Cold Face Test at neck 
cold packs were applied from the 60
th
 to 120
th
 second 
We defined additional experimental setups to investigate the heart rate response when 
cold gel packs were directly applied between the eyes, on the forehead, nose or on the side 
of the face. Results in Figure 3.35 suggest the eyes and side of face to be the most 
appropriate body places which might trigger the diving reflex. 
 
Figure 3.35 Equine HR Response - Cold Face Test on head 
cold packs were applied from the 60
th
 to 120
th
 second 
Horses are very sensible to objects approaching their face. The generally observed 
tachycardia during various versions of cold face test is likely due to fear or pain. In order to 
verify this assumption, the blue gel packs were warm up to room temperature (around 
+20°C) and were applied on different places of the face. Normally most cold receptors and 
pain receptors will not be activated during such a test. Therefore the observed increase of 
heart rate is obviously due to fear (see Figure 3.36, warm packs were applied from the 60th 
to 120th second). The fear factor depends on the location and is more significant on the 
forehead where the heart rate increased by ca. 60%. 
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Figure 3.36 Equine HR Response – Cold Face Test - forehead with +20°C Direct 
cold packs were applied from the 60
th
 to 120
th
 second 
We came to the idea of warming the forehead prior to cooling. This placebo effect should 
reduce the fear factor and develop acclimatization with the experimental conditions. This 
assumption could be verified on Figure 3.37 and Figure 3.38 (packs were applied from the 
300th to 600th second). The subject in Figure 3.37 passed 4 warming tests prior to the cold 
stimulus and was more familiarized with the blue gel pack than subject in Figure 3.38, who 
passed only one warm test. Therefore when deducing the increase of heart rate of 60% due 
to the fear factor from the total heart rate response, it is thinkable that the subjects 
demonstrated bradycardia via diving reflex but this response was damped by the 
sympathetically mediated fear. 
 
Figure 3.37 Equine response to Cold Face Test - forehead with -18°C direct in trained subjects 
cold packs were applied from the 300
th
 to 600
th
 second 
 
Figure 3.38 Equine response to Cold Face Test - forehead with -18°C direct in untrained subjects 
cold packs were applied from the 300
th
 to 600
th
 second 
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 3.8.3 Equine Response to Cold Pressor Test 
Cold pressor test was first performed by applying cold packs at the distal part of forelimbs 
(cannons). When using an isolating bandage between the skin and the packs, no heart rate 
change was noticed neither at 4°C nor at -18°C (see Figure 3.39 and Figure 3.40, packs were 
applied from the 180th to 360th second). 
 
Figure 3.39 Equine HR Response - CPT at distal position with 4°C 
cold packs were applied from the 180
th
 to 360
th
 second 
 
 
Figure 3.40 Equine HR Response - CPT at distal position with -18°C 
cold packs were applied from the 180
th
 to 360
th
 second 
 
Applying -18°C directly to the skin without isolation, triggered tachycardia (Figure 3.41, 
packs were applied from the 180th to 360th second).This increased heart rate was weaker 
than the one observed in humans. Cold acclimatization could explain the damped response. 
Horses are used to low ambient temperature on their legs in the stables.  
Both Figure 3.42 and Figure 3.43 reveal an interesting observation, QT intervals durations 
slightly increase whereas RR intervals shorten. This unusual physiological behavior was first 
investigated in [101] and explained by denser parasympathetic nerve innervations in equine 
ventricles than in human ventricles. Figure 3.42 illustrates changes in QT intervals durations, 
the first 90 values were recorded before the application of cold and the last 90 during cold 
application. Figure 3.43 shows a RR vs. QT plot of the first 60 seconds during cold 
application.  
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Figure 3.41 Equine HR Response – CPT at distal position with -18°C direct 
cold packs were applied from the 180
th
 to 360
th
 second 
 
Figure 3.42 Equine QT Response - CPT at distal position with -18°C direct 
first 90 values were recorded before the cold application 
last 90 values were recorded during cold application 
 
 
Figure 3.43 Equine RR-QT Response - Cold Pressor Test Distant with -18°C Direct 
 
Additional investigations were made with cold packs at -18°C applied directly to the skin 
of equine forelimbs instead of the metacarpus. The response was less strong than on the 
metacarpus, however the observed increase of heart rate lasted longer (see Figure 3.44, 
packs were applied from the 180th to 360th second). 
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Figure 3.44 Equine HR Response – CPT at proximal position with -18°C Direct 
 
As conclusion, equine response to Cold Face Test or Cold Pressor Test is different from 
the response in humans. Both tests involve emotional factors such as fear and pain. 
Acclimatization and cold sensibility of the subjects can modulate the results significantly. 
Horses should be firstly trained with the experimental conditions in order to reduce 
interferences due to pain and fear. The most appropriate body places where the cold tests 
could trigger expected cardiovascular response were the forehead, the nose and the 
forelimbs.  
3.9 Conclusion 
In Chapter 1 we have demonstrated major limitations of current methods for assessing 
cardiovascular control and proposed novel mathematical models in Chapter 2. 
In this Chapter 3 we have undertaken non-invasive experiments in order to gather 
physiological data for model validation. The experiments were selected from well-known 
clinical diagnostic tests of cardiovascular function, focusing on acquiring non-invasive 
cardiovascular signals. Our approach to signal processing was to apply specific known 
methods, selecting key parameters which are pertinent to the specific problem of 
cardiovascular control. The intellectual contribution in this chapter is the acquisition of data 
on human and animal subjects; and the selection of signal processing methods, and 
specifically on the selection of signal features for inclusion in the integrative models.  
In the next Chapter 4 we deal with estimation of values for model parameters for specific 
experimental data. We will present methods that we believe to be a considerable step 
towards distinct quantitative assessment of both sympathetic and parasympathetic 
branches of the autonomic nervous system. 
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Chapter 4. Our Approach to Model-based Quantification 
of Autonomic Nervous Tone 
We developed an integrated physiologically-based model of cardiovascular control in 
Chapter 2. Our model is characterized by input variables, internal state variables, output 
variables, known constants and unknown parameters. We performed non-invasive 
experiments in Chapter 3 and collected cardiovascular signals which can now be used to fit 
the model in order to estimate the values of the unknown parameters for each subject. This 
is equivalent to resolve an optimization problem. The current chapter will present selected 
optimization algorithms and develop methods for model-based quantification of autonomic 
nervous tone. 
4.1 Optimization Methods 
Generally speaking, for some inputs and initial guessed parameter values, the model 
would produce simulated values of output variables. This simulated behavior of the system 
can differ from the observed behavior obtained during physical experimentation. Parameter 
estimation aims to minimize that difference. The goal of this activity is to find the unique set 
of parameter values for which the difference between simulated and observed behavior is 
closed to zero. That difference is called objective function. Estimating the parameters is an 
optimization problem of the objective function. There is a range of methods for parameters 
estimation including approaches based on non-linear least squares, maximum likehood, 
Bayesian estimation, simplex method …   They can be divided in two groups: unconstrained 
optimization methods, where the objective function is a function of many variables without 
any constraints; and constrained optimization, where variables of the objective function are 
constrained. 
In the following paragraphs we will present selected methods for local unconstrained and 
constraint optimization which will be applied for estimating values of parameters from Table 
2.9.4 from section 2.9. Some theoretical background of the methods can be found in more 
details in the eBook by Frandsen1. 
4.1.1 Newton-like Methods 
In the unconstrained optimization problem, we look for the smallest, i.e. a local minimizer 
of a real-valued function  where  is a vector of real variables. In other words, we seek a 
vector , such that     for all  close to . 
Newton's method gives rise to a wide and important class of algorithms that require 
computation of the gradient vector  and the Hessian matrix . Although the 
computation or approximation of the Hessian can be a time-consuming operation, there are 
many problems for which this computation is justified. The method forms a quadratic model 
of the objective function around the current iterate :  	 
  
. The model function 
is defined by:  
   	 
 	  

. The idea is to minimize the model  at 
the current iterate. If  is positive definite, then  has a unique minimizer at a point 
where the gradient of  equals zero, i.e. where  	 
  0. 
                                                      
1
 Frandsen P. E., Jonasson K., Nielsen H. B., and Tingleff O. (2004). Unconstrained Optimization (3rd Edition 
ed.) [PDF Document]. http://www2.imm.dtu.dk/pubdb/views/edoc_download.php/3217/pdf/imm3217.pdf 
(Accessed May 18, 2010) 
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Hence, in Newton’s method the new iteration step is obtained as the solution to this last 
equation. The algorithm is given by: 
 
           
        
  !        "  	 
    # $ % $$& 
& 
Convergence is guaranteed if the starting point is sufficiently close to a local minimizer  
at which the Hessian is positive definite. Moreover, the rate of convergence is quadratic. In 
most circumstances, basic Newton method has to be modified to achieve convergence.  
4.1.2 Levenberg-Marquardt Method 
Some difficulty is caused in Newton-like methods by non-positive definite Hessian matrices. 
In this case the underlying quadratic function does not have a unique minimizer and the 
method is not defined.  
A number of methods have been proposed to overcome this problem. We shall 
concentrate on the so-called damped Newton methods, which are considered to be the 
most successful in general. The framework for this class of methods is: 
   	 '(
)*  !  "  	 +
)* &,#$ ' 
In Levenberg–Marquardt type methods ' is updated in each iteration step. Given the 
present value of the parameter, the Cholesky factorization of  	 '(  is employed to 
check for positive definiteness, and ' is increased if the matrix is not significantly positive 
definite. Otherwise, the solution 
)* is easily obtained via the factorization as follows. 
 
          ' " '    #&  $ 
   -   0 
    
      .
  	 '(  $  && 
         ' " 2' 
         	 '(
)*  ! 
      01#  %    !  	 
)*0 ! 
)*          2 3 
          "  	 
)* 
         ' " '  max 713 , 1 ! 2 ! 1
;< 
      $ 
         ' " 2' 
      - " - 	 1 
      =& #& 
   # #&  - 2 ->?@ & 
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4.1.3 Non-Linear Least Squares Method 
The nonlinear least squares problem has the following general form:  
A& ,  % 11B  
A  12CD

>
DE
 12 FF
  12
 
.
 D: H* I H    #%$ 
Least squares problems often arise in data-fitting applications. Suppose that some 
physiological process is modeled by a nonlinear function J, D  that depends on a 
parameter vector  and time D. If D  is the measured output of the process at time D, then 
we can compute the discrepancy between the predicted and observed outputs as residuals 
D  J, D ! D. 
Provided that f has continuous second partial derivatives, we can write its Taylor expansion 
as  	 
   	 K
 	 LF
Fwhere K is the Jacobian. 
Thus, the gradient is A  K  and the Hessian is A  KK 	
∑ DDNN>DE . If  is a local minimizer, then A  0. 
In many practical circumstances, the residuals are small at the solution and the Gauss-
Newton method can be used to find that local minimizer. The Gauss–Newton method is 
based on a linear approximation to the components of  in the neighborhood of  :  for 
small F
F we see from the Taylor expansion that  	 
 O  	 K
 . Therefore 
A 	 
 O P
  A 	 
K 	 
KK
. 
The Gauss-Newton step 
Q* minimizes P
 using the algorithm below: 
 
          #&  $ 
   -   0 
    
           RKKS
Q*  !K 
          "  	 
)*          - " - 	 1 
         =& #& 
   # #&  - 2 ->?@ & 
4.1.4 Nelder-Mead Method 
Physiologically based models usually adopt some simple parameters constraints in form 
of a finite range (a minimum and a maximum value). This is a bound-constrained 
optimization problem. More complicated linear and nonlinear constraints between 
parameters can be defined.  The structure of the most common constrained optimization 
problems is essentially: 
11B ,  T H* 
$#,%  %D  0,  T U                       %D V 0,  T ( 
where  is the objective function. %D are the constraints. U is the index set of equality 
constraints. (  is the index set of inequality constraints. The most simple type of 
unconstrained optimization is obtained when the functions   and %D  are linear 
functions of . This is the so-called linear programming problem, which can be solved using 
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the downhill simplex method or Nelder-Mead method [158]. This method requires only 
function evaluations, not derivatives. It approximately finds a locally optimal solution to a 
problem with N variables when the objective function varies smoothly. In the N-dimensional 
space, a simplex is a polyhedron with N+1 vertices. The method chooses the N+1 points and 
defines an initial simplex. The method iteratively updates the worst point by four operations: 
reflection, expansion, one-dimensional contraction, and multiple contraction. Reflection 
involves moving the worst point (vertice) of the simplex (where the value of the objective 
function is the highest) to a point reflected through the remaining N points. If this point is 
better than the best point, then the method attempts to expand the simplex along this line. 
This operation is called expansion. On the other hand, if the new point is not much better 
than the previous point, then the simplex is contracted along one dimension from the 
highest point. This procedure is called contraction. Moreover, if the new point is worse than 
the previous points, the simplex is contracted along all dimensions toward the best point 
and steps down the valley. By repeating this series of operations, the method finds the 
optimal solution. 
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4.2 Quantification of Resting Autonomic Tone 
4.2.1 Resting Parasympathetic Tone 
Parasympathetic tone is characterized by the model parameter ev,0,maxf  (maximal intrinsic 
firing rate of vagal nerves). It has a typical value of 1 Hz at intrinsic heart rate (i.e. 100 
beats/min). Subjects with low resting heart rate will have a higher tone (e.g. 20 Hz for 40 
beats/min). In order to estimate the individual values for each subject who participated in 
our studies, a least-squares formulation minimizing the errors between measured heart rate 
measHR  and simulated heart rate simHR  was defined. We used measured heart rate obtained 
from baseline recordings at rest during quiet breathing. An algorithm was developed, that 
goes through all cardiac autonomic tests performed by the subject (using the metadata 
structure introduced in Figure 3.11) and selects the baseline recording with the lowest mean 
heart rate. Selecting baseline recording at rest with lowest heart rate might ensure that 
parasympathetic activity is the main source of control of heart rate. The corresponding cost 
function, i.e. the discrepancy between measured and simulated values is defined as 
optimization criteria as follows, where n  is the number of data points. 
 
ev,0,max
n 2
f meas sim ev,0,max
i=1
J = HR (i) - HR (i, f )  ∑  (4.2.1) 
The model presented in Chapter 2 was implemented in the Matlab Simulink environment. 
All model inputs (refer to Table 2.9.1) were set to null as well as synaptic weight constants 
which modulate sensory inputs to parasympathetic premotor neurons (refer to Table 2.5.5). 
This setup allows us to simulate a physiological condition where parasympathetic efferent 
activity is determined only by tonic vagal discharge, and not by sensory inputs. In order to 
calculate the value of parameter 
,0,maxevf  that minimizes the cost function ,0,maxevfJ  we 
implemented the following algorithm in the Matlab environment. 
Load measured baseline heart rate data for all experiments and Determine measHR  with the lowest average 
Set subject’s age as input of model 
Set all other inputs to null 
Set all synaptic weights that modulate sensory inputs to parasympathetic premotor neurons to null 
Loop by varying model parameter 
,0,maxevf  in the interval [1 .. 20] 
Simulate the model for the current value of 
,0,maxevf   and calculate the corresponding simHR  
Calculate and store the corresponding value of cost function 
,0,maxevfJ   
End Loop 
Return the value of 
,0,maxevf  for which 
,0,maxevfJ  was the lowest 
The algorithm loads measured heart rate data and calculates the best estimates for 
model parameter 
,0,maxevf  in the boundary [1 .. 20] Hz. This boundary was chosen because it 
best agrees with the minimal resting heart rate (ca. 40 beats/min, subject n=37) and 
maximal resting heart rate (ca. 100 beats/min, subject n=7) that we encountered in our 
studies.
 ,0,maxev
f was estimated for all 72 subjects after 13 hours of simulations on a 2.1 GHz 
processor with 1.5 GB RAM.  
Results show higher parasympathetic tone on young subjects with a decreasing trend 
with increasing age as depicted in Figure 4.1, what agrees with heart rate variability 
measurements in literature [45]. Young female subjects had a mean parasympathetic tone 
 5.65±3.11 Hz whereas young male subjects had 7.31±3.16 Hz. A possible explanation why 
young women had a lower tone is that this group included 6 subjects (ca. 26% of all young 
women) with mean age 16 years. At such young age, the intrinsic heart rate is high causing 
the resting heart rate to be elevated even with high parasympathetic activity. 
Parasympathetic tone is a major factor determining resting heart rate as shown in Figure 4.2.  
Young black men had the highest parasympathetic tone (11±5.66 Hz), which however 
decreases with aging faster than by white men. With a parasympathetic tone averaging 
7.15±3.29 Hz, young white women surpassed black female subjects by 47%. Subjects with 
cardiovascular diseases were not distinguished from others according to their 
parasympathetic tone. We obtained the mean value 4.25±2.55 Hz. The only observation we 
made, concerns 3 subjects with palpitations, who had lower parasympathetic tone (2±0.5 
Hz).   
Since the resting parasympathetic tone might change over the time, it is useful to know 
how an experimental setup might impact the tone. For example tonic changes during cold 
application on the forehead gives information about the degree of heart rate response, thus 
provides an evaluation of trigemino-cardiac reflex. As explained in section 2.5.2, our model is 
able to predict the firing rate of parasympathetic premotor neurons 
pmev
f for given 
experimental data. We denote the simulated premotor neurons signal corresponding to 
maximal parasympathetic tone by denoted by 
pmev max
f   . The simulated premotor neurons 
signal corresponding to current parasympathetic tone is denoted by 
pmev current
f   . We define 
parasympathetic level parT  in a normalized scale between 0 and 1 as the ratio between both 
signals as follows. 
 
pm
pm
ev
current
par
ev
max
f
T =
f
 
 
 
 
 (4.2.2) 
Simulation of parT  will be developed in details in the frame of experimental vagal 
maneuvers in sections 4.3.2, 4.5.2 and 4.5.3. 
 
Figure 4.1 Effect of age and race on parasympathetic tone 
Young (less than 29 years); Older (30 to 59 years); Elderly (over 60 years) 
 
  
Figure 4.2 Parasympathetic tone and resting heart rate 
4.2.2 Respiratory Sinus Arrhythmias 
Respiratory Sinus Arrhythmias (RSA) are characterized by model parameters 
,resp vW  that 
represents a synaptic weight applied to inputs from inspiratory-expiratory somatic motor 
neurons. Its value tells in which extend respiration affects heart rate and might provide a 
measure of high frequency heart rate variability that is correlated to the respiration cycle. 
We selected the experimental condition provided by the deep breath test (DBT) which is 
known to induce RSA with high amplitude (see section 3.4 for details). The RSA performance 
( )EI i  was calculated as the difference between the highest heart rate and the lowest heart 
rate during the thi  respiration cycle. We further computed the overall RSA performance (
totalEI ) as sum of  all individual ( )EI i  and used it as key performance indicator to select the 
best data set (i.e. the heart rate recording with the greatest totalEI ) for each subject. We 
developed an algorithm that goes through all cardiac autonomic tests performed by the 
subject (using the metadata structure depicted in Figure 3.11) and selects the baseline 
recording with the greatest totalEI . In order to estimate the optimal value of parameter 
,resp vW  for each subject, we formulated a least square problem which should minimize the 
sum of squared of the RSA performance ( )EI i  for all n  respiration cycles as follows. 
 
,
,
,
resp v
n 2
W meas sim resp v
i=1
J = EI (i) - EI (i W )  ∑  (4.2.3) 
In some experimental setups, respiration signal was either recorded using a thoracic 
movement transducer or derived from ECG signal as explained in section 3.1.6. The 
respiration signal was then used as input to the model as well subject’s age. Subject’s 
parasympathetic resting tone was initialized with the value obtained by the algorithm 
described in section 4.2.1. Intracardiac influences on the estimation of RSA parameter were 
eliminated by setting the model parameter 
rsaT
G (gain of intracardiac high frequency 
fluctuations) to null. This setup allows us to only simulate heart rate fluctuations which are 
matched to respiration.  
In order to calculate the value of 
,resp vW  that minimizes the cost function ,resp vWJ , we solved 
the corresponding nonlinear least-squares problem in the Matlab environment using the 
lsqnonlin function. Gradient function was calculated by finite-differencing, Hessian was used. 
The maximal number of iterations was set to 1e5. The trust-region-reflective algorithm was 
used instead of Levenberg-Marquardt in order to enforce parameter boundaries in the 
interval [0.1 .. 5] Hz with initial value 0.1 Hz. The minimal and maximal steps were set to 0.1 
and 10. They define the steps used by the algorithm within the boundary region. The trust-
region-reflective algorithm is based on the interior-reflective Newton method described in 
 [159]. Each iteration involves t
method of preconditioned conjugate gradients
,resp vW was estimated for all 72 subjects after 
processor with 1.5 GB RAM. Results show a similar trend with aging as 
tone, but a more rapid decay of respiratory modulation of heart rate is observed with aging.  
Figure 4.3 also exhibits a predominant RSA 
for white subjects although the black population was older (40±15 years) than the wh
population (32±18 years). Figure 
(n=37) during the deep breath test. 
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 4.2.3 Intracardiac High Frequency Fluctuations 
The frequency of intracardiac fluctuations is captured by the model parameter rsaf  and its 
amplitude by model parameter 
rsaT
G . They should represent residual heart rate variability 
which is related neither to respiration nor to neural regulation. Their real values could be 
obtained by fitting the model to recordings performed on a denervated heart, what is rarely 
possible in human research. Therefore we selected baseline recordings with the greatest 
totalEI  during quiet breathing, or if possible during breathe holding. In order to estimate the 
optimal value of parameter rsaf  and rsaTG  for each subject, we formulated a least square 
problem which should minimize the sum of squared of the RSA performance ( )EI i  for all n  
respiration cycles present in the measurement as follows. 
 , ,
rsa T rsarsa
n 2
f G meas sim rsa T
i=1
J = EI (i) - EI (i f G )  ∑  (4.2.4) 
The respiration signal was used as input to the model as well subject’s age. Subject’s 
parasympathetic resting tone was initialized with the value obtained by the algorithm 
described in section 4.2.1. RSA parameters were initialized using values estimated in section 
4.2.2. In order to calculate the value of rsaf  and rsaTG  that minimizes the cost function
rsa Trsaf G
J , we solved the corresponding nonlinear least-squares problem in the Matlab 
environment using the lsqnonlin function where both parameters were constrained in the 
intervals [0.1 .. 1] Hz and [0.01 .. 0.1] s respectively, with initial guessed values set to 0.1 Hz 
and 0.01 s. Estimated values clearly show elevated intracardiac fluctuations at a mean 
frequency of 0.16 Hz on young subjects with amplitude 0.03 s. The frequency decreases 
down to 0.106 Hz at older ages, and the amplitude to 0.02 s. No big difference was observed 
between older and elderly subjects. Parameters values are given in Figure 4.5 for each age 
group and gender. No significant difference was found for subjects with cardiovascular 
diseases. Hypertensive subjects had 0.101 Hz fluctuations with amplitude 0.016 s, while 
subjects with palpitation or cardiac insufficiency had 0.11 Hz and 0.019 s.  
 
 
Figure 4.5 Parameter values for intracardiac fluctuations 
Young (less than 29 years); Older (30 to 59 years); Elderly (over 60 years) 
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4.2.4 Resting Sympathetic Tone in Heart 
Efferent sympathetic tone to heart is characterized by the model parameters 
,0,es highf  ( 
firing rate of pacemaker sympathetic premotor neurons), 
, ,0c esW  (synaptic weight applied to 
sensory inputs from chemoreceptors) and QTk  (gain factor of elastance on QT interval 
duration). They quantify the tonic discharge of sympathetic nerves on the cardiovascular 
system. In order to estimate the individual values for each subject who participated in our 
studies, a least-squares formulation minimizing the errors between measured measQT  and 
simulated QT interval durations simQT  was defined. We used measured QT interval durations 
obtained from baseline recordings at rest based on the assumption that sympathetic 
modulation of ventricle depolarization duration is controlled by tonic sympathetic discharge 
at rest, parasympathetic innervations of ventricles being negligible. An algorithm was 
developed, that goes through all cardiac autonomic tests performed by the subject (using 
the metadata structure depicted in Figure 3.11) and selects the baseline recording with the 
longest mean QT interval duration. Selecting baseline recording at rest with longest mean QT 
interval might ensure that only tonic (basal) sympathetic activity is the main source of 
control. The corresponding cost function, i.e. the discrepancy between measured and 
simulated values is defined as optimization criteria as follows, where n  is the number of 
data points. 
 ,
es,0,high c,es,0 QT
n 2
f W k meas sim es,0,high c,es,0 QT
i=1
J = QT (i) - QT (i, f ,W k )  ∑  (4.2.5) 
After the model has been initialized with subject’s age and parameters values estimated 
in previous sections, we solved a nonlinear least-squares problem aiming to minimize the 
cost function 
es,0,high c,es,0 QTf W kJ in the Matlab environment using the lsqnonlin function where both 
parameters were constrained in the intervals [2  .. 12] Hz, [1 .. 5] (dimensionless unit) and 
[10 .. 20] mmHg-1 mL  respectively, with initial guessed values set to 10 Hz, 3 and 10 mmHg-1 
mL . The parameters boundaries were chosen according to the minimal and maximal values 
of physiological variables (RR and QT interval durations).  
Parameters were estimated for all 72 subjects after 7 hours of simulation on a 1.8 GHz 
processor with 4 GB RAM. Results show predominant sympathetic tone for women at all 
ages. The firing rate 
,0,es highf  of pacemaker sympathetic premotor neurons was found to be 
8.84±1.58 Hz for women and 7.92±1.63 Hz for men. The synaptic weight 
, ,0c esW  applied to 
sensory inputs from chemoreceptors contributing to tonic sympathetic activity equaled 
1.86±0.55 for women and 1.97±0.57 for men. QTk  was found to be ca. 10 mmHg
-1 mL  for all 
subjects. 
   
Figure 4.6 Parameter values for sympathetic tone 
Young (less than 29 years); Older (30 to 59 years); Elderly (over 60 years) 
 
As explained in section 2.5.1, our model is able to predict the firing rate of sympathetic 
premotor neurons 
pmsi
f for given experimental data. The simulated premotor neurons signal 
corresponding to maximal sympathetic tone is denoted by 
pmsi max
f   . The simulated 
premotor neurons signal corresponding to current sympathetic tone is denoted by 
pmsi current
f   . We define sympathetic level symT  in a normalized scale between 0 and 1 as the 
ratio between both signals, averaged over all vascular beds (with i  equals v  for ventricles, b  
for brain, m  for skeletal muscles, s for splanchnic and e for extrasplanchnic) as follows. 
 
,
1
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pm
pm
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i=n v,b,m,s,e si
max
f
T =
f
 
 
 
 
∑  (4.2.6) 
 4.2.5 Resting Vascular Tone 
Low oscillation in cardiovascular variables such as heart rate and blood pressure (so-
called Mayer waves) are represented by model parameters , which determine 
the number of burstings per time. The frequency of low oscillation increases with decreasing 
values of both parameters. The synaptic weight applied to low frequency oscillators in 
sympathetic premotor neurons is represented by the model parameter 
,0,es lowW . We used 
power spectral density and represented the heart rate signal in the frequency domain using 
Least-Squares Spectral Analysis (LSSA) and evaluated the low frequency LF  in the band 
[0.015 .. 0.15] Hz.  
In order to estimate the values of model parameters , , 
,0,es lowW  for each 
subject, a least-squares formulation minimizing the errors between magnitude of low 
frequency components in measured heart rate signal ( measLF ) and low frequency 
components in simulated heart rate signal ( simLF ) was defined. The corresponding cost 
function, i.e. the discrepancy between measured and simulated values is defined as 
optimization criteria as follows. 
 
,0 , ,0 , ,0 , ,0, ,0, ,0,
, ,
es low es low es low
2
r k W meas sim es low es low es lowJ = LF (i) - LF (i,r k W )    (4.2.7) 
Model parameters , , 
,0,es lowW  were bounded in the intervals [1 .. 5] 
(dimensionless unit), [0.01 .. 0.1] (dimensionless unit) and [1 .. 5] (dimensionless unit) 
respectively, with initial values 3, 0.05 and 3. They were estimated for all 72 subjects after 12 
hours of simulation on a 1.8 GHz processor with 4 GB RAM. Values are given in Figure 4.7. 
 
  
 
Figure 4.7 Parameters values for low frequency fluctuations 
 
 
 
,0,es lowr ,0,es lowk
,0,es lowr ,0,es lowk
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4.3 Quantification of Autonomic Tone during Vagal Maneuvers 
4.3.1 Estimation of Parameters of Cold Receptors 
The cold face test is a vagal maneuver which has been introduced in section 3.2. A normal 
response is decreasing heart rate which can be subject-specific. An accurate evaluation of 
the response requires estimating model parameters related to trigeminal cold receptors 
located on the forehead. The parameters and corresponding model equations were 
described in section 2.4.5. Parameters are 
sat ,max
f  (upper saturation level of facial cold 
receptor), which is closely related to the extent of bradycardia, i.e. the maximal number of 
heart beats decrement observed during the application of cold stimuli; 
fat
k  (slope of the 
exponential decay of cold receptor), which indicates the duration of the bradycardia 
response. In order to better understand the meaning of both parameters, model simulations 
were made when fixing one and varying the second. Table 4.3.1 shows statistics values 
obtained for 
fat
k  with 
sat ,max
f  fixed to 50 Hz. Mean heart rate  testmean(HR ) , calculated 
during cold application, increases with increasing 
fat
k . The difference, in beats, between 
heart rate before the test and heart rate during the test, diffmean (HR)  decreases with 
increasing 
fat
k . The percentage of decrease, incrmean (HR) , what is a measure of the 
bradycardia during CFT, also decreases with increasing 
fat
k . A second simulation was 
performed with 
fat
k  fixed to 0.19  s-1. Table 4.3.2 shows values obtained when varying 
sat ,max
f . Increasing values for  
sat ,max
f  cause increasing bradycardia. 
 
Table 4.3.1 Effect of the slope of the exponential decay of facial cold receptor 
fat
k
 
[ s-1 ] 
testmean(HR )  
beats/min 
diffmean (HR)  
beats/min 
incrmean (HR)  
% 
0.01 32.54 35.54 52.20 
0.1 50.54 17.54 25.76 
0.19 54.14 13.93 20.47 
0.28 55.76 12.31 18.09 
0.37 56.63 11.45 16.81 
0.46 56.90 11.18 16.42 
0.55 57.26 10.81 15.88 
0.64 57.37 10.71 15.73 
0.73 57.59 10.49 15.43 
0.82 57.78 10.30 15.13 
0.91 57.95 10.13 14.88 
1 57.96 10.11 14.86 
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Table 4.3.2 Effect of upper saturation level of facial cold receptor 
sat ,max
f
 
[Hz] 
testmean(HR )  
beats/min 
diffmean (HR)  
beats/min
 
incrmean (HR)  
%
 
0 59.44 8.64 12.69 
10 58.93 9.15 13.44 
20 57.79 10.29 15.12 
30 56.66 11.41 16.77 
40 55.32 12.75 18.79 
50 54.14 13.94 20.47 
60 53.11 14.97 21.99 
70 52.58 15.48 22.74 
80 52.03 16.05 23.57 
90 51.53 16.55 24.31 
100 51.10 16.98 24.94 
 
In order to estimate the individual parameters values for each subject who underwent 
the cold face test, we developed an algorithm that goes through all cold face tests 
performed by the subject (using the metadata structure depicted in Figure 3.11) and selects 
the recording measHR  with the highest percentage of heart rate fall fallHR  between baseline 
recording baselineHR  and recording during cold face test testHR , defined as follows. 
 
meas baseline test
test
fall
baseline
HR HR HR
min(HR )HR = 100 1-
mean(HR )
= ∪
 
⋅ 
 
 (4.3.1) 
 A least-squares formulation minimizing the errors between selected (measured) heart 
rate measHR  and simulated heart rate simHR  was defined. The corresponding cost function, 
i.e. the discrepancy between measured and simulated values is defined as optimization 
criteria as follows, where n  is the number of data points. 
 ,
at ,max at s fs f
n 2
f k meas sim at ,max at
i=1
J = HR (i) - HR (i, f k )  ∑  (4.3.2) 
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After the model has been initialized with subject’s age and parameters values estimated 
in previous sections, we solved a nonlinear least-squares problem aiming to minimize the 
cost function 
at ,max ats ff k
J in the Matlab environment using the following algorithm. 
Load measured heart rate data for all CFT experiments and Determine 
measHR  with the highest heart rate fall fallHR  
Load timestamps for baseline, preparatory and test phases; and generate temperature signal 
Open Simulink model file 
Set subject’s age as input of model 
Set subject’s parameters related to respiratory sinus arrhythmias, sympathetic tone and vascular tone 
Estimate parasympathetic tone using baseline recording prior to CFT using the algorithm described in section 4.2.1 
Loop by varying model parameter 
fat
k   in the interval [0.01 .. 1] and 
sat ,max
f in the interval [0 .. 100] 
Simulate Simulink model file for the current parameters values and calculate model output 
simHR  
Calculate and store the corresponding value of cost function 
at ,max ats ff k
J  
End Loop 
Return the value of  
fat
k  and 
sat ,max
f  for which 
at ,max ats ff k
J  was the lowest 
fat
k  and 
sat ,max
f were estimated after 8 hours of simulation on a 1.8 GHz processor with 4 
GB RAM for all 50 subjects who underwent the cold face test. Table 4.3.3 shows mean values 
obtained per gender and age group. Women exhibit a clear linear trend with aging; the 
response duration (reflected by 
fat
k ) and response intensity (reflected by 
sat ,max
f ) decrease 
with aging. This trend is not visible for men because only 4 from 18 were young subjects. 
They demonstrated a weaker response to cold stimuli than older men.  
 
Table 4.3.3 Parameters values for cold receptors 
Sex Age Group fat
k   [s-1] 
sat ,max
f  [Hz] 
F 
  
Young 0.25 14.17 
Older 0.20 10.33 
Elderly 0.09 6.67 
F Total 0.21 11.50 
M 
  
Young 0.08 10.00 
Older 0.26 13.33 
Elderly 0.08 7.50 
M Total   0.20 11.94 
Grand Total  0.20 11.67 
 
Figure 4.8 shows heart rate change during cold application for a young female (n=32) and 
older (n=4) female. Parameters values for 
fat
k  and 
sat ,max
f  are plotted, as well as the 
corresponding baseline parasympathetic tone 
,0,maxevf and the difference between mean 
heart rate diffmean (X) .  Our mathematical model responded correctly from the view of an 
order of values of the output values but incorrectly from the viewpoint of absolute values. 
Even so the model proved importance to give correct trends and interpretable results. 
  
Figure 4.8 Heart rate response to cold face test  
data are from a young female (top graph) and an older female (bottom graph) 
4.3.2 Parasympathetic and Sympathetic Response to Cold Face Test 
The feedback-feedforward loop regulating temperature and cardiovascular response 
during the cold face test can be summarized as depicted in Figure 4.9. The model consists of 
a negative feedback part for controlling the core temperature. Its current value is measured 
by the hypothalamus central thermoreceptors. The set point of the controlled variable is the 
target temperature (we use the average body temperature 37 °C, which is however subject 
to considerable variation [79]). The feedback controller is the hypothalamus 
thermoregulatory center. It receives temperature as input and generates a command signal 
in form of sympathetic neuron tone to the actuator (medulla cardiovascular control center). 
The sympathetic command originated from the hypothalamus reaches the medulla where it 
is integrated in the cardiovascular control vasocenter. An actuating signal is generated to 
peripheral vessels for vasoconstriction. Combined feedback and feedforward significantly 
improves the model of thermoregulation. With feedforward control, major external 
disturbance can be measured before it affects the system output [160]. The cold stimulus 
(CS) when applied to the skin induces heat loss by conduction from the blood in skin vessels. 
This disturbance is sensed by skin thermoreceptors. The mechanism of transduction of 
temperature change is not fully understood [86]. For simplification we assumed that 
receptors sense the average of the cold stimulus temperature, room temperature and blood 
temperature, which make together 22 °C. This measured disturbance is relayed by the Pons 
into the medulla vagal cardiovascular control center that generates a parasympathetic 
output signals affecting heart rate. Changes in heart rate and peripheral resistance affect 
blood flow, and temperature in the vasculature. The new temperature is feedback to the 
controller and the regulatory process starts again. 
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Figure 4.9 Block diagram of regulatory processes during CFT 
The level of resting parasympathetic tone on the heart determines how strong 
bradycardia response to CFT will be. In the previous optimization activities, we estimated the 
resting parasympathetic using the baseline heart rate signals with the lowest mean heart 
rate ever recorded on the subject. The algorithm has been explained in section 4.2.1. Both 
resting parasympathetic tone and baseline parasympathetic tone might differ, for example, 
while subject 32 had a resting parasympathetic tone equals to 4.44 Hz; the tone was 3.53 Hz 
just before the cold face test. It is necessary to transform the absolute parasympathetic tone 
into parasympathetic level parT  and sympathetic level symT  in a range between 0 and 1 as 
indicated in section 4.2.1 and 4.2.4. Graphs in Figure 4.10 illustrate the obtained minimum 
and maximum tone of both branches of the autonomous nervous system during CFT. Young 
subjects had higher tone of sympathetic activity to the vasculature at rest, whereas older 
subjects had the predisposition to experience a stronger sympathetic discharge during CFT.  
The former group had higher parasympathetic level at rest, but it increased to a greater 
extend for younger subjects. We published these results in [104]. 
  
 
 
Figure 4.10 Sympathetic and parasympathetic level during CFT 
Y-axis is normalized in the interval [0 .. 1] in dimensionless unit 
Group 1 - Young (less than 29 years); Group 2 - Older (30 to 59 years); Group 3 - Elderly (over 60 years) 
4.3.3 Vagally-mediated Tachycardia 
It is expected that vagally maneuvers such as cold face test (section 3.2) and oculocardiac 
reflex test (section 3.3) will produce a decrease in heart rate. However some subjects in our 
studies demonstrated a paradoxal reflex tachycardia. Instead of bradycardia, they had a 
visible increasing heart rate above baseline value when pressure was applied on eye balls as 
illustrated in Figure 4.11 (subject n=37, healthy young man).  
 
Figure 4.11 Tachycardia during oculocardiac reflex test 
 
During the oculocardiac reflex test, nociceptors sense painful sensation and depending on 
their threshold and operating range, they might elicit a reflex tachycardia which could mask 
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the diving reflex. In such a case, the heart receives not only parasympathetic discharge but 
also a pain-related pressor sympathetic discharge. Studies in [161] indicate that 
simultaneous activation of sympathetic nervous system and parasympathetic nervous 
system was observed in conditioned fear rats. Evidences suggested that simultaneous co-
activation may lead to a more efficient cardiac output than activation of the sympathetic 
limb alone, allowing the system to overcome constricted vascular tree as it is the case during 
the diving response [98]. It has been found that postganglionic vagal fibers and vasoactive 
intestinal polypeptide play a role in mediating the vagal tachycardia in anaesthetised dogs 
[162]. This hypothesis has been included in our model using the parameter  
,nor vog
k which tells 
to which extend the concentration of acetylcholine released by the parasympathetic 
preganglionic neuron in autonomic ganglia would modulate the release of norepinephrine in 
SA and AV nodes. 
While evaluating a tachycardia response to oculocardiac reflex test, we are interested in 
determining the values of model parameter 
,nor vog
k  (see section 2.7 for more details about the 
model equations). For simplicity we assume that this parameter is described by a linear 
function of the pressure signal generated by pressure sensors in eyes. The analytic form of 
oculo-pressure sensor response aof  has been given in section 2.4.6. We obtain the following 
relationship.  
 
,
( ) ( )
nor vog vt ao
k t k f t= ⋅  (4.3.3) 
where vtk  is a scalar parameter.  
 aof  is characterized by the model parameters ao,maxf  (upper saturation of oculo-pressure 
receptor) and aok ( slope of the sigmoid response of oculo-pressure receptor). In order to 
estimate their value as well as the value of the scalar parameter vtk , we formulated a least-
squares optimization problem minimizing the errors between measured heart rate measHR  
and simulated heart rate simHR . 
We found the values 14.98 Hz, 0.43 s-1 and 4 for ao,maxf , aok  and vtk  respectively for the 
subject whose tachycardia response was illustrated in Figure 4.11. The corresponding 
simulated firing rate of oculo-pressure receptors can be seen in the upper panel of Figure 
4.12 when pressure is applied from 60th to 110th second. The lower panel shows that our 
model could successfully predict the paradoxal tachycardia response. Heart rate increases 
despite of more acetylcholine being produced at ganglionic site, as it can be seen in Figure 
4.13, pre-ganglionic parasympathetic neurons increase their activity during oculocardiac 
reflex test by 11.97% while pre-ganglionic sympathetic neurons decrease their activity by 
8.07%. One should excpect a bradycardia response, but this is not the case because post-
ganglionic parasympathetic neurons enhance the release of norepineprine at SA node site, 
as shown in Figure 4.14. Vagally-mediated norepinephrine production increases by over 
1000% which completely masks the increase in acetylcholine concentration (only 11.97%). 
Out of these results, our model simulation brings additional evidence that a possible 
explanation why some subjects demonstrate tachycardia during vagal maneuver could be a 
vagally-mediated production of sympathetic neurotransmitters at heart site. 
  
Figure 4.12 Vagally-mediated tachycardia during oculocardiac reflex test 
 
 
 
Figure 4.13 Preganglionic neurotransmitters on heart during vagally-mediated tachycardia 
Y-axis is normalized in the interval [0 .. 1] in dimensionless unit 
 
 
 
Figure 4.14 Postganglionic neurotransmitters on heart during vagally-mediated tachycardia 
Y-axis is normalized in the interval [0 .. 1] in dimensionless unit 
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4.4 Quantification of Autonomic Tone during Sympathetic Maneuvers 
4.4.1 Estimation of Parameters related to Mental Stress 
When submitting the subject to mental arithmetic stress we are interested in determining 
the values of model parameters as,maxf  and ask  which are related to upper saturation of 
mental stress sensors  and the slope of the mental stress sensor response respectively, as 
described in section 2.4.7. In order to estimate the individual parameters values for each 
subject who underwent the mental stress test, we formulate a least-squares optimization 
problem minimizing the errors between measured heart rate measHR  and simulated heart 
rate simHR ; between measured mean arterial blood pressure measMAP  and simulated mean 
arterial blood pressure simMAP ; between galvanic skin level ,mp measG  measured at finger site 
and simulated galvanic skin level 
,mp simG . The corresponding cost function, i.e. the 
discrepancy between measured and simulated values is defined as optimization criteria as 
follows, where n  is the number of data points. 
[ ] [ ]
, ,as,max as
n n n 22 2
f k meas sim meas sim mp meas mp sim
i=1 i=1 i=1
J = HR (i) - HR (i) MAP (i) - MAP (i) G (i) - G (i) + +  ∑ ∑ ∑
 (4.4.1) 
After the model has been initialized with subject’s age and parameters values related to 
sympathetic tone and vascular tone as estimated in previous sections, we solved the 
nonlinear least-squares problem in the Matlab environment as follows. 
Load measured heart rate, blood pressure and galvanic skin level data 
If respiration was measured, then load respiration signal, otherwise generate respiration signal from ECG  
Load timestamps for baseline, preparatory and test phases 
Open Simulink model file 
Set subject’s age as input of model 
Set subject’s parameters related to respiratory sinus arrhythmias, sympathetic tone and vascular tone 
Set subject’s respiration signal 
Estimate parasympathetic tone using baseline recording by applying the algorithm described in section 4.2.1 
Loop by varying model parameter 
as,max
f  in the interval [1 .. 50] and 
as
k in the interval [0.1 .. 1] 
Simulate Simulink model for current parameters values and return model outputs 
,
, ,
meas sim mp simHR MAP G  
Calculate and store the corresponding value of cost function 
as,max as
f kJ  
End Loop 
Return the value of  
as,max
f  and 
as
k for which 
as,max as
f kJ  was the lowest 
The parameters as,maxf  and ask  were estimated to 14.07 Hz and 13.22 s-1 for a young 
healthy man (subject n=37). Results are depicted in Figure 4.15 when subject was asked to 
perform a mental arithmetic task from 120th to 190th second. Heart rate increased by 12% 
and galvanic skin level increased by 0.42 microSiemens. The results show an acceptable fit 
between simulated and measured data. We computed the parasympathetic level parT  and 
sympathetic level 
symT  as indicated in section 4.2.1 and 4.2.4 in a range between 0 and 1. For 
the normalization, the maximal firing rate of sympathetic premotor neurons simulated for 
young subjects was used; it was equal to 60 Hz. The maximal firing rate of parasympathetic 
premotor neurons was found to be 10 Hz. Results in Figure 4.16 show increasing 
 sympathetic level to heart by 24.31% from baseline level 0.6852 to the value 0.8518 during 
stress.  Vagal level decreases by 7.76% from 0.8058 to 0.7431.  
In order to compare the obtained results with heart rate variability, we evaluated the low 
frequency (LF) and high frequency (HF) components of the heart rate signal before and 
during mental stress. Figure 4.17 shows a comparison with model-based estimates of 
autonomic tone (sympathetic and parasympathetic level). Spectral power density values for 
low frequency components (LF) increased by 27.94%, what agrees with the increased in 
model-based estimate of sympathetic tone (24.31%). However there is no agreement 
between values of high frequency (HF) components and model-based estimate of 
parasympathetic tone. While HF increases by 2.69%, the former decreases by 7.76%. We 
would rather expect a decrease in HF components during pressor response. Obviously our 
model-based estimates of parasympathetic tone give more plausible values. 
 
Figure 4.15 Simulation response to mental stress 
 
 
Figure 4.16 Sympathetic and parasympathetic level during mental stress 
Y-axis is normalized in the interval [0 .. 1] in dimensionless unit 
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Model-based estimates
4.4.2 Estimation of Parameters related to 
Immersing subject’s hand or foot in cold water induces a global pressor response with 
increased heart rate, peripheral vascular resistance and blood pressure (see section 
order to quantify autonomic response during pressor test, we need to estimate the model 
parameters related to cold receptors at hands and feet level. These are 
saturation of cold receptor on hands and feet
cold receptor on hands and feet
error between model output and measured data 
previous section 4.4.1. Both parameters were found to be equal to 72.32 Hz and 
respectively for a healthy young man (su
increases by 72% from 49.55 beats/min to 83.68 beats/min. Cold stimuli was applied from 
120th to 160th second. The global pressor response is clearly reflected by model
estimates of autonomic tone, as depicted in 
by 80% whereas sympathetic level to muscles increases by more than 1000%. 
Parasympathetic level decreases by 10%.
Figure 
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4.17 HRV parameters and model-based estimates 
 are normalized in the interval [0 .. 1] in dimensionless unit 
Cold Pressor Test 
) and 
sat
k ( slope of the sigmoid response of 
). We defined an optimization task aiming to minimize the 
similar to the one presented 
bject n=37). As shown in Figure 
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Figure 4.19 Sympathetic and parasympathetic level during cold pressor test 
Y-axis is normalized in the interval [0 .. 1] in dimensionless unit 
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4.5 Quantification of Autonomic Tone during Mixed Maneuvers 
We selected the Valsalva Maneuver (VM) as a cardiac autonomic test which triggers a 
combined sympathetic and parasympathetic response; and is therefore suitable for 
assessing the integrity of autonomic nervous control on the cardiovascular system [100]. Its 
physiological background and experimental setup was introduced in section 3.6. In the 
following sections we will present some limitation of heart rate variability (HRV) as tool for 
assessing autonomic nervous control during the VM and show how our mathematical model 
produces better results. We published results presented in this section as conference 
contribution [163]. An extended version was submitted as a journal publication [164]. 
4.5.1 Limitations of HRV as Measure of Autonomic Activity 
There exist signal analysis methods for evaluating cardiovascular response during the 
Valsalva Maneuver including wavelets transform [165] and T-wave width alteration [150]. 
Although such methods provide insight information, the contribution of neural pathways 
involved was not covered. An attempt using frequency domain analysis of heart rate 
variability (HRV) was made in [166] and [167]. HRV analysis of autonomic balance during the 
Valsalva Maneuver can held erroneous results because of the very short duration of the test 
(15 to 30 seconds). Recording of approximately 1 minute is needed to access the high 
frequency components of HRV; while 2 minutes are needed to evaluate the low frequency 
components. Very low frequency assessment from short-term recordings (less than 5 
minutes) is a dubious measurement and should be avoided [29]. The spectrum of the HRV 
signal is usually calculated using non-parametric methods based on Fast Fourier Transforms. 
A rigorous evaluation requires at least 60 seconds ECG. This basic condition is not met by the 
Valsalva Maneuver, which is usually performed for less than 30 seconds. Therefore time-
domain analysis is more suitable in the evaluation of HRV during VM. The standard deviation 
of NN intervals (SDNN) reflects the overall variability, but strongly depends on the duration 
of the signal. SDNN increases with the length of recording. The square root of the mean 
squared differences of successive NN intervals (RMSSD) estimates high frequency variations 
of heart rate and is proposed as a measure of parasympathetic activity.  
We calculated time-domain estimates of HRV for heart rate signals recorded during our 
own experiments, as described in section 3.6. Selected data sets and corresponding HRV 
values are presented in Table 4.5.1. The SDNN and RMSSD for each single phase were 
calculated on the portion of NN intervals of that phase. Changes in SDNN are visible from 
one phase to the next phase of the maneuver. Greatest heart rate variability occurs in the 
phase 2, where SDNN equals 39.23 ms compare to 20.97 ms before the maneuver. Phase 2 is 
also characterized by a decreased RMSSD from 29.75 ms before the maneuver to 19.17 ms, 
which suggests a withdrawal of vagal activity and increased sympathetic activity as response 
to the transient decrease in blood pressure. Phase 4 bradycardia is characterized by an 
increase of RMSSD from 19.17 ms in phase 3 to 37.57 ms in phase 4. Table 4.5.1 additionally 
includes the Valsalva Ratio (VR) computed as the maximal heart rate recorded in phase 2 
divided by the minimal heart rate recorded in the bradycardia phase 4. 
Although RMSSD and SDNN provide a measure of the degree of autonomic modulation, 
they do not indicate the level of autonomic tone regulating heart rate for each single phase 
of the VM. Moreover RMSSD and SDNN can be subject-specific; values for single data sets do 
not always correspond to the expected increase or decrease of autonomic nervous activity. 
For example, in data set 7, RMSSD surprisingly increases from 13.51 ms in phase 1 to 28.86 
ms in phase 2 although phase 2 should be characterized by a decrease of parasympathetic 
 activity. Such inconsistency motivated us to investigate the usage of estimates of autonomic 
tone based on our mathematical model. 
 
Table 4.5.1 Time-domain estimates of heart rate variability (in milliseconds) during the Valsalva Maneuver for 
12 data sets obtained on 5 healthy subjects 
Mean 
Data Set 
1 
Data Set 
2 
Data Set 
3 
Data Set 
4 
Data Set 
5 
Data Set 
6 
Data Set 
7 
Data Set 
8 
Data Set 
9 
Data Set 
10 
Data Set 
11 
Data Set 
12 
S
D
N
N
 
Baseline 20.97±5.29 ms 17.12 21.30 22.11 17.03 25.38 30.74 19.03 19.88 14.23 13.13 24.97 26.68 
Phase 1 13.49±4.79 ms 19.27 18.90 11.85 12.98 19.31 10.01 11.16 18.09 7.60 6.11 9.71 16.83 
Phase 2 39.23±3.59 ms 39.93 38.21 41.13 44.47 34.66 43.33 42.60 41.58 38.18 33.98 38.50 34.19 
Phase 3 28.21±7.6 ms 17.23 28.26 37.10 28.07 23.68 34.04 22.68 27.93 14.13 34.31 37.61 33.44 
Phase 4 23.13±10.34 ms 38.59 11.24 18.51 14.01 31.68 16.42 38.45 12.96 35.27 13.82 23.90 22.72 
Post VM 21.13±1.12 ms 21.39 21.16 21.53 20.63 18.44 21.43 23.36 20.74 20.49 21.45 21.66 21.34 
R
M
S
S
D
 
Baseline 29.75±7.4 ms 24.44 30.41 31.57 24.31 34.04 43.87 27.16 28.38 20.32 18.74 35.64 38.08 
Phase 1 17.96±9.96 ms 27.11 28.80 13.92 16.95 33.29 9.68 13.51 29.57 7.00 3.52 9.85 22.32 
Phase 2 24.8±7.34 ms 23.76 15.55 25.89 19.53 24.10 22.83 28.86 18.59 18.04 18.59 34.40 35.45 
Phase 3 19.17±6.27 ms 21.26 11.44 19.13 13.43 25.29 17.13 31.11 12.85 14.82 13.95 25.28 24.38 
Phase 4 37.57±7.01 ms 38.15 35.38 41.19 46.52 37.03 44.45 43.10 44.66 34.53 25.36 35.19 25.32 
Post VM 30.5±1.74 ms 29.79 29.93 30.44 28.98 34.87 30.28 32.91 29.35 28.55 30.36 30.57 29.98 
VR 1.41±0.04  1.413 1.405 1.425 1.45 1.361 1.46 1.45 1.44 1.4 1.36 1.4 1.36 
4.5.2 Parameters Estimation for Intra-thoracic Pressure Elevation 
Mathematical models look as a promising tool for evaluating autonomic nervous control 
of blood pressure, heart rate and vascular resistance during each single phase of the Valsalva 
Maneuver. A simple mathematical model for estimating the baroreflex gain during the VM is 
presented in [168], which however does not cover the pulmonary aspect.  Authors of [169] 
and [84] proposed integrated cardiovascular and respiratory models for the VM. Both 
models include multiplicity of mechanisms for simulating hemodynamic response; atrial, 
ventricular and lung mechanics. We adopted a different approach focusing on neural control 
during the model development activities we have performed in Chapter 2. The section 2.8.6 
of that chapter included a model of hemodynamic changes due to intra-thoracic pressure 
elevation. The model parts involved during VM are schematically depicted in Figure 4.20.  
 
 
Figure 4.20 Block diagram describing cardiovascular control during the Valsalva Maneuver 
 
Measured galvanic skin response signal ( measGSR , refer to section 3.1.7) was used to 
approximate measured peripheral vascular resistance at finger site as follows: 
 
,
1
mp meas
meas
R
GSR
=  (4.5.1) 
The model equations were implemented using the Systems Biology Toolbox 2 for Matlab 
[170]. The toolbox calls Matlab ode23s solver for resolving the ordinary differential 
equations. ode23s is a one-step differential equation solver based on a modified Rosenbrock 
formula of order 2 [171].  
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We formulated a weighted least-squares problem minimizing the errors between 
measured data (
,
,meas mp measHR R ) and model outputs ( ,,sim mp simHR R ). The corresponding cost 
function is given as follows.  
 [ ] 22
, ,
1 1,
1 1( ) ( ) ( ) ( )
n n
meas sim mp meas mp sim
i imeas mp meas
J HR i HR i R i R i
n HR n R= =
 = − + − 
⋅ ⋅
∑ ∑ (4.5.2) 
where n  is the number of data points in the time series (value is 600 data points). measHR , 
,mp measR   are mean of values in vectors containing individual heart rate  and peripheral 
vascular resistance values measured during the experiments on a beat-to-beat basis. 
,
,sim mp simHR R are their corresponding simulated values. 
In order to find the parameters values that minimize the cost function J , the Nelder–
Mead algorithm [158] was used for bound-constrained optimization. It is based on cost 
functional evaluations of sequences of downhill simplexes (see section 4.1.4). The model 
includes unknown parameters, which are related to intra-thoracic pressure elevation during 
the VM (see Table 2.5.20 in section 2.8.6). They were estimated for each data set after an 
average of 2983 iterations and 38468 functions evaluations with a final optimal cost function 
value in order of 0.000228002. Mean parameters values are presented in Table 4.5.2 for 12 
data sets obtained from 5 subjects.  
Figure 4.22 and Figure 4.23 show a good fit of model outputs to data obtained from 
individual measurements on one representative 23 years old healthy man. 97.16% and 
97.44% of residuals for heart rate and peripheral vascular resistance resp. are within the 
confidence interval with 95% significance level. The corresponding parameter estimates are 
included in Table 2 under data set 5.  
During Phase I of the maneuver, the gradual increase in intra-thoracic and intra-
abdominal pressure causes aortic and peripheral vessels compression. It follows an increase 
in peripheral resistance resulting in a mild increase in blood pressure from 15th to 16th 
second (see Figure 4.21). 
During Phase II, the sustained high intra-thoracic and intra-abdominal pressure hinders 
venous return, leading to a decrease in cardiac output and consequently a marked decrease 
in arterial systolic pressure from the 16th to the 20th second (see Figure 4.21). This fall in 
arterial pressure is detected by baroreceptors in the carotid artery sinus and aorta. The 
parasympathetic level parT  and sympathetic level symT  were computed as indicated in section 
4.2.1 and 4.2.4 in a range between 0 and 1.   The autonomic response includes an increase of 
sympathetic tone (see Figure 4.24-b) to the heart and vessels as well as a decrease of 
parasympathetic tone (see Figure 4.24-a) in the heart. This causes a reflex tachycardia and 
peripheral vasoconstriction (see increased peripheral vascular resistance in Figure 4.23). The 
sympathetically mediated response results in some rise of arterial blood pressure from 20th 
to 30th second (see Figure 4.21), which however does not overcome the elevated intra-
thoracic pressure. Since the blood pressure is still below the normal level, the baroreflex 
remains active in the whole phase II,  resulting in a continuous  rize of heart rate [172].  
During Phase III, the forced expiration is released, resulting in a decrease in intra-thoracic 
pressure, thus the pressure around the aorta decreases and consequently arterial blood 
pressure slightly decreases from 30th to 31st second (see Figure 4.21). Meanwhile heart rate 
is still elevated.  
During Phase IV, the accumulated venous blood returns to the heart and is pumped into 
the constricted arteries causing an “overshoot” of arterial pressure above the normal level 
 from 31st to 38th second (Figure 4.21). This is detected by the baroreceptors and results in a 
reflex bradycardia. Sympathetic discharge to the heart decreases (see Figure 4.24-b) 
whereas parasympathetic discharge increases (see Figure 4.24-a), causing a decrease of 
heart rate. As result arterial blood pressure returns to normal level. 
 
Table 4.5.2 Estimated values of model parameters for VM 
 
Mean ±STD 
Data 
Set 1 
Data 
Set 2 
Data 
Set 3 
Data 
Set 4 
Data 
Set 5 
Data 
Set 6 
Data 
Set 7 
Data 
Set 8 
Data 
Set 9 
Data 
Set 10 
Data 
Set 11 
Data 
Set 12 
 0.29±0.08 0.36 0.26 0.33 0.29 0.12 0.30 0.42 0.28 0.23 0.26 0.36 0.32 
 0.57±0.12 liter 0.58 0.62 0.46 0.47 0.77 0.49 0.75 0.49 0.73 0.47 0.57 0.44 
 2.49±0.55 sec 2.30 2.91 2.55 2.22 2.82 2.24 2.16 4.01 2.21 2.15 2.25 2.09 
 1.18±0.24 µMho
-1
 1.05 1.06 1.61 1.36 1.02 1.15 1.01 1.71 1.08 1.02 1.04 1.03 
 3.94±1.06 sec 2.40 4.52 4.99 4.43 2.92 4.79 2.41 4.42 2.41 4.90 4.50 4.63 
 2.46±0.6 µMho
-1
 2.05 2.01 2.03 2.47 3.00 2.26 4.05 2.94 2.21 2.06 2.16 2.32 
 3.66±0.91 sec 3.08 4.59 4.73 2.52 2.65 4.67 2.49 3.61 3.21 4.76 4.36 3.22 
 3.06±0.08 µMho
-1
 3.03 3.00 3.02 3.00 3.01 3.05 3.23 3.01 3.05 3.02 3.22 3.05 
 2.24±0.21 2.29 2.30 2.31 2.25 1.57 2.31 2.31 2.29 2.35 2.31 2.30 2.24 
 
 
Figure 4.21 Mean arterial pressure (plain line) and heart rate (dashed line) changes during the VM 
The maneuver covers the timeline from the 15th  to the 30th second. Phase I goes from 15th to 16th second, 
phase II ends at 30th second, followed by phase III. The last phase IV runs from 31st to 38th second. 
 
Figure 4.22 Heart rate change during VM 
(a) predicted value (dashed line) and experimental data (plain line) shows a 97.16% good fit (b) 
  
Figure 4.23 Changes in peripheral vascular resistance during VM 
(a) predicted value (dashed line) and experimental data (plain line) shows a 97.44% good fit (b) 
 
 
 
Figure 4.24 Predicted parasympathetic (a) and sympathetic (b) activity during VM 
Y-axis is normalized in the interval [0 .. 1] in dimensionless unit 
The maneuver was performed on a 23 years old healthy man and covers the timeline from the 15
th
  to the 30
th 
second. Phase I is characterized by slight increase of parasympathetic activity from 15
th
 to 18
th
 second; there is 
baroreflex mediated parasympathetic withdrawal and increased sympathetic tone in phase II until 30
th
 second. 
Bradycardia characterizes phase IV which runs from 33
rd
 to 36
th
 second. Sympathetic activity is reduced in phase IV 
in order to compensate arterial pressure overshot. 
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4.5.3 Model-based Estimates of Autonomic Tones 
As an alternative to heart rate variability we defined some markers of autonomic activity 
during the Valsalva Maneuver. The first class of model-based estimate is the so-called Mean 
Autonomic Tone (MAT) which is calculated as the average parasympathetic or sympathetic 
tone for a given phase of the Valsalva Maneuver using the formulas below. The index i  
represents the phase of the maneuver which can be baseline (i.e. before the maneuver), 
phase 1, phase 2, phase 3, phase 4 and post VM (i.e. after the maneuver). { }parT i  is the 
portion of the parasympathetic signal corresponding to the phase i . { }symT i  is the portion of 
the sympathetic signal corresponding to the phase .   parMAT  and symMAT  are the average 
parasympathetic tone and  average sympathetic tone in the phase  respectively. 
 
{ }( )
{ }( )
( )
( )
par par
sym sym
MAT i mean T i
MAT i mean T i
=
=
 (4.5.3) 
A second class of model-based estimate is the so-called Total Autonomic Tone (TAT) 
which is calculated as the sum of all individual tones within the portion of parasympathetic 
or sympathetic signal for a given phase using the following formulas. 
 
{ }( )
{ }( )
( )
( )
par par
sym sym
TAT i sum T i
TAT i sum T i
=
=
 (4.5.4) 
The third and fourth classes of model-based estimates are the so-called Minimal 
Autonomic Tone (MIAT) and Maximal Autonomic Tone (MAAT) which are calculated 
respectively as the minimum and maximum tone within the portion of parasympathetic or 
sympathetic signal for a given phase using the following formulas.  
 
{ }( )
{ }( )
{ }( )
{ }( )
( )
( )
( )
( )
par par
sym sym
par par
sym sym
MIAT i min T i
MIAT i min T i
MAAT i max T i
MAAT i max T i
=
=
=
=
 (4.5.5) 
The last class of model-based estimate is the so-called Autonomic Tone Balance (ATB) 
which is calculated as the ratio of total sympathetic tone over total parasympathetic tone for 
a given phase using the following formulas.  
 
( )( ) ( )
sym
par
TAT i
ATB i
TAT i
=  (4.5.6) 
The model-based estimates of autonomic nervous activity were calculated for each data 
set and each phase of the Valsalva Maneuver. We therefore obtained 12 values per phase 
for each model-based estimate.  
The mean values of parMAT , symMAT , parTAT , symTAT  and ATB  for all subjects are 
reported in Table 4.5.3 in dimensionless units. The Mean Autonomic Tone for 
parasympathetic activity parMAT  decreases from its baseline value 0.872±0.032 down to 
0.386±0.227 in phase 3, indicating a baroreflex-mediated withdrawal of parasympathetic 
activity. In the bradycardia phase 4, parMAT  increases to the average value 0.674±0.296. 
Heart rate increase during phase 2 is mostly due to higher balance between parasympathetic 
and sympathetic tone. This is reflected in the value of Autonomic Tone Balance ATB , which 
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increases by 500% from  its baseline value 0.065 to 0.378 in phase 2. Mean sympathetic 
activity is the highest in the phase 2 when baroreflex attempts to compensate arterial 
pressure fall. This is reflected in the increase of Mean Autonomic Tone for sympathetic 
activity 
symMAT  from 0.057±0.018 to 0.256±0.087. 
Table 4.5.4 shows model-based estimates for maximal and minimal autonomic tones 
which were calculated for a 23 years old healthy man based on data set 5. The Maximal 
Autonomic Tone of parasympathetic activity parMAAT  obtained in phase 4 was found to be 
equal 0.835 whereas Maximal Autonomic Tone of sympathetic activity equals only 0.128 in 
that phase.  Sympathetic activation in phase 2 was promoted by a decrease of 
parasympathetic activity down to a Minimal Autonomic Tone parMIAT  equals 0.102.   
We investigated possible correlations between time-domain indexes of heart rate 
variability and the model-based estimates proposed in this work. Results are presented in 
Figure 4.25. Some correlations were found between the standard deviation of NN intervals 
(SDNN) and the total autonomic tone (TAT , defined as sum of parTAT  and symTAT ). When 
moving from phase 1 to phase 2, SDNN increases by 79% while TAT  increases by 400% (see 
Figure 4.25-a). Both quantities are correlated in the same direction, but with different 
extent. The amplitude of SDNN change is small compared to TAT  because the later is a 
cumulative variable depending on the duration of the phase while SDNN is a cumulative 
mean value. A similar correlation is observed when moving from phase 3 to phase 4; where 
SDNN decreases by 33% while TAT  decreases by 80%. Both SDNN and TAT  reflect the 
overall heart rate variability; they however have the disadvantage to increase with the 
length of recording.  TAT  can be used as alternative to SDNN when the length of recording 
is less than one minute. 
A stronger correlation was found between SDNN and the autonomic tone balance ( ATB
). As shown in Figure 4.25-b SDNN and ATB  increase by resp. 79% and 84% from phase 1 to 
phase 2. Both quantities respectively decrease by 33% and 23% from phase 3 to phase 4. 
ATB  does not depend on the duration of recording because it is a ratio between parTAT  
and 
symTAT .  Since ATB  shows a stronger correlation with SDNN and is moreover 
independent of the length of recording, it is a good candidate for duration-independent 
measure of overall heart rate variability during the Valsalva Maneuver. 
Another correlation was found between the square root of the mean squared differences 
of successive NN intervals (RMSSD) and mean autonomic tone of parasympathetic activity (
parMAT ).Figure 4.25-c shows 28% RMSSD decrease corresponding to 12% decrease for  
parMAT  from phase 1 to phase 2. RMSSD increases by 48% from phase 3 to phase 4 whereas 
parMAT  increases by 19%. This correlation suggests that parMAT  might be used as a 
quantitative marker of parasympathetic activity as an alternative to RMSSD. 
These results do not to emphasize on correlations between our model-based estimates 
and HRV parameters, they rather demonstrate that our method is more reliable in the 
special case of very short ECG recordings (e.g. 15 seconds). 
 (a)
(c)
Figure 4.25 Correlation between time
Y-axis for model-based estimates is normalized in the interval [0 .. 1] in dimensionless unit.
 (a) SDNN (standard deviation of NN intervals
from phase 1 to phase 2 and from phase 3 to phase 4. (b) SDNN 
(autonomic tone balance) from phase 1 to phase 2 and from phase 2 to phase 4. (c) RMSSD (
differences of successive NN intervals
parasympathetic activity). ATB
Table 4.5.3  Mean values of model-based estimates of autonomic tone
unit
 
Mean Autonomic Tone
 
parMAT  MAT
Baseline 0.872±0.032 
Phase 1 0.880±0.033 
Phase 2 0.595±0.052 
Phase 3 0.386±0.227 
Phase 4 0.674±0.296 
Post VM 0.877±0.036 
Table 4.5.4 Model-based estimates for minimal and maximal autonomic tone
dimensionless 
 
Minimum Autonomic Tone
 
Baseline 
Phase 1 
Phase 2 
Phase 3 
Phase 4 
Post VM 
   (b)
 
-domain indexes of HRV and model-based estimates
 in milliseconds) is correlated with TAT  (total autonomic tone) 
is additionally correlated with 
 in milliseconds) is correlated with parMAT  (mean autonomic tone
 and parMAT  
were amplified by a factor of 100 for graphical presentation.
 
 (normalized in the interval [0 .. 1] in dimensionless 
) obtained from five healthy subjects during VM 
 Total Autonomic Tone 
Autonomic Tone Balance
ATB
sym  parTAT  symTAT  
0.057±0.018 13.086±0.475 0.856±0.275 0.065
0.054±0.018 2.270±0.479 0.137±0.054 0.060
0.256±0.087 7.501±0.645 2.833±0.744 0.378
0.254±0.146 1.451±0.945 0.961±0.624 0.662
0.137±0.136 2.913±0.796 0.437±0.334 0.150
0.050±0.027 20.25±1.425 1.171±0.662 0.058
 
 (normalized in the interval [0 .. 1] in 
unit) obtained on a 25 years old healthy man 
 Maximum Autonomic Tone 
parMIAT  symMIAT  parMAAT  symMAAT  
0.777 0.08 0.833 0.111 
0.791 0.098 0.800 0.103 
0.676 0.102 0.793 0.172 
0.677 0.128 0.747 0.171 
0.747 0.079 0.835 0.128 
0.800 0.079 0.835 0.098 
   
 
 
ATB  
mean squared 
 for 
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4.6 Sensitivity Analysis 
While parameter estimation assumes the availability of reliable experimental data, this is 
not the case in reality. Experiments are not perfect and measurements are always 
deteriorated by noise. In further steps the following question should be answered: is the 
quality of the measurement data sufficient for identifying the model parameters? This 
includes computing the confidence region of the parameter estimates, computing how 
sensitive model outputs are when inputs change or computing how sensitive outputs are 
when parameters change. This information gives feedback on the experimental condition 
and helps adjusting elements such as frequency of measurements and duration of 
experiments. This is generally called Optimal Experimental Design problem. Local sensitivity 
analysis can be performed by direct differentiation of model output with respect to the 
parameter of interest. The direct differentiation method is only possible when the model 
equations are available in an analytical form. Otherwise it is preferable to use the numerical 
integration method. [173] 
Our model is rather complex and includes a large amount of differential equations 
relating 33 model parameters to 4 model outputs. Direct differentiation would imply a lot of 
error prone manual calculations since the Matlab Simulink environment does not offer ways 
to partially derivate model outputs automatically. The same difficulty is encountered with 
numerical integration.  Under the assumption that all parameters behave like a Gaussian 
random variable, sensitivity analysis can be performed by varying the values of a given 
parameter with a known variance; and calculating the variance of the mean value of each 
model output. A similar approach has held good results in [174]. We compute the sensitivity 
of each model output Y  with regards to a given parameter k  by determining how much 
variance the parameter produces in a significant statistic 
,jk stat
Y  of model output Y . We 
choose the following four statistics and subdivide the parameters in four groups accordingly: 
parameters that affect mean values of model outputs form group 1, parameters that affect 
low frequency fluctuations in model outputs are in group 2, parameters that affect high 
frequency fluctuations in model outputs form group 3 and those that affect the difference 
between mean value of model output before and during experimental stimulation are in 
group 4. An overview of the parameter groups and model outputs is given in Table 4.6.1.  
Parameters related to intra-thoracic pressure elevation were not included for simplicity.  
For group 1, sensibility is calculated from the variance of the mean values of model 
outputs. For group 2, sensibility is calculated from the variance of low frequency 
components of model outputs, measured in absolute value of power. For group 3, sensibility 
is calculated from the variance of high frequency components of model outputs, measured 
in absolute value of power. For group 4, sensibility is calculated from the variance of the 
differences between mean values of model outputs before the stimuli and after the stimuli. 
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Let’s consider k  a model parameter bounded in the interval maxmink …k  , Y  a model 
output and f  a function representing our model. The sensitivity of model output Y  with 
regards to model parameter k  is denoted 
,Y kS and is calculated as follows: 
For each 
,k iV  in the interval [ ]min maxk …2 k⋅  
 Generate a random set of 10 real numbers in the interval [ ]min maxk …k  with variance ,k iV  
 For each jk in the random set 
  Calculate model output ( )
jk jY f k=   
If k  is member of Parameter Group 1 
Calculate 
,jk stat
Y  as mean value of model output 
End If 
If k  is member of Parameter Group 2 
Calculate 
,jk stat
Y  as low frequency components measured in absolute values of power 
End If 
If k  is member of Parameter Group 3 
Calculate 
,jk stat
Y  as high frequency components measured in absolute values of power 
End If 
If k  is member of Parameter Group 4 
Calculate 
,jk stat
Y  as difference between mean value of model output before and during the 
stimuli  
  End If    
End For 
 Determine the variance of model outputs 
, ,jY i k stat j=1…10V = variance(Y )  
Store the variances 
, ,
( ,1)Y k k iS i V=  and  , ,( , 2)Y k Y iS i V=  
End For 
Return the sensitivity matrix 
,Y kS  where ,k iV  is the first column and ,Y iV  is the second column 
In order to illustrate how the algorithm works, let’s consider ev,0,maxk f= , the model 
parameter representing parasympathetic tone, bounded in the interval 
[ ] [ ]min maxk …k 1…20= . We are interested in calculating the sensitivity , ev,0,maxHR fS  of model 
output HR  (heart rate) with regards to ev,0,maxf . For each ,ev,0,maxf iV  in the interval 
[ ] [ ]min maxk …2 k = 1…40⋅ , the algorithm chooses a random set of 10 real numbers in the 
interval [ ]1…20  with variance 
,ev,0,maxf iV . For example if ev,0,maxf ,iV = 4.53 , then the random set 
could be { }7.54,6.76,9.24,9.83,8.58,6.69,7.14,10.06,11.87,4.4551 . For each jev,0,maxf  in the 
random set, the algorithm simulates the model and calculates the mean value of simulated 
heart rate 
,ev,0,max jf stat
HR . After the mean value of heart rate has been obtained for all 
jev,0,max
f  
in the random set, the algorithm computes the variance of the mean values as 
,HR iV , which is 
equal to 1.85  in the case of 
ev,0,maxf ,iV = 4.53 . By repeating the process, we obtain an output 
variance 
,HR iV  for each parameter variance  ,ev,0,maxf iV . The set of such couples forms the 
sensitivity of  HR  (heart rate) with regards to ev,0,maxf (parasympathetic tone), as shown in 
the table attached to Figure 4.26.  
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Table 4.6.1 Sensitivity degrees of model outputs with regards to parameters (≥ 1 means 
high sensitivity, 0 means no sensitivity) 
Group Name Description HR  QT  
as
P  mpG  
Overall 
Sensitivity 
Group 1 –
Parameters with 
mean effect 
,0,es highf  firing rate of pacemaker sympathetic premotor neurons 0.0035 0.2312 0.0494 0.1618 0.4459 
, ,0c esW  
synaptic weight applied to sensory inputs from chemoreceptors 0.0065 1 1 1 3.0065 
ev,0,maxf  
parasympathetic tone (maximal intrinsic firing rate of vagal 
nerves) 
0.2255 0.1444 0.1839 0.0011 0.5549 
,nor vog
k
 
modulation factor of vagally-mediated tachycardia  1 0.0342 0.6975 0.0037 1.7354 
QTk
 
gain of elastance on QT interval duration 0 0.1592 0 0 0.1592 
mpG
k
 
gain parameter applied to peripheral vascular resistance in 
skeletal muscles 
0 0 0 0.7191 0.7191 
Group 2 - 
Parameters with 
low frequency 
fluctuation 
effect 
es,0,lowW  
synaptic weight applied to low frequency oscillators in 
sympathetic premotor neurons 0.5875 0.2396 0.9856 0.1077 
1.9204 
es,0,lowr  parameters determining the rate of low frequency oscillators in 
sympathetic premotor neurons 
0.6905 0.4148 0 0.6456 1.7509 
es,0,lowk  0 0 0.0001 0 0.0001 
Group 3 - 
Parameters with 
high frequency 
fluctuation 
effect 
resp,vW  
synaptic weight applied to inputs from inspiratory-expiratory 
somatic motor neurons 0 0.996 0.0037 0.0014 
1.0011 
rsa
f
 
frequency of intracardiac high frequency fluctuations 1.2189 0.0046 0.0013 0.0037 1.2285 
rsaT
G  gain of intracardiac high frequency fluctuations 0.0002 0.0203 0.3696 0.4297 0.8198 
Group 4 - 
Parameters 
related to 
external stimuli 
fat ,max
f  upper saturation of facial cold receptor 0.0959 0.139 0.6185 0.2418 1.0952 
fat
k  slope of the exponential decay of cold receptor on face 0.046 0.0009 0.0808 0.0762 0.2039 
sat ,max
f  upper saturation of cold receptor on hands and feet 0.528 0.7791 0.4236 0.7146 2.4453 
sat
k
 
slope of the sigmoid response of cold receptor on hands and feet 0.0022 0.0283 0.0264 0.0307 0.0876 
as,maxf  upper saturation of mental stress sensors 0.3079 0.2631 0.2149 0.1815 0.9674 
ask  slope of the mental stress sensor response 0.1263 0.1333 0.1417 0.1403 0.5416 
ss,maxg  
maximal value of effects due to gravitational forces during active 
standing from sitting 0.0004 0 0.0016 0 
0.002 
ssk  
slope of the heart rate response during active standing from 
sitting 0.0202 0.0001 0.2554 0.0003 
0.276 
tt,maxg  
maximal value of effects due to gravitational forces during head-
up tilt 0.0056 0.0001 0.0622 0 
0.0679 
ttk  slope of the heart rate response during head-up tilt 0.0012 0 0.2329 0 0.2341 
ao,maxf  upper saturation of oculo-pressure receptor 0.0517 0.0055 0.0067 0 0.0639 
aok  slope of the sigmoid response of oculo-pressure receptor 0 0.0033 0.006 0.0002 0.0094 
 
  
,ev,0,maxf iV  ,HR iV  
 
0.59 0.51 
4.53 1.85 
6.35 2.70 
6.58 3.50 
7.63 3.49 
9.74 4.85 
10.82 6.68 
12.21 5.91 
21.86 10.29 
27.95 14.47 
37.63 18.35 
Figure 4.26 Sensitivity of heart rate with regards to parasympathetic tone 
 
The plot in Figure 4.26 shows that the more we vary model parameter ev,0,maxf  , the more 
model output HR  varies in the same direction. In other terms, heart rate is sensitive to 
changes in model parameter representing parasympathetic tone. 
In order to assess the degree of sensitivity for each of the four groups of parameters, we 
normalized each axis of plots like the one obtained in Figure 4.26 in a scale between 0 and 1 
by dividing the values over the maximal variance. After fitting the resulting plot to a 
polynomial of order 1, we calculate the slope of the line as  degree of sensitivity, which tells 
us in which extent the model output is sensitive to the given model parameter. Figure 4.27 
shows results obtained for heart rate and parameters which affect its mean value (i.e. Group 
1). While mean heart rate is very sensitive to modulation factor of vagally-mediated 
tachycardia (
,nor vog
k ) and parasympathetic tone ( ev,0,maxf ) with degree of sensitivity equal to 1 
and 0.2255 respectively; varying the parameters 
,0,es highf , , ,0c esW , QTk , mpGk  has almost no 
effect on mean heart rate; degree of sensitivity was 0.0035, 0.0065, 0 and 0 respectively. 
The same procedure was applied for calculating the degree of sensitivity of remaining model 
outputs QT (QT interval duration), asP  (arterial blood pressure) and mpG (level of galvanic 
skin response). The obtained degrees of sensitivity are reported in Table 4.6.1. While model 
parameter 
, ,0c esW  does not affect heart rate; QT , asP  and mpG are highly sensitive to its 
values (degree of sensitivity was 1). For each parameter we additionally calculate the overall 
sensitivity as sum of individual degrees of sensitivity obtained from all model outputs. This 
allowed us to rank parameters globally from the most sensitive to the less sensitive: 
, ,0c esW  
was the parameter with the greatest overall sensitivity (=3.0065) whereas  
es,0,lowk   was 
almost not sensitive (overall sensitivity = 0.0001) to any model output and we might 
consider transforming it into a model constant. The overall sensitivity is reported in Table 
4.6.1 as well. Details about how model outputs vary when parameters vary can be verified in 
Figure 4.27 to Figure 4.42, for each parameters group.  
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Figure 4.27 Sensitivity of heart rate with regards to parameters from Group 1 
 
 
Figure 4.28 Sensitivity of heart rate with regards to parameters from Group 2 
 
 
Figure 4.29 Sensitivity of heart rate with regards to parameters from Group 3 
 
 
Figure 4.30 Sensitivity of heart rate with regards to parameters from Group 4 
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Figure 4.31 Sensitivity of QT interval with regards to parameters from Group 1 
 
 
Figure 4.32 Sensitivity of QT interval with regards to parameters from Group 2 
 
 
Figure 4.33 Sensitivity of QT interval with regards to parameters from Group 3 
 
 
Figure 4.34 Sensitivity of QT interval with regards to parameters from Group 4 
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Figure 4.35 Sensitivity of arterial blood pressure with regards to parameters from Group 1 
 
 
Figure 4.36 Sensitivity of arterial blood pressure with regards to parameters from Group 2 
 
 
Figure 4.37 Sensitivity of arterial blood pressure with regards to parameters from Group 3 
 
 
Figure 4.38 Sensitivity of arterial blood pressure with regards to parameters from Group 4 
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Figure 4.39 Sensitivity of galvanic skin response with regards to parameters from Group 1 
 
 
Figure 4.40 Sensitivity of galvanic skin response with regards to parameters from Group 2 
 
 
Figure 4.41 Sensitivity of galvanic skin response with regards to parameters from Group 3 
 
 
Figure 4.42 Sensitivity of galvanic skin response with regards to parameters from Group 4 
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4.7 Conclusion 
Our main contribution lies in the development of an integrative model for cardiovascular 
control activity in Chapter 2, and its validation with non-invasive in-vivo data (human and 
equine, see Chapter 3) and optimization methods as outlined in this Chapter 4.  
Results bring supporting evidences that Mayer waves result from a rhythmic sympathetic 
discharge of pacemaker-like sympathetic premotor neurons. We show that vagally-mediated 
tachycardia could be related to the secretion of vasoactive neurotransmitters by the vagal 
nerve. We could quantify the resting sympathetic and parasympathetic tone separately; and 
demonstrate correlation with aging and gender. Our method appeared to provide more 
consistent results than heart rate variability during short-term cardiovascular control in a 
timeframe up to 30 seconds. 
Conclusions include the selection of specific integrative model parameters for their ability 
to provide quantitative analysis of cardiovascular control. Conclusions from the in-vivo 
experimentation show that the models do allow trend and behavioral effects to be modeled. 
A subsidiary contribution with a more practical bent of pattern recognition and feature 
extraction for telemedicine and biofeedback will be presented in the next Chapter 5. 
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Chapter 5. Perspectives for Application in Research and 
Clinical Environments 
We have proposed methods for quantitatively assess autonomic nervous activity on 
cardiovascular system in the previous chapters. Experimental arrangements were performed 
and obtained data were used to fit our integrative model of cardiovascular control. This 
allowed us to estimate sympathetic and parasympathetic tones of individual subjects. 
Features related to gender, age and disease state were highlighted. In this chapter we 
demonstrate how the model could be used to simulate and generate cardiovascular signals 
when common experimental setups do not allow them to be measured noninvasively. We 
will also open some perspectives for clinical application of the results and present a software 
package that was developed in the frame of this research.  
5.1 Generation of Training Data for Artificial Neural Networks 
Measuring the tonic level of parasympathetic activity delivered by the brain to the heart 
is a very delicate operation in laboratory on animals, involving identifying the vagus nerve 
and placing electrodes. Muscle sympathetic nerve activity might be easier to record using 
microneurographic technique, which involves inserting tungsten microelectrodes 
pericutaneously into sympathetic fascicles in the peroneal nerve and recording multiunit 
sympathetic nerve discharge. A prominent study was made in [44] where preganglionic 
sympathetic neural discharge was recorded from third left thoracic sympathetic ramus 
communicans, and efferent vagal neural discharge was simultaneously recorded from left 
cervical vagus in an artificially ventilated decerebrate cat. Such recordings are very rare on 
animals and difficult to realize on humans.  
The lack of experimental data has put the emphasis on developing methods for predicting 
the behavior of sympathetic and parasympathetic nerves using data which are available non-
invasively such as the Electrocardiogram (ECG). We developed such methods based on the 
model of cardiovascular control presented in Chapter 2 and used optimization methods to fit 
experimental data and estimated the level of activity of both sympathetic and 
parasympathetic branches in Chapter 4.  In this section, both estimated signals are further 
used to train artificial neural networks that are capable of combining the information 
obtained from the recorded physiological signal with the information derived from 
mathematical models. Artificial Neural Networks (ANN) have shown great performance in 
identifying hidden relationships between data [175] [176] and approximation of functions 
[177]. Biologically inspired neural nets have been applied to model the baroreceptor reflex 
responsible for the short-term blood pressure regulation [178]. Classifiers were applied to 
risk stratification in hypertension [179]. 
5.1.1 ANN for Estimating Autonomic Tone during Orthostatic Stress 
We published results presented in this section in [180]. Postural change from a lying 
position to an upright posture causes decrease of arterial blood pressure and triggers the 
baroreflex. Experiments were performed using a tilt table during heart rate, pulse and 
galvanic skin response recording, as described in section 3.7.2. 
We used the software Statistica Neural Networks to investigate multi-layer perceptrons 
(MLP). The selected MLP neural network (see Figure 5.1) has two hidden layers with 27 and 
9 nodes, three inputs and three outputs. The inputs to the network are measured heart rate 
in beats/min., measured mean arterial blood pressure in mmHg and measured galvanic skin 
response in μMho. The outputs from the MLP are simulated heart rate in beats/min., 
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 information for predicting the health status and sex. The classifier was able to assign the 
right health status to unknown patients based on the corresponding estimated values of 
model parameters. More difficult task was the prediction of age and weight. In both cases 
the MLP has been employed as a regression model. After training the ANN responded 
correctly from the view of an order of values of the output values but incorrectly from the 
viewpoint of absolute values. Even so the network proved importance to give correct trends 
and interpretable results. 
 
Figure 5.3 Galvanic skin response during orthostatic stress 
 
Figure 5.4 Mean heart rate response during orthostatic stress 
 
Figure 5.5 Mean parasympathetic and sympathetic tone 
Y-axis is normalized in the interval [0 .. 1] in dimensionless unit 
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 5.1.2 ANN for Estimating Parasympathetic Level during Cold Face Test 
We submitted results presented in this section as journal publication in [181]. Most 
results were published within a Master thesis [182] under our supervision.  The intellectual 
contribution of the thesis was the architecture of the ANNs and the implementation of the 
software tool in Matlab. 
The estimated parasympathetic level (PL) obtained via model fitting to data recorded in 
experiments with cold stimuli (as described in section 4.2.1) was used as training set for 
multi-layer perceptrons (MLP). Experimental data were recorded during the cold face test 
(CFT), which is a non-invasive clinical test known to inhibit sympathetic efferent activity to 
the sinoatrial node and enhance parasympathetic activity [183] [125]. Because the response 
to CFT on heart rate is exclusively parasympathetic, it offers a suitable experimental setup 
for gathering training data for our MLPs. Results include a software tool for simulating the 
networks and displaying the PL together with an estimate of cardiac health status in 
response to the CFT. 
The cold face test was performed as described in section 3.2. Additionally a standard 
clinical check of cardiovascular autonomic function was performed by physicians on each 
subject. Cuff blood pressure was measured; heart and thorax sounds were consulted; clinical 
signs were observed. Furthermore subjects underwent basic cardiac autonomic tests 
including Valsalva Maneuver, cold pressor test, active standing, deep breathing test and 
oculocardiac reflex test. The physician evaluated all results and assigned a health status 
score to the subject, 10 being perfect health of cardiac autonomic control and 1 being total 
insufficiency. The data was saved in a table with two columns, the first showing the ID of the 
subject and the second his health status score. 
The response to cold face test can be strongly modulated by factors related to the 
emotional state of the subject. The emotional perception or level of discomfort was 
provided by the subject and added as input for the network on a range from 0 to 5. Strong 
pain (e.g. headache) causing abrupt interruption of the experiment corresponds to score 5, 
localized intense but sustainable pain corresponds to score 4, localized mild pain 
corresponds to score 3, fear sensation corresponds to score 2, calmness corresponds to 
score 1 and total comfort corresponds to score 0. The data was saved in a table with two 
columns, the first showing the ID of the subject and the second his emotional factor. 
 
Figure 5.6 Architecture of the ANN-based evaluation of CFT response 
In order to make use of features of artificial neural networks for quantitative assessment 
of parasympathetic level we developed a solution whose architecture is depicted in Figure 
5.6.  We distinguish two main components, a first one for signal processing (Process ECG) 
and a second one for ANN simulation (Process CFT). 
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The entry of Process ECG is the ECG signal recorded during the cold face test. This 
component is responsible for signal processing and extraction of the time series preNN , testNN ,
preHR  and testHR . preHR  and testHR  are further used as input of the inputs of Process CFT 
component. A MLP artificial network ANN1 uses the inputs and estimates the corresponding 
parasympathetic time series PL . ANN1 also returns a prediction of heart rate time course 
during CFT which is further compared to the measured values in order to compute a 
percentage of confidence (%confidence ) telling how much error was made by ANN1  when 
estimating testHR .  ANN1 additionally predicts the emotional factor ( _Emotional Factor ) of the 
subject according to modulations of his response to CFT by emotional factors such as fear 
and pain. A second MLP artificial neural network ANN2 is designed to predict the patient’s 
health status. It takes as input, the parasympathetic level and predicts the health status (
_Health Status ) in a normalized on a scale of 1 to 10. Units for both ANN1 and ANN2 are 
threshold units which use a sigmoid as activation function. It is non polynomial and is 
therefore suitable to our case since Multi Layer Perceptrons with non polynomial activation 
function are theoretically able to approximation any function. [22].  Process CFT also 
produces the rate of decrease of the heart rate ( DELTA , also called fallHR ) during the cold 
face test, calculated according to equation (4.3.1) from section 4.3.1. 
After processing experimental data we obtained time series for preHR  and testHR  as well two 
tables containing the _Health Status  and _Emotional Factor . Our model of cardiovascular 
control (presented in Chapter 2) was fit to each heart rate signal and the estimated level of 
parasympathetic activity prePL  and testPL  was also used as training data for the networks. 
We investigated Multi-Layer Perceptrons using the Neural Networks Toolbox version 5.1 
of Matlab version 7.1. For ANN1 several tests have been achieved on different MLP with 
three layers, 120 inputs and 181 outputs and the results were not satisfactory due to the big 
sizes of ANN. We therefore decided to normalize the durations of cold stimulus to 20 
seconds, 30 seconds, 40 seconds and 60 seconds. Thus we obtained 4 groups of training data 
for precisely 4 ANNs which were mounted into the final network. The structure of networks 
for ANN1 was (20-35-31), i.e. 20 neurons in the input layer, 35 neurons in the hidden layer 
and 31 neurons in the output layer. The sizes of input and output layers were determined by 
the number of variables from which the model is expected to establish. The number of the 
hidden neurons was randomly chosen, as we cannot explain, but this number relatively 
provides satisfaction. Similiarly the structures of ANN2 having presented the best 
performance had 2 neurons in the input layer, 27 neurons in the hidden layer and 1 neuron 
in the output layer. The inputs were reduced to ( )premean PL  and ( )testmean PL . 
The evaluation of the ANN was done by Holdout [184]. The holdout consists of randomly 
dividing the original pattern set into three disjoint sets: training (60%), validation (20%) and 
test set (20%). The validation of the ANN was done during each iteration of the training. It 
told if the ANN was converging to minimal error. The test set was used to estimate the 
confidence of the network ( %confidence ). Performance of the network measured by cross-
validation [184] using the coefficient of correlation of Pearson (~ 0.98) , the number of 
iterations (~ 38), the retained gradient error (~ 5.9e−4) and the absolute mean square error 
(~ 4.31e −5) shows a rapid convergence to the solution.  
 A ratio between the parasympathetic level returned by the artificial neural networks for 
the period before and during the cold face test was calculated as indicator of 
parasympathetic response in percentage as follows. 
 test
ratio
pre
mean(PL )
PL = 100 - 1
mean(PL )
⋅
 
 
 
 (5.1.1) 
Overall results from trained ANN show a mean increase of PL during the cold face test by 
43% (
ratioPL ) from baseline value 0.472±0.275, which agrees with a mean increase of RMSSD 
by 45% (
ratioRMSSD ) from baseline value 8.75±5.10. Table 5.1.1 shows the results obtained for 
8 representative subjects. PL increased only by 8% for hypertensive subjects (from 0.76 to 
0.83) obviously because this condition is characterized by higher sympathetic activity. HRV 
was surprisingly higher for those subjects (RMSSD increased by 46% from 15.01 to 21.97) 
suggesting that RMSSD unfortunately also includes fluctuations due to sympathetic activity. 
Subjects with cardiac insufficiency had the lowest increase of PL (only 4%) suggesting a 
parasympathetic impairment. A similar response was also observed on subjects with 
palpitation. Subject with hepatitis had low resting PL (0.15), but the response to CFT was 
significant (PL increased by 48%).  Young subjects had a higher parasympathetic response 
(heart rate dropped by 33% from 72±8 bpm) than older subjects (heart rate dropped by 18% 
from 76±13 bpm). Figure 5.7 shows how parasympathetic level was changing during CFT for 
a 17 years old female subject (n=17). 
Table 5.1.1 Statistical analysis of HRV parameter and parasympathetic level obtained from ANNs 
Subject Baseline Cold Face Test Ratio 
n 
Sex Age 
years 
Health Status HR 
beats/min 
RMSSD 
ms 
PL 
n.u 
HR 
beats/min 
RMSSD 
ms 
PL 
n.u 
HRratio 
% 
RMSSDratio 
% 
PLratio 
% 
4 F 50 Healthy 68 11.45 0.64 54 17.67 0.92 20% 54% 44% 
5 M 51 Hepatitis B 91 2.15 0.15 83 3.40 0.22 10% 58% 48% 
6 M 54 Healthy 89 2.59 0.18 57 20.12 0.35 36% 676% 94% 
16 F 50 Hypertension 66 15.01 0.76 54 21.97 0.83 18% 46% 8% 
20 F 70 Cardiac insufficiency 61 7.34 0.84 54 8.43 0.87 12% 14% 4% 
26 F 43 Palpitation 86 3.94 0.37 75 4.29 0.47 12% 9% 28% 
31 M 23 Healthy 66 12.64 0.26 48 23.80 0.81 29% 88% 206% 
32 F 17 Healthy 78 14.18 0.37 50 34.42 0.64 36% 142% 73% 
 
 
Figure 5.7 Estimated parasympathetic level during CFT 
measurements were performed on subject with ID n=32 
cold stimuli was applied from 40
th
 to 80
th
 sec 
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 We developed a Matlab software tool offering a user interface (see Figure 5.8) for loading 
an ECG signal which was recorded during the cold face test in ASCII format and entering the 
sampling frequency. The user can additionally enter the starting timestamp of the cold face 
test as well as its duration. The tool automatically detects QRS complexes, performs 
smoothing, filtering and generates NN intervals HR time series. The software tool simulates 
the artificial neural networks and estimates the parasympathetic level, ratio of heart rate 
decrease and health status of the subject. The software offers some plotting tools for the 
visualization of heart rate and parasympathetic level time course.  
 
Figure 5.8 User interface of the Matlab software tool for CFT evaluation using ANNs 
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5.2 A Telemedicine Platform for Cardiology 
5.2.1 Background 
We published parts of results presented in this section in [185] [186]. The software was 
partly developed within two Bachelor Theses [187] [188] under our supervision. The 
intellectual contribution of the theses was within software architecture and coding. 
Several studies have linked some patterns of variability to pathological states of the 
cardiovascular system. Cardiovascular autonomic dysfunction may result in substantial 
disability, morbidity and even death [189].  The features include orthostatic hypotension, 
baroreflex failure, cardiac arrhythmias, poor exercise tolerance, infarction and sudden 
death.  Diabetic autonomic neuropathy is known to be the most common autonomic 
neuropathy in the majority of industrialized countries. Myocardium infarction is another 
leading cause of death worldwide.  
Monitoring patients is a very important part of disease management, especially after a 
heart attack. When patients leave the hospital it might be necessary to access cardiovascular 
function remotely in some cases. Blood pressure monitoring of hypertensive patients is a 
crucial part of the treatment. Risk stratification is another major reason of preventive 
cardiovascular assessment. Evaluation of heart rate variability has been proven to help with 
prognosis for low vagal tone and diagnostic of lethal arrhythmias. Cardiac autonomic tests 
such as Valsalva Maneuver, Cold Face Test, Tilt-Table Test or Deep Breath Test offer means 
to trigger reflex arcs with a cardiovascular response reflected in cardiac signals (see Chapter 
3). Physicians and researchers usually extract time-frequency parameters which could 
provide emerging physiological properties of the subject. Despite of diverse evaluation 
methods of tests there is a growing need for a framework for tests management, signal 
processing and parameters estimation which could be applied to families of tests.  
The goal of this project is to realize a web-based telemedicine platform allowing 
cardiovascular signal uploading and remote assessment of cardiac function. Methods for 
cardiovascular signal acquisition, storage, processing, and evaluation should be 
implemented. Results should include a web-based software package for managing patients, 
experiments and signals. Additionally features for simulation and statistical evaluation can 
be provided. The software should provide means for manually uploading e.g. an 
Electrocardiogram (ECG) signal using a web interface and automatically analyzing the signals 
in order to extract time-frequency parameters. An important feature of the software is to 
include messaging tools. Patients can share ECG signals, links, photos, videos, status 
messages and comments with other patients or physicians. This work should make use of 
available open-source software components for signal processing, modeling and simulation. 
Conversation tools and features for social networks should be included, such as Emails and 
Forums.  
We will present the work products in the next sections following Software Engineering 
guidelines [78]. The requirements analysis phase consisted of gathering requirements for the 
software to be developed and investigating what the system should ideally do. We retrieved 
functional, access, security, performance and other relevant requirements in a requirements 
document. In the system design phase, we proposed system architecture for more flexibility 
and better user experience. In the implementation phase code was developed, a 
deployment infrastructure was chosen and a prototype of the software was finalized. 
 5.2.2 Requirements Analysis 
 
Figure 5.9 Use cases for Telemedicine Platform 
As depicted in the UML Use Cases Diagram in Figure 5.9, the software should offer a set 
of functionalities to 1) manage patients, test suites, test cases, physiological components 
and processes; 2) manage cardiovascular signals and other patient files; 3) perform statistical 
evaluation; 4) simulate mathematical models of cardiovascular control and estimate cardiac 
parameters 5) discuss with doctors and other patients using forums and social networks.  
The use case Manage Patients provides the doctor with features to view, update, add or 
delete data of patients which are assigned to him. Each patient can choose one or several 
doctor who can have access to private files in the user case Manage Own Doctors.  
In the use case Manage Test Suites, doctor is able to define a test suite and assign it to a 
patient. The patient can also create own test suites and choose which doctor will have 
access to its data. A test suite is a set of test cases aiming to diagnose particular disease 
stages, e.g a battery of cardiac autonomic tests including Valsalva maneuver, active standing 
and deep breath test might be used to diagnose autonomic neuropathy in diabetes. 
In the use case Manage Signals the doctor or patient can upload measurements 
performed during a test case.  The system automatically extracts relevant information, e.g. 
RR interval durations are extracted from a raw Electrocardiogram (ECG) signal. The doctor 
can compute statistical parameters (e.g. mean heart rate) in the use case Perform Statistical 
Evaluation. User can also upload other files than signal files, such as scanned images of a 
paper ECG or print outs of an echocardiogram in the use case Manage User Files. 
When performing autonomic tests, the measured cardiac signals are usually used to 
determine hidden cardiac parameters, such as sympathetic tone, parasympathetic tone or 
ventricle contractility. The system includes mathematical models for given cardiac 
autonomic tests, which can be used by the doctor to estimate the values of cardiac 
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 parameters in the use cases Perform Simulation Tasks and Manage Cardiac Parameters. 
Doctor can analyse both cardiac parameters and statistical parameters in order to make a 
diagnostic and assign a disease or disease stage to the patient in the use case Assign Disease 
to Patient. Disease information can be managed by doctors in the user case Manage 
Diseases. A disease is characterized by some properties such as symptoms, clinical signs, 
causes, prognoses features and management. 
In the Telemedicine social network a conversation is a stream of text, images, audio files, 
but also signal files, cardiac parameters, statistical parameters. Within a conversation 
System offers shortcuts for the user to upload new signals or other objects. System displays 
a step by step wizard, where user can select existing test suites/test case or create new 
ones, enter signal attributes, upload signal file, and choose doctors who should have access 
to the files. The user can also insert existing objects to a conversation. System displays 
snapshots of conversation objects such as images and signals using thumbnails. When the 
user clicks on the object, System offers a detailed view of the object, e.g. using a signal 
viewer applet. Furthermore doctors have shortcuts for performing statistical evaluation, 
cardiac parameters estimation and disease assignment. These are all features available in 
the use cases Communicate and Manage Social Networks. Guest users can only make use of 
the Forum. 
5.2.3 Software Design 
In order to fulfill the requirements elicited in section 5.2.2 the system has been designed 
in a modular way using three-tier architecture (Figure 5.10). The GUI components are 
grouped in a Client Tier that presents an interactive and mostly web-based user interface 
and relays user requests to a remote Application Tier, where the processing logic is 
implemented.  The application tier is built on the top of existing software grouped together 
in the External Software Package Tier. Our system benefits from its interface to the Systems 
Biology Toolbox 2 [170] in order to estimate values of the cardiovascular model parameters 
and evaluate their sensitivity in the Matlab environment. It makes use of the WaveForm 
DataBase software package from the Physionet project [190] for signals processing. Signals 
are visualized using the open-source JFreeChart API2[191]. 
 
Figure 5.10 System Architecture of the Telemedicine Platform 
 
Persistent application objects are stored in a relational database with structure depicted 
in Figure 5.11 as UML Class Diagram. A Test Suite is a set of Test Cases, each having 
components to be tested, a description of the dynamic of these components, measured 
cardiac signals, evaluated statistical parameters and simulated cardiac parameters. The 
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 components to be tested are physiological cardiac components that can be tissues (e.g. 
sinoatrial node), organs (e.g. heart), single neurons (e.g. ophthalmic trigeminal 
thermoreceptors) or autonomic nervous centers (e.g. medulla). The Test Dynamic describes 
the messages passed between physiological components during an autonomic test. For 
example during the orthostatic stress test the baroreceptors send a message (decreased 
blood pressure) to the vasomotor center, which sends a message (increased sympathetic 
tonus) to the sinoatrial node.  
 
Figure 5.11 UML class diagram of the Telemedicine platform 
 
Implemented mathematical models of cardiovascular control are stored in the Computer 
Model entity of the database. They are used to fit the measured data and estimate model 
parameters, which are further stored in the Cardiac Parameter entity. The Statistical 
Parameter entity stores results of statistical evaluation performed using Basic Statistical 
Functions or Plug-Ins, which are external pieces of software uploaded by the user to perform 
special statistical tasks. 
Cardiac signal data are managed in three layers. In the Raw Signal Layer, signal data are 
represented as time series of real numbers with properties such as name, sampling 
frequency, data unit and signal type (e.g. electrocardiogram, impedance cardiogram, blood 
pressure, galvanic skin response, skin temperature or respiration rate). A signal has a data 
matrix, with the first row showing the timestamps in seconds and the second row showing 
the signal values. It also has an events matrix, first row showing the timestamps and second 
row showing the events text (e.g. ‘cold compress applied to the forehead during the cold 
face test’). The Parameterized Signal Layer provides tools to extract information from raw 
signals. For example RR interval durations are extracted from the ECG signal; Left Ventricular 
Ejection Times are extracted from the impedance cardiogram signal. In the Statistical Signal 
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 Layer, statistical calculations are performed on the parameterized signals using statistical 
functions and formulas. Signal data can be exported or imported in the ASCII format. 
5.2.4 Implementation 
Our software package is object-oriented and developed in PHP, Java, C, SQL and Matlab 
programming environments. It delivers a powerful web based interface with a set of 
portable HTML pages and Java-Scripts. The main menu for patients management is depicted 
in Figure 5.12. Doctors can log in; define some autonomic tests (see Figure 5.13 and Figure 
5.14); process and evaluate measured signals; and establish diagnosis; all this from their 
Internet browser without additional software. The database is initialized with diseases 
information selected from the Oxford handbook of cardiology [192], see Figure 5.15. 
The Web-based user interface relays user requests to an Ubuntu 8.10 Linux Server 
including an Apache 2.2 web server and a PHP 5 engine, where the processing logic for 
patients and test cases management is implemented. A special PHP module makes use of 
command-line tools from the Wave Form DataBase (WFDB) library for signal processing. The 
system can be easily extended with additional signal processing tools. Signals are visualized 
with a WebStart Java applet, making use of the JFreeChart API and running on the client’s 
browser (see Figure 5.16). 
 
 
Figure 5.12 Telemedicine platform - menu for patients management 
  
Figure 5.13 Telemedicine platform - menu for test suites management 
 
Figure 5.14 Telemedicine platform - menu for test cases management 
 
Figure 5.15 Telemedecine platform - disease database 
 
  
Figure 5.16 Telemedicine platform – signals visualization 
A special PHP module implements features for statistical evaluation. Statistical parameters 
are stored as formulas containing the statistical function used; as well as the time range of 
the signal to which it applies. Basic statistical functions are functions which are available in 
PHP (e.g. min, max, mean, standard deviation, variance, and covariance). Support for plug-
ins is also enabled. These are statistical functions, which are not available in our system, but 
the user can implement and upload executables to the system in order to perform special 
statistical calculation, such as total spectral power of a heart rate signal. A parser has been 
implemented using the PHP Tokenizer, in order to parse and evaluate statistical formulas 
such as (longest R-R interval) / (shortest R-R interval) for the Valsalva ratio, or mean[1:60] 
for the mean of signal values from the 1st to the 60th second. The corresponding screenshot 
is given in Figure 5.17. 
 
Figure 5.17 Telemedicine platform - statistical evaluation 
Data are stored in a MySQL 5 database server running on the same server as the web 
server for fast data access. Signal data are stored in the database, however big signals are 
automatically stored on a FTP server. A special PHP module streams the signal file and makes 
its storage type transparent to the rest of the system. 
Mathematical models are stored in the database or on the FTP server. Systems Biology 
Toolbox 2 models are small text files which are stored in the database directly. Simulink 
models, Matlab M-files, Systems Biology Toolbox 2 projects are stored on the FTP server. We 
implemented a special Matlab bridge (see Figure 5.18) to download or upload models from 
or to the FTP server. The Matlab bridge makes also use of the Matlab Database Toolbox to 
 connect to the MySQL server and process patient data and signals for parameters estimation 
tasks (see Figure 5.19). 
 
Figure 5.18 Telemedicine platform - Matlab bridge GUI 
 
Figure 5.19 Telemedicine plattform - parameters estimation GUI 
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5.3 A Portable Biofeedback Device for Autonomic Tone Assessment 
5.3.1 Background 
Several devices have appeared on the market to train body's natural relaxation response 
against stress, chronic pain, depression, anxiety or asthma. They usually measure finger 
pulse, galvanic skin response or skin temperature and display the measured signal on a small 
display. For example the StressEraser3 is a device that measures real-time beat-to-beat heart 
rate via an infrared finger photoplethysmograph sensor. It breaks the heart rate signal into 
waves and analyzes the amplitude and smoothness of each wave in order to estimate 
respiratory sinus arrhythmias. The StressEraser is proprietary, rather expensive and does not 
provide a programmable interface. Other existing devices include simple signal processing 
software for band pass filtering and features extraction. Although they offer interesting 
services for remote assessment of cardiovascular function; they are not yet per default 
shipped with integrated software for modeling and simulation. Some attempts have been 
made by systems such as the Task Force Monitor4  which offers continuous blood pressure , 
electrocardiogram and impedance cardiogram measurement together with a computer 
station for performing signals analysis and heart rate variability all-in-one. Such systems are 
being included in the clinical practice to a higher extend but they are expensive and rather 
inaccessible for mobile users. Mobility has become an important requirement for high 
quality medical care. The concept is being applied for monitoring elderly including fall risk 
assessment, breathing and pulse monitors. In sport mobile devices measure the 
effectiveness of the heart as a pump compared to the exercise load, thus giving a feedback 
on the next level of training. Ambulatory services benefit more and more from mobile 
devices, easy to wear, which can give adhoc information on the cardiovascular state of the 
patient. Telemedicine is offered by private clinics together with some private health 
insurances, the target group being patients with chronic heart diseases, highly mobile 
patients such as business travelers, who want to be coupled with their doctors back home. 
These services are highly professional but very expensive and demand a complex network of 
infrastructure.  
Our goal is to develop solutions for intelligent multi-purpose configurable portable 
devices for continuous biofeedback and assessment of cardiovascular function. This includes 
a series of mobile hardware devices with embedded software for cardiovascular signal 
acquisition and local evaluation using biofeedback techniques. The devices should have 
common interfaces for low-cost sensors plug-and-play. For example an infrared sensor might 
provide finger pulse measurement into a microprocessor unit. An embedded mathematical 
model fits the heart rate and estimates the level auf autonomic tone continuously. The level 
is displayed by a led system or a digital display in a three-color scale (red, orange, green). 
User groups spam from mobile patients requiring continuous monitoring by private 
doctors, e.g. diabetic, hypertension patients; to elderly requiring continuous monitoring by 
doctors and family members. Athletes requiring mobile performance evaluation, monitoring 
of resting heart rate, exercise recovery time, sympathetic activation time, and 
parasympathetic recovery time also belong to the target group. Subjects, psychotherapists, 
physiotherapists requiring holistic therapy, stress management, psychological self-therapy, 
self-perception of biological signals can find some usage of these solutions. Furthermore 
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 subjects under diet or fitness program who needs calorie and cardiac health control; fat cells 
estimator; energy consumption balance are also part of the target group.  
5.3.2 Requirements analysis 
 
Figure 5.20 Use cases diagram for biofeedback solution 
The Biofeedback solution should be designed to fulfill the requirements of mobility, 
portability, low cost, efficiency, and usability as depicted in Figure 5.20. The device should be 
as small as a mobile phone with interfaces for USB, Wifi, infrared or Bluetooth sensors plug-
ins. Light-weight sensors for pulse, skin temperature, electromyography, galvanic skin 
response measurement should be designed for providing cardiovascular information in the 
user case Perform Measurements. The device should have a built-in digital display for 
providing feedback to the user in an understandable format.  The portable device needs an 
operating system which interfaces with the underlying hardware and offers means to access 
the sensors, the memory, the processor and the display in the use case Call Operating 
System Commands.  
An API should be developed on the top of the operating system to enable customized 
software units for modeling and simulation in the use case Perform Modeling and 
Simulation. The device should make use of the model of cardiovascular control proposed in 
Chapter 2 making it portable, small and efficient enough to run on smaller hardware 
environments. Portable environment such as mobile phones, personal data assistants have 
limitations in processing capabilities, working memory and display interface. Running a 
complex cardiovascular model might be more than challenging. Modeling and simulation is a 
resource consuming task demanding high processing capacity and memory. Paradigms for 
embedded software development for modeling and simulation purposes should be 
investigated. Efficient algorithm should be developed for differential equations solving in a 
light processing environment in the use case Run Embedded Model Solver. The solver will be 
embedded in a mobile device with limited CPU and RAM, therefore should be optimized to 
run in real-time and provide continuous results for a continuous input. 
Mathematical models of cardiovascular control are usually resolved in computational 
environments such as Matlab using built-in functions. Since our devices will have their own 
model solvers we need to define a language for writing models that can be read by the 
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 solver. The constructs of such a language should be defined to support the translation of 
mathematical formulas into computer-like instructions. A parser and interpreter for the 
language should be realized and load into the operating system environment of the device in 
the use case Simulate Model. 
A communication module should be developed on the top of the operating system to 
interface the mobile device with the telemedicine platforms presented in section 5.2 via the 
internet for updates, user profiling, cardiovascular signals download in the use case 
Download Data from Telemedicine Platform. The module should provide means for 
automatically uploading signals from the device to the server for evaluation by doctors in the 
use case Upload Data to Telemedicine Platform. Doctors can also push configuration 
elements towards the device to set up some parameters and influence signals measurement 
in the use case Push Data to Telemedicine Platform. Doctors can also push messages or 
signals to the patient via this channel. 
5.3.3 Design of the Biofeedback Solution 
 
Figure 5.21 Architecture of the biofeedback solution 
As depicted in Figure 5.21 the system is designed as three components including 
Biomedical Sensors, a Mobile Device and the Telemedicine Platform. A Temperature Sensor 
provides sensory information about skin temperature, while a Pulse Sensor provides a signal 
describing the pulse waveform at finger level. Both information are processed in a 
Microcontroller and converted by an I/O Adapter into a ready-to-use format. The Mobile 
Device component implements a higher processing logic for signal processing, simulation 
and remote communication. Such features are realized by a Biofeedback Application that 
makes used of an Application Programming Interface offered by the mobile device to call 
commands of the Mobile Operating System. This later component controls hardware 
components such as input ports from the Biomedical Sensors, keyboard and display for user 
interaction. The Biofeedback Application also acts as client and communicates with the 
remote Telemedicine Platform using a network technology. The Telemedicine Platform has 
been described in section 5.2 and is augmented with a Telemedicine Biofeedback Bridge for 
pushing information to the mobile device or downloading information which is further saved 
in the Telemedicine Database System. 
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 5.3.4 Realization of the Biofeedback Solution
We chose to build own sensors and
Interface Controller (ooPic) which is a Microchip PIC microcontroller
programmable in Object Oriented Basic, C, or Java programming languages.
A feedback thermometer detects skin temperature with a 
taped to a finger and connected to a
works following the principle that, when two wires with dissimilar metals are joined and one 
of the ends is heated, there is a continuous current that flows i
the circuit is read and the temperature is derived using an algorithm programmed in the 
ooPic controller. 
A Led emitting infrared light 
connected to the ooPIC-R board vi
whose resistance changes depending on
the circuit is measured and the corresponding finger pulse peaks are approximated in the ooPic 
controller. 
ooPic program for controlling the thermocouple, infrared Led and photoresistor uses 
objects from the ooPic library. 
I/O lines to control the brightness of the LED in order to illuminate the skin. The oA2D10 
object is used to read the voltage on the input lines corresponding to the 
photoresistor with a 10-Bit resolution. 
serial I/O port with a 4-byte buffer
information to the RS232 lines. An adapter is used to convert RS232 serial signals to USB. 
The ooPic board is connected to a mobile phone via USB. We chose the Nokia E51 model
because it is programmable, low cost and offers high performances. 
available for user applications and can be extended 
MiniUSB v2.0 slot for transferring data and supports various types
including GPRS, EDGE, UMTS and HSDPA.
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Nokia E51 runs on the Symbian 9.2 operating system with Series 60 3rd Edition user 
interface. Symbian is the most popular open source operating system designed for mobile 
devices and the so-called smart phones 7. We use its subsystems responsible for networking 
via sockets and serial communication via USB in order to access the ooPic sensors. Symbian 
also offers a Java Micro Edition virtual machine and a software development kit or 
application programming interface, on the top of which we develop the biofeedback 
application.   
The biofeedback application includes a Java-based simulation system, called JSim8, for 
building quantitative numeric models and analyzing them with respect to experimental 
reference data. JSim has built-in numeric solvers for solving ordinary differential equations, 
linear and non-linear equations as those specified in our model in Chapter 2. 
                                                      
7
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Chapter 6. Conclusion 
6.1 Methodology 
The model developed in this thesis quantifies autonomic nervous system’s influence on 
the cardiovascular system.  
It has become common to use heart rate variability, blood pressure variability or 
baroreflex sensitivity as measure of autonomic activity. Parametric transfer functions and 
plasma concentration of cardiac neurotransmitters are complementary methods 
encountered. After an extensive study of such existing approaches and using data available 
in the literature we came to the conclusion that they do not adequately capture the 
nonlinear character of vagal and sympathetic neural outflow. Conventional mathematical 
models based on control theory are gaining more attention since they solve certain 
limitations of signal-based methods for assessing cardiovascular control. Most of them 
however picture a reciprocal control of cardiac vagal and sympathetic nervous activity, as 
seen during a baroreflex. Many other reflexes however involve simultaneous co-activation of 
both autonomic efferent branches. Furthermore current mathematical models lack to 
integrate cardiovascular reflexes across their many levels of organization and therefore they 
miss to exhibit emerging properties of the regulatory processes. 
In contrast to current trends we adopted an integrative approach first by covering single 
levels of cardiovascular neural pathways from receptors to effectors, then merging the 
information at a system level in order to integrate emerging properties such as resting 
sympathetic and parasympathetic tone. This methodology allowed us to combine the 
interaction between baroreflex and diving reflex, Mayer waves and tonic activity of 
sympathetic premotor pacemaker neurons, respiration and heart rate variability, etc. Thus 
we simulated a working control system with diverse feedback and feedforward loops 
interfering with each other. This integrative approach is key to understand paradoxal 
phenomenon such as vagally-mediated tachycardia and fluctuation of sinoatrial rhythms on 
denervated heart. 
Our integrative model of cardiovascular control would have remained just a theoretical 
tool if it would have not been validated against experimental data. Ideal circumstances 
(noiseless measurements gathered for an infinite amount of time) and excellent model 
fitting demand an excellent experimental setup. We carefully planned experiments over 
different times of the year and different geographical places. We included subjects of 
different race, age and gender in our studies since physiological behavior can be correlated 
to these factors. Noninvasive cardiovascular provocative maneuvers were induced with 
simple mechanical stimuli such as tilt table; or physical stimuli such cold or mental stimuli 
such as stress. Thus we created a fixed set of conditions where the same subject might show 
different cardiovascular behaviors. Devices for signals recording were chosen for optimizing 
the quality of raw data. For effectively processing the signals we developed algorithms and a 
software application that was able to deal with the huge amount of data, to extract signal 
parameters, perform statistical evaluation and generate plots automatically.  
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6.2 Achieved Results 
Newton implementation of the nonlinear least square method and the downhill simplex 
method resolve our optimization task and calculation of parameter data.  
Simulating output variable performances have shown a good fit with experimental data, 
for example the model could simulate heart rate change upon arterial pressure drop after 
standing. Low frequency fluctuations in arterial blood pressure were also simulated 
successfully. This supports the hypothesis that Mayer waves also result from a rhythmic 
sympathetic discharge of pacemaker-like sympathetic premotor neurons in the vasomotor 
brain centers. Simulation results also support the fact that vagally-mediated tachycardia, 
observed during the diving reflex on certain subjects could be related to the secretion of 
vasoactive neurotransmitters at the effector site by the vagal nerve. The model was also able 
to simulate variables which are normally not measurable, like discharge frequency of 
barareceptors, premotor neurons, efferent sympathetic nerves, efferent vagal nerve, 
ventricle elastance. Several values agree with those reported from in-vitro experiments on 
animals after a simple conversion based on weight differences. 
We identified model parameters for estimating the resting tone of efferent sympathetic 
and vagal nerves. Results show higher parasympathetic tone on young subjects with a 
decreasing trend with increasing age. This agrees with the data from heart rate variability 
studies. Furthermore parasympathetic tone appears to dynamically change during vagal 
maneuvers with cold stimuli applied to the forehead, the so-called diving reflex. Finally 
parasympathetic tone turned out to be a major factor determining resting heart rate 
whereas sympathetic tone largely affectes the baseline QT interval duration. The tonic 
sympathetic activity was found to provide from pacemaker premotor neurons, but also from 
activation of chemoreceptors to a lesser extent. 
Respiratory sinus arrhythmias appeared to be controlled by vagal inhibition during 
inspiration, but also from intracardiac fluctuations which are not neurally mediated. Results 
show a similar trend with aging as with parasympathetic tone. Although a more rapid decay 
of respiratory modulation of heart rate is observed with aging.  There was a predominant 
respiratory sinus arrhythmia on black subjects compared to white subjects. Simulation 
results also show elevated intracardiac fluctuations on young subjects. 
After normalizing the sympathetic and parasympathetic levels in the range 0 to 1, we 
could define model-based estimates for mean, total, minimal, maximal autonomic level, and 
for autonomic balance. These estimates were used in each phase of the Valsalva Maneuver 
and results suggest that mean parasympathetic tone might be used as a quantitative marker 
of parasympathetic activity. It might serve as a better alternative to the square root of the 
mean squared differences of successive NN intervals from heart rate variability. The 
autonomic balance estimate shows a stronger correlation with the standard deviation of NN 
intervals, independence of the length of recording, and thus a good candidate for overall 
heart rate variability. 
We developed a software package as prototype for clinical applications of our results. It 
includes a telemedicine platform that connects doctors with remote patients, since 
monitoring patients is a very important part of disease management, especially after a heart 
attack. It allows to access cardiovascular function remotely. The software offers features for 
signal storage and processing so that patients can measure basic cardiovascular signals such 
as heart rate and blood pressure and upload to the server. The doctor is provided with 
statistical features, modeling and simulation tools to estimate sympathetic, parasympathetic 
tone and additional cardiovascular parameters for emerging physiological and 
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pathophysiological properties of the subject. Patients and doctors can discuss using 
messaging tools, to optimize remote diagnosis. For this purpose signals, links, photos, 
videos, status messages and comments can also be shared with other patients or doctors. 
We also designed a mobile solution including cardiovascular signal acquisition, which 
allows remote consultation and also biofeedback training. For this purpose a low-cost sensor 
provides skin temperature and finger pulse measurements to a microcontroller that is 
connected to a mobile phone. The mobile phone runs an application empowered with 
modeling and simulation capabilities. Patients can upload cardiovascular signals to the 
telemedicine infrastructure which is accessible to doctors, who can push messages or 
configuration items to the patient in order to tune biofeedback therapy. 
6.3 Perspectives 
This work opens several opportunities in the field of modeling cardiovascular control. 
Our mathematical models suggest the design of complementary invasive experiments 
with drugs and direct neural recordings, as well as measurement of neurotransmitter 
concentrations, e.g. norepinephrine spillover in future research works. The data obtained 
would help determining qualitative parameters for the simulation of sympathetic, 
parasympathetic activity in absolute values. We plan to compare the estimated value for 
sympathetic and parasympathetic tones with data obtained from similar neural recordings 
on animals. From such experiments we will develop algorithms for processing action 
potentials and define transfer functions to variables in our model. 
Future research also includes validating the predicted markers of autonomic tones against 
data from experiments with pharmacological sympathetic and parasympathetic blockers. We 
expect the model to return a mean parasympathetic tone equal to zero in the presence of 
atropine and mean sympathetic tone close to zero in the presence of beta blockers. Another 
validation can be made against measurements of muscle sympathetic nerve activity (MSNA). 
The proposed model-based estimates of autonomic activity are closely related to signals 
recorded during the provocative maneuvers such as cold face test or Valsalva maneuver. The 
principles of the method could be extended to other provocative procedures on the 
cardiovascular system.  
Another future work would include an extensive benchmark of our model-based 
estimates with the already commonly used parameters, like frequency-domain parameters 
of heart rate variability such as HF and LF components. Extending the model to study the 
effect of gender, age and health status on the value range of the model-based estimates is 
part of a future research as well. 
A statistical analysis for benchmarking model-derived and experimental data is an 
important milestone. It is necessary to study the reproducibility of our oculocardiac reflex 
tests and Valsalva Maneuver statistically. A statistical analysis on the impact of health, 
background and education on the cardiovascular response to cognitive task is also 
considered as future effort. During experiments with active change of posture, we noticed 
that elderly stand slower than younger subjects. The effect on cardiovascular response 
should be studied in a future modeling effort as well. It is also required to verify whether 
equine experiment with cold stimuli would have brought additional evidences of denser 
innervations of equine ventricles with parasympathetic nerve endings than on human. 
We will put additional effort into our Telemedicine software and our cooperation with 
physicians in order to make it ready for application in hospitals and clinic. The same effort 
applies to the biofeedback device, where it is necessary to miniaturize the sensors. 
Developing complex models of cardiovascular control efficient enough to be executed in real 
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time on a mobile phone is also part of future research. Analyzing residuals and plausibility of 
the parameters estimates as well as evaluation of the variances and correlation of estimates 
using advanced sensibility analysis should help reducing model size. 
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 Appendices 
A1. Equations of the Cardiovascular System Model 
Conservation of Mass at Pulmonary Arteries  
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Balance of Forces at Pulmonary Arteries 
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Conservation of Mass at Pulmonary Peripheral Circulation  
 
1 ( )pp pp pvpa
pp pp
dP P P
F
dt C R
−
= −  (A1.3) 
Conservation of Mass at Pulmonary Veins  
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Conservation of Mass at Systemic Arteries  
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Conservation of Mass at Heart Veins 
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Conservation of Mass at Brain Veins 
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Conservation of Mass at Muscle Veins 
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Conservation of Mass at Splanchnic Veins 
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Conservation of Mass at Extrasplanchnic Veins  
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Conservation of Mass at Left Atrium 
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Blood flow entering left ventricle  
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Conservation of Mass at left Ventricle 
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Viscous Resistance of Left Ventricle 
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Instantaneous Left Ventricle Pressure 
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Conservation of Mass at Right Atrium 
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Blood flow entering right ventricle  
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Conservation of Mass at Right Ventricle 
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Viscous Resistance of Right Ventricle 
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Instantaneous Right Ventricle Pressure 
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A2. Table of Experimental Subjects and Sessions 
n: unique identifier for the subject 
sex: gender of the subject, F for female, M for male 
age: age of the subject in years 
city: city where the subject lives 
disease: list of diseases presented by the subject on the day of experiments 
session: date when the experiment took place in the format yyyymmdd 
cardiac autonomic tests: abbreviation of tests which the subject undertook 
Table A2.1 Subjects – part 1/3 
n Sex Age Race City Disease Session Cardiac Autonomic Tests 
1 F 26 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
2 F 16 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
3 M 45 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
4 F 50 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
5 M 51 Black Bafoussam Hepatitis B 20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
6 M 54 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
7 F 53 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
8 F 51 Black Bafoussam 
palpitation, cardiac 
insufficiency, gastric ulcer 20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
9 M 52 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
10 M 50 Black Bafoussam Palpitation, gastric ulcer 20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
11 F 49 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
12 F 20 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
13 F 29 White Prague  20090225 CFT 
13 F 29 White Prague  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
14 F 20 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
15 F 70 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
16 F 50 Black Bafoussam hypertension 20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
17 F 34 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
18 F 48 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
18 F 48 Black Bafoussam  20100128 CFT, DBT, MST, VM, CPT, ASS, OCT 
19 M 55 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
20 F 70 Black Bafoussam 
cardiac insufficiency, 
hypertension 20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
21 F 11 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
22 F 41 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
23 M 54 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
24 F 24 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
25 F 47 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
26 F 43 Black Bafoussam palpitation 20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
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Table A2.1 Subjects – part 2/3 
n Sex Age Race City Disease Session Cardiac Autonomic Tests 
27 M 56 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
27 M 56 Black Bafoussam  20100128 CFT, DBT, MST, VM, CPT, ASS, OCT 
28 F 38 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
29 M 38 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
30 F 17 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
31 M 23 Black Yaounde  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
32 F 17 Black Douala  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
32 F 17 Black Douala  20100128 CFT, DBT, MST, VM, CPT, ASS, OCT 
33 F 23 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
34 F 49 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
35 F 29 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
36 M 56 Black Bafoussam  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
37 M 29 Black Prague  20090225 CFT 
37 M 29 Black Prague  20090428 TTT, VM, CPT, OCT 
37 M 29 Black Prague  20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
38 F 42 Black Bafoussam sleep apnea 20100127 CFT, DBT, MST, VM, CPT, ASS, OCT 
39 M 25 White Prague  20090225 CFT 
40 F 27 White Prague  20090225 CFT 
41 M 48 Black Bafoussam diabetes mellitus type I 20090225 CFT 
42 M 26 White Liberec  20090225 CFT 
43 F 25 White Bruxelles  20090225 CFT 
44 F 25 White Prague  20090225 CFT 
45 M 53 White Liberec hypertension 20090225 CFT, CPT 
46 F 55 White Liberec  20090225 CFT, CPT 
47 M 73 White Liberec  20090225 CFT, CPT 
48 F 58 White Liberec  20090225 CFT, CPT 
49 M 82 White Liberec  20090225 CFT, CPT 
50 F 77 White Liberec  20090225 CFT, CPT 
51 F 21 White Kladno  20090428 TTT, VM, CPT, OCT 
51 F 21 White Kladno  20090520 TTT, VM, OCT 
52 M 22 White Kladno  20090428 TTT, VM, CPT, OCT 
53 F 24 White Kladno  20090428 TTT, VM, CPT, OCT 
54 F 20 White Kladno allergies 20090428 TTT, VM, CPT, OCT 
55 F 21 White Kladno hypertension 20090428 TTT, VM, CPT, OCT 
56 M 23 White Kladno aortic stenosis 20090428 TTT, VM, CPT, OCT 
57 M 23 White Kladno  20090428 TTT, VM, CPT, OCT 
57 M 23 White Kladno  20090520 TTT, VM, OCT 
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 Table A2.1 Subjects – part 3/3 
n Sex Age Race City Disease Session Cardiac Autonomic Tests 
58 M 23 White Kladno  20090428 TTT, VM, CPT, OCT 
59 F 22 White Kladno  20090428 TTT, VM, CPT, OCT 
60 F 21 White Kladno multiple sclerosis 20090428 TTT, VM, CPT, OCT 
61 F 21 White Kladno  20090428 TTT, VM, CPT, OCT 
62 M 22 White Kladno  20090428 TTT, VM, CPT, OCT 
63 M 28 White Kladno  20090428 TTT, VM, CPT, OCT 
64 M 23 White Kladno  20090520 TTT, VM, OCT 
65 F 46 White Kladno  20090520 TTT, VM, OCT 
66 F 15 White Kladno  20090520 TTT, VM, OCT 
67 F 23 White Grenoble  20090520 TTT 
68 M 23 White Kladno  20100322 DBT 
69 M 23 White Kladno  20100322 DBT 
70 M 23 Asian Kladno  20100322 DBT 
71 M 23 White Kladno  20100322 DBT, MST 
72 M 23 White Kladno  20100322 DBT, MST 
 
 List of Abbreviations 
ANS autonomic nervous system 
SA node sinoatrial node 
AV node atrioventricular node 
MSNA muscle sympathetic nerve activity 
RSA respiratory sinus arrhythmias 
ACh acetylcholine 
HR heart rate 
QT qt interval 
BP blood pressure 
MAP mea arterial blood pressure 
PP pulse pressure 
PPT pulse travel time 
PA pulse amplitude 
PTT pulse transit time 
GSR galvanic skin response 
SCL skin conductance level 
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HRV heart rate variability 
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CV coefficient of variation of the NN intervals 
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FFT fast fourier transform 
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CFT cold face test 
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DBT deep breath test 
MST mental stress test 
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